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ABSTRACT 
 
Rationale 
Retailers use segmentation methods to identify groups of distinct and homogeneous 
customers, tailoring their products and services to these groups. In healthcare, patient-
centred integrated care also aims to design care models around the patient, but the use of 
data to support this is limited. Data-driven segmentation could be used to identify patients 
with similar care needs, who might benefit from integrated care initiatives. 
 
Aim 
To define the potential role of data-driven population segmentation in designing patient-
centred integrated care.  
 
Methods 
Existing applications of segmentation in healthcare were explored through literature, case 
study and systematic reviews. Segmentation analyses were performed on a 300,000-patient 
database, containing primary and secondary care data. Methods included k-means cluster 
analysis, regression analysis, artificial neural networks and decision trees, in addition to 
descriptive and statistical analyses. 
 
Results 
Several integrated care programmes apply segmentation, but their use of data-driven 
methods is limited. Nevertheless, there exist many healthcare studies that used cluster 
analysis to segment patient populations. Segmenting a whole population resulted in eight 
distinct care user segments, providing an evidence base for population health. Segmenting 
the subpopulation of patients with ACSC hospitalisations identified four different care 
utilisation patterns, each requiring different preventive interventions. Risk stratification is a 
segmentation method in itself, but descriptive segmentation can help to identify different 
groups within the high-risk population. Where no patient-level data is available, an a priori rule 
can be used to identify high-needs patients. 
 
Conclusion 
Data-driven segmentation can play an important role in designing patient-centred integrated 
care. It can be used to describe different patient groups within a population, a subpopulation, 
or a high-risk population, and design integrated care interventions around the needs of each 
segment. It can also be used to predict which patients are in the target group for integrated 
care initiatives.
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CHAPTER 1: INTRODUCTION 
 
The thesis explores the role of data-driven segmentation in designing patient-centred 
integrated care. This chapter aims to define this topic by describing what segmentation is, 
what patient-centred integrated care is, and how the two relate. It then presents the aim, 
objectives and structure of this thesis. 
 
The results of the Delphi study described in this chapter have been published on the Health 
Affairs blog: Vuik S, Siegel S, Darzi A. How Should We Measure The Distribution Of Health In 
A Population? Health Affairs Blog [Internet] 2017. Available from: 
http://healthaffairs.org/blog/2017/03/17/how-should-we-measure-the-distribution-of-health-in-
a-population/. 
 
 
1.1 INTRODUCTION TO SEGMENTATION 
1.1.1 What is segmentation? 
Customer or market segmentation has been used for decades by companies to tailor their 
services and products to the customer’s needs, preferences and characteristics.
1, 2
 Rather 
than producing one product, sold in one type of store, following one set of service guidelines, 
the offering is differentiated for specific groups of customers. The creation of these groups of 
customers with similar needs or other characteristics is customer segmentation. As Tsiptsis 
and Chorianopoulos have defined it
3
: 
 
“Segmentation is the process of dividing the customer base into distinct and internally 
homogeneous groups in order to develop differentiated marketing strategies 
according to their characteristics” 
 
1.1.2 Why use segmentation? 
In healthcare, studies often rely on averages to describe a certain outcome. Metrics such as 
disease prevalence, care utilisation and mortality are generally expressed as rates or 
percentages across the entire population. When an outcome is normally distributed, this 
average combined with some explanation of the variance can give an accurate representation 
of the reality (see scenario A in Figure 1). However, when there are different groups in a 
population with different outcomes, a single average may not explain much. Scenario B in 
Figure 1 has the same mean and standard deviation as scenario A, but the distribution in the 
population is very different. The average of 5.3 GP visits does little to describe the actual 
situation, where patients are more likely to have either 3 or 7 visits. 
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Figure 1: Illustrative example of using average values to describe populations 
 
 
There are many reasons why a health outcome would not be uniformly distributed in a 
population. Factors such as socio-economic status, age, morbidities, geography and access 
to care - which influence health status and are themselves not uniformly distributed - create 
distinct population groups with different health outcomes. For any policy, care model or 
intervention aiming to address health outcomes, it is important to understand these 
distributions.
4
 Targeting and tailoring interventions to different population segments allows 
resources to be used efficiently and effectively. 
 
Population segmentation becomes even more important when multiple outcomes are being 
considered at the same time. Figure 2 shows a hypothetical scenario where the health of a 
population is assessed through three different metrics. The population averages do not 
provide information on the distribution of these metrics compared to each other. There could 
be significant overlap, as shown in potential population I, or the outcomes could be largely 
independent, as in potential population II. Segmentation allows health outcomes to be 
reported for different subgroups, providing a more comprehensive overview of population 
health. 
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Figure 2: Hypothetical representation of measuring population health through average values 
and segmentation 
 
 
1.1.3 A priori versus data-driven segmentation 
There are two methods for defining segments
5, 6
: 
 A priori methods define the segments without or before data analysis. The segments 
are determined by researchers, managers or clinicians, based on their experience 
and knowledge. 
 Post hoc or data-driven methods are empirical, and analyse patterns and 
correlations in the data to identify the segments. 
 
A priori segmentation is very common in epidemiology, where results are often reported 
separately for population groups that are known to have different outcomes - for example 
reporting life expectancy by gender. Data-driven segmentation is less common, and requires 
expertise in data mining to identify the patterns. 
 
Consider the example given in scenario B of Figure 1, where there is a need to measure an 
outcome across different population groups. Figure 3 shows the two approaches one could 
take. If researchers have a good idea of what a priori group is causing the difference in 
outcomes, the results can be presented separately for each group. In this hypothetical case, 
segmenting the population by age closely reflects the two different groups that could be 
observed in the overall outcomes. 
 20 
 
Figure 3: Illustrative comparison of a priori and data-driven segmentation 
 
 
However, this is not feasible in situations where the appropriate subgroups are unknown, or 
where multiple factors are in play. Data-driven segmentation divides the population into 
groups of patients with similar outcomes. Afterwards, the data-driven segments can be 
profiled to understand their characteristics. In this case, the first data-driven segment consists 
almost uniquely of under 75-year olds, and the second one of mostly over 75-year olds. 
 
The two approaches are not mutually exclusive and can be applied as hybrid or nested 
methods.
5, 6
 The results of the data-driven analysis could be used to identify the relevant a 
priori groups, which could then be used for segmentation going forward; or data-driven 
segments could be supplemented with a priori groups where there is a practical need to do 
so. 
 
1.1.4 A priori segmentation methods 
A priori population segmentation divides a population based on a characteristic known to 
influence health outcomes. When the outcome is strongly related to a characteristic - for 
example, incidence of cardiovascular disease to age - deciding on a segmentation approach 
is simple. However, for complex issues such as overall population health and integrated care 
this is less straightforward. 
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A priori segmentation is often based on socio-economic status,
7-10
 geography,
7-10
 gender,
7-9
 or 
ethnicity.
7-9, 11
 In addition, population health can be measured across disease or age groups.
9, 
12, 13
 Since risk factors play an important part in determining population health,
14
 they could 
also provide a basis to segment the population. Finally, policymakers may want to consider 
specific societal or clinical groups of relevance, such as school children, prisoners, homeless 
people, disabled people or drug users.
4, 13
 
 
To prioritise these different population groups, a Delphi study was conducted.
15
 The panel 
was composed of 28 healthcare experts (25 responded), who were asked to identify which 
population segments should be considered to measure the distribution of population health. 
While all participants agreed on the importance of measuring population health across 
different groups, there was no consensus on which groups to use. All options were 
considered 'very important' or 'important' by a large majority of participants (see Figure 4). 
This illustrates that a priori segmentation is a useful approach when the relevant groups are 
known or easily identified; but it may not be appropriate when this is not the case. Instead, 
data-driven methods can be used. 
 
Figure 4: Responses from Delphi participants on segmentation approaches 
 
Source: Vuik, Siegel and Darzi
15
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1.1.5 Data driven segmentation methods: Descriptive versus predictive 
In machine learning, there exist two subclasses of methods: supervised and unsupervised 
(see Table 1).
16
 Supervised methods require a training dataset in which a class is specified 
for each object. This data is used to train the algorithm to classify observations. The algorithm 
can then be used on a test dataset where the class has not been specified, to predict the 
most likely classification for each observation. Unsupervised methods do not require class 
label information. They learn from observing patterns in the data, rather than by example. 
They are descriptive, as they describe groups that exist in the data. 
 
Table 1: Comparison of predictive and descriptive methods 
 Predictive Descriptive 
Machine learning approach Supervised Unsupervised 
Learning by ... Example Observation 
Practical application Prediction Description 
Outcome variables Single Multiple 
Example application for segmentation Risk stratification Cluster analysis 
 
For population segmentation, the two methods can be used in different situations. When a 
single outcome exists upon which the segments should be based, predictive methods can be 
applied. An algorithm can be trained to predict the specific outcome for each patient, and a 
population can then be stratified into groups with a similar predicted risk. For example, this 
method can be used by a primary care doctor to determine whether a specific patient is at risk 
of an emergency hospitalisation. Risk prediction methods and their application as a 
segmentation tool will be further explored in chapter 9. 
 
However, integrated care aims to bring together different care settings, and a segmentation 
analysis therefore needs to be able to take into account multiple variables. In this case, 
cluster analysis can be used to find common patterns and combinations of these variables. 
Patients with similar values across the outcome variables are clustered into segments, 
describing the different groups that exist within the population. Descriptive segmentation 
methods will be the focus of this thesis as they are able to consider different care settings at 
the same time. The methods are explored in chapter 5 and the applications are explored 
through cluster analyses in chapters 6, 7 and 8. 
 
The two methods can also be combined. Once the segments have been identified through 
cluster analysis, predictive methods can be used to try and predict patients' membership of a 
certain segment. Predictive methods will be applied to predict membership of descriptive 
clusters in chapter 10. 
 
1.2 INTRODUCTION TO PATIENT-CENTRED INTEGRATED CARE 
Both integrated and patient-centred care are worldwide trends in healthcare. The term 
patient-centred care has been used primarily to contrast with illness- or provider-centred 
 23 
care.
17
 Where historically care services have been organised for specific diseases and 
around clinicians or healthcare organisations, the idea of patient-centred care aims to shift the 
focus to the patient and their complete set of health needs. The term integrated care is less 
clearly defined, and over 175 different concepts and definitions have been identified.
18
 
Integration can mean many things: care can be integrated within a single provider, across 
multiple organisations, across primary and secondary care; or even bringing together health 
and social care.
19
  
 
Whether across wards, provider types, or care settings, by integrating care it can be 
organised around patients' needs instead. Integrated care and patient-centred care are 
therefore closely linked: the integration of care around patients rather than healthcare 
providers or settings allows patient-centred services to be delivered.
20
 In fact, many policy 
initiatives and reports combine the two concepts.
20-23
 For example, the Health and Social 
Care Act of 2012 aims to improve quality of care by ensuring “care is integrated around the 
needs of the patient”
23
. The WHO sees integrated care as a way to “[respond] more 
effectively to people’s needs” by “[allowing] a more holistic approach to health, centred on the 
health needs of individuals and communities”
24
.  
 
Yet while the two terms are closely related, and indeed used interchangeably,
25
 not all 
integrated care is patient-centred. For example, care services can be integrated to improve 
efficiency for the providers, by reducing waste or increasing flexibility.
21
 This type of 
integration does not involve tailoring care around the patient’s needs. 
 
This thesis uses the term ‘integrated care’ to refer to any care delivery system which aims to 
integrate services across traditional settings in healthcare, following the definition described 
by Kodner and Spreeuwenberg
21
:  
 
“[Integrated care] is a coherent set of methods and models on the funding, 
administrative, organisational, service delivery and clinical levels designed to create 
connectivity, alignment and collaboration within and between the cure and care 
sectors.”
21
 
 
This thesis considers patient-centred integrated care a type of integrated care, where the new 
models are formed around patients to address their holistic care needs. 
 
1.3 DATA-DRIVEN SEGMENTATION FOR PATIENT-CENTRED 
INTEGRATED CARE 
Segmentation techniques have been applied for decades in marketing to tailor products and 
services to different customer groups.
3, 26, 27
 They enable companies to better understand 
their customer base, and target their marketing, services and products more accurately. By 
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differentiating their approach for distinct customer groups, these companies have moved from 
product- or brand-focused marketing to a customer-centred approach.
1, 28
 
 
In most Western health systems a similar shift is occurring towards a patient-centred 
approach.
17, 29
 However, it is not feasible to develop tailored policies and care models for 
each individual patient. Instead, care models can be developed around groups of patients 
who have similar needs, and who would benefit from similar models of care.
30
 Segmentation 
methods as applied in marketing could help to define these patient groups and deliver patient-
centred integrated care. 
 
However, the sophistication of population segmentation in healthcare is still limited. Many 
patient-centred integrated care initiatives differentiate their approach based on simple 
characteristics such as chronic conditions or age.
12, 31-34
 While originally segmentation in 
marketing used a similar approach – grouping customers based on basic characteristics like 
product purchased or region – there has been a major shift towards using more advanced 
data mining methods.
2, 28, 35
 
 
Data mining is a discipline that has emerged as a result of the progress in digital data 
capturing and storage.
36
 It can be described as: “The analysis of (often large) observational 
data sets to find unsuspected relationships and to summarize the data in novel ways that are 
both understandable and useful to the data owner”
36
. Companies use their large customer 
datasets for data-driven segmentation, to gain comprehensive insight into their customer 
base.
3
 
 
The same way that data-driven segmentation helps companies design customer-centred 
marketing, applying segmentation techniques to administrative healthcare databases could 
help providers, commissioners and policymakers design patient-centred care (see Table 2). 
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Table 2: Examples of the potential applications of segmentation in marketing and in 
healthcare 
Applications of segmentation in 
customer-centred marketing
3
 
Potential patient-centred care 
analogy 
Understanding your customer base Understanding your patient population  
Developing new products and services 
tailored to a specific segment 
Developing care models that cater for 
patient groups with similar needs or 
preferences 
Redesigning existing services tailored to 
a specific segment 
Redesigning patient pathways for 
specific segments 
Providing tailored incentives to each 
segment 
Creating tailored self-management tools 
depending on patient preferences and 
care needs 
Adjusting the communication and 
advertising message and channel to the 
segment 
Tailoring public health messages to 
different population segments 
Choosing the appropriate sales channel Providing care in different settings for 
different segments 
More effective resource allocation Identify and target the segments with the 
highest needs 
Prioritisation of marketing initiatives Identify and target the segments most 
amenable to healthcare interventions 
 
1.4 AIM 
The aim of this research is to define the potential role of data-driven population 
segmentation in designing patient-centred integrated care.  
 
The audience for this research is policymakers and healthcare professionals engaged in 
innovating the delivery of care. It therefore focuses on existing and accessible methods, and 
the practical implications of the results. 
 
1.5 OBJECTIVES 
To achieve this aim, the following objectives were set: 
 To understand how segmentation is currently being used in integrated care (Chapter 
2) 
 To develop a framework for the applications of segmentation in patient-centred 
integrated care (Chapter 3) 
 To understand how data-driven segmentation methods have been used in healthcare 
(Chapter 4) 
 To identify the quantitative methods and processes required to conduct a data-driven 
segmentation of a patient population (Chapter 5) 
 To explore the application of data-driven segmentation methods in a general 
population, a subpopulation and a high-risk population (Chapters 6, 7 and 8) 
 To understand how risk stratification is being used as a predictive segmentation 
method for integrated care (Chapter 9) 
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 To develop a predictive method to identify patients who might benefit from integrated 
care (Chapter 10) 
 
1.6 STRUCTURE OF THE THESIS 
This thesis consists of three parts. Part one sets the context of segmentation in integrated 
care, part two explores different data-driven segmentation methods, and part three applies 
data-driven segmentation to a patient population (see Figure 5). Following the framework, the 
analyses look at descriptive segmentation - identifying segments within a general population, 
a subpopulation and a high-risk population - and predictive segmentation, in the form of risk 
stratification. The final analysis chapter brings everything together, by developing an a priori 
rule to predict which descriptive segment a patient belongs to. 
 
Figure 5: Structure of this thesis 
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CHAPTER 2: CURRENT APPLICATIONS OF POPULATION 
SEGMENTATION IN INTEGRATED CARE - A CASE STUDY 
ANALYSIS 
 
This chapter provides a narrative overview of how population segmentation is currently being 
used to design and provide integrated care through six international case studies. The case 
studies were analysed to identify the practical considerations associated with using 
segmentation in integrated care. It concludes that while there are examples of integrated care 
initiatives using segmentation, the application of data-driven methods is limited and 
complicated by data availability. 
 
A paper based on this research was published in the journal Health Affairs: 
Vuik SI, Mayer EK, Darzi A. Patient Segmentation Analysis Offers Significant Benefits For 
Integrated Care And Support. Health Aff (Millwood). 2016;35(5):769-75. 
 
 
Parts of the case study information presented here are based on personal communications 
with the relevant organisations: 
 Domingo Orozco-Beltran, Coordinator of Regional Network of Innovation in Public 
Health Management, Region of Valencia – 9
th
 of September 2015  
 Shaun Danielli, Director, Healthy London Partnership, and Patrice Donnelly, 
Programme lead for Urgent and emergency care, Healthy London Partnership – 17
th
 
of September, 2015, follow-up on the 21
st
 of September 
 Claire Naumann, Transformation Manager Integrated Care at Counties Manukau – 
3
rd
 of September, 2015, follow up on the 7
th
 of September 
 
 
2.1 INTRODUCTION 
Across the world, integrated care is considered a way to create effective and efficient health 
systems that are responsive to patients' needs.
18
 Patient-centred integrated care aims to 
break down the traditional structures of healthcare, such hospitals, primary care practices and 
community clinics, to provide care that is integrated around patients and their needs. 
 
To develop patient-centred integrated care models, health systems first need to understand 
the needs of the patients in their population.
37
 Through segmentation, groups of patients with 
similar needs can be identified, around whom tailored delivery systems can be developed.
38
 
Segmentation also allows the identification of high-needs patients who might benefit from 
targeted integration intitiatives.
39
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While many health systems have used segmentation implicitly, for example by developing 
specific programmes for people with a certain disease, an explicit segmentation can help 
guide strategies and programmes. A number of examples exist from around the world where 
integrated care systems have done this.  
 
This chapter explores how population segmentation is currently being used for designing 
patient-centred integrated care. Firstly, a number of international case studies are described. 
Secondly, these case studies are used to explore the practical considerations around using 
segmentation. 
 
2.2 INTERNATIONAL CASE STUDIES OF SEGMENTATION IN 
INTEGRATED CARE 
 
2.2.1 Choose Health Delaware (United States) 
Choose Health Delaware, a body convening the State Department of Health and Social 
Services, academics and industry, was set up to reform care in the state of Delaware.
40
 To 
transform care services across settings and create a patient-centred delivery model, the 
population was segmented a priori according to age and conditions, resulting in 20 descriptive 
segments (see Table 3). This allowed the programme to define specific care priorities for 
various subpopulations, such as ‘improved care coordination’ for patients with multiple 
chronic or mental health conditions, and overall ‘effective diagnosis and treatment’ for people 
with no chronic care needs.  
 
Table 3: Delaware’s State Health Care Innovation Plan segments 
  Age groups  
  
Infants 
Paeds/ 
Adolescents 
Adults Elderly 
Conditions No chronic conditions Segment 1 Segment 2 Segment 3 Segment 4 
 One chronic condition Segment 5 Segment 6 Segment 7 Segment 8 
 Two chronic conditions Segment 9 Segment 10 Segment 11 Segment 12 
 Mild mental health Segment 13 Segment 14 Segment 15 Segment 16 
 Severe mental health Segment 17 Segment 18 Segment 19 Segment 20 
Source: Choose Health Delaware
40
 
 
2.2.2 The London Health Commission (England) 
In their report Better Health for London,
13
 the London Health Commission makes the case for 
the application of segmentation to provide patient-centred, needs-based care for everyone. 
The entire London population was segmented into 15 descriptive patient groups (see Table 
4), around which care should be designed, planned and financed. The model was adapted 
from the Whole Systems Integrated Care (WSIC) project in North West London, which used a 
similar segmentation. The development of the segments followed a hybrid approach. Data 
was used to run a decision tree analysis to determine which characteristics such as 
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morbidities or age groups are significant predictors of cost. This information was then 
discussed with experts and stakeholders to decide on the final segments. 
 
Table 4: The London Health Commission segments 
  Age groups  
  0-12 13-17 18-64 65+ 
Conditions “Mostly” healthy Segment 1 Segment 2 Segment 3 Segment 4 
 One or more long term 
physical or mental 
conditions 
Segment 5 
Segment 6 Segment 7 
 Cancer Segment 8 
 Severe, enduring mental 
illness 
Segment 9 Segment 10 
Segment 11 
 Learning disability Segment 12 
 Severe physical disability Segment 13 
 Advanced dementia, 
Alzheimer’s etc. 
 Segment 14 
 Socially excluded groups Segment 15 
Source: London Health Commission
13
 
 
The Healthy London Partnership was established in May 2015 to deliver on the report, by 
bringing together stakeholders across health and social care into 13 transformation 
programs.
41
 These programs focus on certain segments, such as children, cancer patients, 
people with mental health conditions or homeless people, and work to provide tailored, 
integrated services that meet the segment’s specific needs. 
 
2.2.3 Kaiser Permanente (United States) 
Kaiser Permanente, an integrated care company based in California, has developed a Senior 
Segmentation Algorithm to deliver tailored interventions to older people.
42
 They observed that 
the care needs of older people are variable, ranging from prevention and screening to 
advanced illness and end-of-life care. The Senior Segmentation Algorithm identified four 
groups of older people with distinct needs (see Table 5). The segments were defined a priori, 
based on clinician input.  
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Table 5: Senior Segmentation Algorithm segments 
Segment Clinical indicators Care optimisation 
Robust with 
no chronic 
conditions 
Absence of chronic conditions, obesity, 
HIV/AIDS, depression, major mental health 
issues, substance abuse, TIA, dementia, 
Alzheimer’s, stroke or most lifelong conditions; 
not resident in a nursing facility 
Disease prevention, 
screening and health 
promotion services 
One or more 
chronic 
conditions 
Absence, or less than 5 years duration, of 
dementia or Alzheimer’s; absence of severe 
organ failure, spinal cord disorder, severe 
COPD, stroke, selected cancers; not receiving 
home oxygen therapy or major surgeries or 
procedures  
Disease management 
Advanced 
illness and/or 
end-organ 
failure 
Patients not in any other group Complex case 
management, advanced 
illness coordinated care, 
transitional care, guided 
care, and geriatric 
consultation 
Extreme 
frailty or near 
the end of life 
Presence of end-stage liver disease, liver 
transplant complications, hepatic coma, 
metastatic cancer, acute leukaemia, abnormal 
weight loss in over 85 year olds, combinations 
of dementia, Alzheimer’s and frailty, severe 
dementia; receiving palliative or hospice care, 
home hospital bed or home oxygen therapy 
Home-based care, social 
work outreach, guided 
care, palliative care, and 
hospice care 
Source: Zhou and Wong
42
 
 
The objective of the segmentation was to understand variations in care needs within the older 
population, since “interventions and programs should be tailored and designed to meet the 
distinct needs of patients within care groups”
42
. In addition to supporting population-level 
planning, the Senior Segmentation Algorithm is also being used in clinical practice. In the 
Hawaii region of Kaiser Permanente, patients' electronic health records contain information 
on the segment they have been allocated to. This allows for targeted actions to be taken. For 
example, if patients in the fourth group get hospitalised, they will automatically be 
recommended for a complex care needs evaluation. 
 
2.2.4 Counties Manukau (New Zealand) 
Counties Manukau, a district health board in New Zealand, is integrating care across primary, 
secondary and community care in their System Integration Program.
43
 They use predictive 
segmentation to find At Risk Individuals (ARI) and provide them with personalised care plans 
and coordination services. General practices in Counties Manukau are starting to utilise the 
Combined Predictive Risk Model (CPRM) to stratify their enrolled population. The CPRM 
predicts an individual’s risk of an unplanned hospitalisation in the next six months based on 
data from a large range of sources, including patient registers, primary care consultation data 
and hospital care.
44
  
 
Within the ARI population, the interventions are tailored to different segments. Very high risk 
patients receive intensive case management, including home assessment, care planning and 
implementation, monitoring and review, while high risk patients are assigned a care 
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coordinator and develop a personal care plan with them. Patients may move from one 
segment to the other if their health or personal situation changes. 
 
2.2.5 ValCrònic (Spain) 
ValCrònic is a programme initiated by the Valencian Health Agency in Spain, with the aim of 
improving primary care for patients with chronic conditions and reducing the need for acute 
care in this subpopulation.
45
 It was implemented in 2012 as a pilot covering four health 
centres in Valencia. The allocation of patients to one of sixteen segments (see Table 6) is 
fully automated based on administrative data and shows up in the electronic health record. It 
combines a descriptive, a priori segmentation according to disease profile with a predictive 
data-driven segmentation based on risk of emergency hospitalisation. 
 
Table 6: ValCrònic segments 
  CARS risk score 
  High Medium Low 
Conditions Heart failure Segment 1 Segment 2  
 COPD Segment 3 Segment 4  
 Diabetes  Segment 5 Segment 6 
 Hypertension   Segment 7 
 Heart failure & COPD Segment 8   
 Heart failure & Diabetes Segment 9   
 Diabetes & COPD Segment 10 Segment 11  
 COPD & Hypertension Segment 12 Segment 13  
 Diabetes & Hypertension Segment 14   
 Heart failure & COPD & Diabetes Segment 15 Segment 16  
Source: Bretón
45
 
 
When confirmed by a doctor, the segment allocation triggers a range of highly tailored 
interventions, including nursing visits, planned calls, IT solutions for education, personalised 
alarms and biometric devices.
45, 46
 The programme has been very successful, with 86% of 
patients saying that the programme helped them understand their specific disease better.
47
 In 
addition, a 30% reduction in emergency hospitalisations has been reported.
48
 
 
2.2.6 Virtual wards (England) 
Risk stratification, which allocates people to strata based on their risk of an emergency 
hospitalisation, is widely used in the English NHS to identify patients who might benefit from 
integrated care.
49, 50
 An example of an integrated care programme that uses risk stratification 
is the virtual wards model. 
 
The virtual wards concept uses risk stratification to identify high risk patients and 'admit' them 
to a virtual ward.
51, 52
 This electronic environment functions as a hospital ward without the 
physical building, to improve the coordination and integration between different care 
providers.
53, 54
 The patients on the ward are reviewed by a multidisciplinary team, which may 
include community matrons, district nurses, pharmacists, social workers, physiotherapists, 
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occupational therapists, mental health professionals and representatives from the voluntary 
sector.
51
 The virtual wards programme also offers a shared medical record to be used by all 
providers. 
 
Risk stratification is a central component of the virtual wards programme, as it is used to 
identify the patients who will be admitted to the ward.
54, 55
 In theory any risk prediction tool can 
be used to identify the patients for admission to the ward. Both the Combined Predictive 
Model and the PARR model have been used for this purpose, as well as locally-developed 
algorithms.
53, 54
 
 
2.3 PRACTICAL CONSIDERATIONS OF SEGMENTATION IN 
INTEGRATED CARE 
There are a number of practical issues to consider when applying segmentation, such as data 
requirements, segmentation logic and practical use of the information. This section explores 
these considerations in light of the case studies.   
 
2.3.1 Deciding on a segmentation approach 
The choice of segmentation approach depends on the application of the segmentation. Many 
of the case studies use an a priori approach, focusing on specific conditions or age groups, 
which is often driven by existing programmes or priorities in the organisation. The ValCrònic 
programme focuses on improving care for chronic diseases, and consequently uses a range 
of long-term conditions for their segmentation. The Senior Segmentation Algorithm provides 
an automated way to allocate patients to one of four predefined care groups which each have 
specific disease management strategies.  
 
The alternative is to use a data-driven approach, and define the segments based on analysis 
of patterns in the data. The segmentation for the London Health Commission was adapted 
from the WSIC project in North West London.
12
 WISC used a data-driven approach to 
develop their segments. A purpose-built database was constructed for one of the London 
regions, which linked administrative data from primary, secondary, mental health, community 
and social care settings for approximately 200,000 patients. For each patient, the dataset 
contained information on care utilisation, cost, diagnoses and demographics. A decision tree 
was used to determine which characteristics, such as morbidities or age groups, were 
significant predictors of total cost. This resulted in a long list of potential segmentation factors. 
 
To ensure that the final segments fitted the purpose of the Commission, the characteristic 
identified through the data analysis were reviewed on a number of practical requirements
13
: 
 Patients within a segment had to have broadly similar holistic needs, across physical, 
mental and social care 
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 A patient’s allocation to a segment had to be roughly stable over time, allowing for 
long-term care planning 
 Healthcare professionals had to be able to assign a patient to a segment in dialogue 
and based on good judgement 
 It had to be possible to set financial budgets per segment for the entire group 
 
Besides a priori and data-driven methods, there is also a choice between descriptive and 
predictive methods. Typically, the former is used for strategic, population-level programmes. 
Choose Health Delaware use descriptive segmentation to understand the types of patients 
that exist within the Delaware population and set priorities for the health system. Predictive 
methods are often used at the individual-level as a case-finding tool. Counties Manukau use 
predictive methods to identify patients at risk of an emergency hospitalisation and provide 
them with tailored interventions. However, the methods can also be used in combination. The 
ValCrònic example shows how descriptive segmentation based on chronic conditions was 
used to tailor interventions to disease-specific needs for high-risk patients. 
 
2.3.2 Data for segmentation 
For data-driven segmentation to be used in practice, patient-level data is needed to know 
which patients to allocate to each segment. Importantly, this segment information needs to be 
available to healthcare professionals to enable them to deliver patient-centred care. 
 
In Counties Manukau, the ARI programme uses the CPRM, developed by Greater Auckland 
Integrated Health Network, to stratify the population. The CPRM predicts an individual’s risk 
of an unplanned hospitalisation in the next six months, using data from a large range of 
sources, including patient registers, primary care consultation data and hospital care.
44
 To 
develop the risk algorithm, approval for the creation of a linked dataset was sought and 
obtained from the Auckland Regional Privacy Advisory Group. 
 
However, to use the algorithm in practice requires all primary care providers to have up-to-
date access to a similar dataset. While the case management interventions are already taking 
place, the data governance and IT requirements are still being addressed. Until the risk tool 
becomes universally available, primary care practices are using a set of logic rules to identify 
eligible individuals, based on criteria such as the number of long-term conditions. 
 
The ValCrònic programme uses a shared electronic care record to give both primary and 
secondary care providers access to administrative care data, demographic data, prescribing, 
hospital discharges and activity, and vaccinations.
56
 This information exchange between care 
settings is a crucial enabler for care integration. In addition, the electronic care record is used 
directly for the ValCrònic telemonitoring intervention. It allows patients with chronic conditions 
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to be identified, allocates them to different segments, records the patient-reported 
measurements and monitors outcomes.  
 
The original ValCrònic pilot used the CARS (Community Assessment Risk Screen) score, 
which predicts hospital admission based on three simple criteria: hospital admission in the 
previous 6 months, number of chronic conditions and 5 or more prescriptions.
57
 This method 
has the benefit that it can be easily calculated from basic data in the electronic health record 
at no cost. In 2015 a new stratification method has been validated for the Valencia region: the 
Clinical Risk Groups (CRGs), a more complex methodology developed by the 3M Company.
58
 
Compared to the CARS score it is much more expensive to use, but allows standardisation 
with other health systems using the same method.  
 
In England, the use of risk stratification is fundamental to the virtual wards integrated care 
programme, but poses its own challenges.
54
 Data governance issues inhibit the sharing of 
data across different providers, and therefore the integration of care. While some regions 
have created shared health records, for others it is a major obstacle to the implementation of 
risk stratification. In addition, not all programmes have an online portal.  
 
2.3.3 Developing tailored interventions for the segments 
The aim of segmentation is to develop patient-centred care. By developing different care 
models for each segment, they can be tailored to the segments' specific needs and 
characteristics.  
 
For example, the ValCrònic programme segments the population by condition and risk to 
deliver a highly tailored telemonitoring and education intervention. Patients are grouped 
based on combinations of four long-term conditions: type 2 diabetes, COPD, heart failure and 
hypertension.
46
 Segmenting by condition allows for interventions to be developed for a 
specific disease, including condition-specific education and biometric devices. In addition, 
programs can be adapted to different combinations of diseases, to address important 
multimorbidity issues.  
 
The patient’s risk level determines the intensity of the intervention. Patients in the highest risk 
group are provided with a tablet computer for communicating with their primary care doctor, 
disease-specific biometrical devices, telemonitoring of their biometrics, and education and 
support for self-care.
56
 Patients in the lowest risk level receive communication and education 
through a web portal only.  
 
2.4 DISCUSSION 
Patient-centred integrated care aims to deliver care services that are integrated around the 
patient rather than the structure of the healthcare system. Segmentation methods as applied 
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in marketing could greatly benefit the development of these models by providing insight into 
the different groups and subgroups that exist in a population, as shown through the case 
studies in this chapter.  
 
Segmentation allows policymakers to take a population health perspective and integrate 
prevention, primary care and secondary care in their care planning. As shown by the 
examples of the London Health Commission and Choose Health Delaware, descriptive 
segmentation can support the design of a comprehensive population health strategy that 
addresses the entire population. It ensures that the healthcare needs of all population groups 
are considered, rather than only high-needs patients, and allows stakeholders from various 
care settings to be brought together around specific patient groups. 
 
Segmentation can also be used by individual care providers and doctors as a case finding 
tool, as shown in the ValCrònic, Counties Manukau and virtual ward case studies. However, 
this requires access to technology and training. Advanced risk scoring or segmentation 
software can be costly, and individual providers may not have the required scale to implement 
them. Policymakers could encourage uptake by investing in software research and making 
this available to care providers.
59
 Alternatively, they could follow the example set by Valencia 
and implement a system-wide program. This provides everyone with high quality analytics, 
and standardises the approach across the health system. 
 
The case studies highlight the importance of access to datasets linked at the patient-level, 
which is still limited in many countries.
60
 The example of Counties Manukau shows how data 
governance and technology can complicate the implementation of segmentation-based care 
models in practice. To be able to design integrated care programmes, integrated datasets are 
needed to cover all the relevant care settings.  
 
The examples presented in this chapter illustrate how segmentation is currently being used to 
support the design and delivery of patient-centred integrated care. It shows that many 
programmes rely on a priori segmentation approaches, rather than using data to identify 
patients with similar care needs or other characteristics. Better access to patient-level data 
across care settings is crucial to allow case finding and to develop better segments. As 
healthcare continues to move towards a patient-centred approach, and big data and analytics 
will become even more ingrained, segmentation can be expected to start playing an important 
role in integrated care.  
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CHAPTER 3: POPULATION SEGMENTATION FOR PATIENT-
CENTRED INTEGRATED CARE - A THEORETICAL FRAMEWORK  
 
This chapter outlines a framework for the application of population segmentation in patient-
centred integrated care. It is based on the different population strategies that are used in 
integrated care: whole population, subpopulation and high-risk population. Each of these 
populations can be better understood through descriptive segmentation. In addition, risk 
stratification is a form of predictive segmentation. This framework guides the analyses in 
chapters 6, 7, 8 and 9. 
 
A paper based on this research was published in the journal Health Affairs: 
Vuik SI, Mayer EK, Darzi A. Patient Segmentation Analysis Offers Significant Benefits For 
Integrated Care And Support. Health Aff (Millwood). 2016;35(5):769-75. 
 
 
3.1 INTRODUCTION 
Chapter 2 explored how segmentation has been used in integrated care to deliver patient-
centred care models and interventions. The case studies varied from high-level strategic 
plans to local interventions, highlighting a great diversity in the applications of segmentation. 
This chapter will develop a framework to define this wide range of applications. 
 
The application of segmentation will depend on the population strategy underlying the 
integrated care model. Therefore, this chapter first looks at the different population strategies 
that integrated care models use. This information is then used to develop a framework for the 
application of data-driven segmentation in patient-centred integrated care. 
 
3.2 POPULATION STRATEGIES IN INTEGRATED CARE 
Integrated care models can take many forms.
19, 21
 Besides the degree of integration in terms 
of the type and number of care organisations involved, there is a range of areas within which 
integration can occur: co-localisation of services, transfer agreements, mergers, centralised 
information, care management, joint care planning, inter-agency planning and on-call 
arrangements are just a few examples.
21
 Nevertheless, several research groups have defined 
broad levels of integration. 
 
Leutz identified three levels of integration, reflecting different degrees of cooperation and 
coordination
61
: 
 Full integration occurs when new programmes or models are created that pool 
resources and responsibilities from several systems. Instead of merely coordinating 
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services, the new model holds control of the resources and is fully responsible for 
delivery. 
 Coordination depends on providers working together to provide ongoing care for 
patients in a coordinated manner, through joint planning, information sharing and 
clear accountability. 
 Linkage happens when clinicians are trained to identify the needs of their patients 
beyond their own services, and have ways to interact with other providers to deliver 
coordinated care. 
 
The King’s Fund identified three population strategies for integrated care, which are similar to 
Leutz’ classification
19, 62
: 
 Macro-level integrated care, which provides a full set of services to an entire 
population. These models are more common in the United States, with examples 
such as Kaiser Permanente and the Veterans Health Administration. 
 Meso-level integrated care, which provides integrated care services to a specific 
sub-population. Often this sub-population is defined based on a chronic condition 
(e.g. diabetes, mental health) or age (e.g. older people), allowing specific specialist 
services to be included in the integrated care package. 
 Micro-level integrated care focuses on selected individuals, by providing them with 
care coordination services and focused care. Rather than integrating the entire care 
delivery system, this type of integrated care relies on specific teams to provide 
coordination and deliver additional services. 
 
Valentijn et al. also describe macro-, meso- and micro-levels of care integration, however 
their definitions are slight different as they approach classification from an organisational 
angle rather than a population view
63
: 
 Macro-level system integration, a holistic integration of the entire health system, 
designed to provide patient-centred care. 
 Meso-level organisational and professional integration, focusing on relations 
between care organisations and between clinicians. Through collaboration and 
coordination between organisations and professionals, continuous and 
comprehensive care can be delivered. 
 Micro-level clinical integration, centring around the individual patient and the care 
process, where care services need to be coordinated across professional and 
institutional boundaries. 
 
While the classifications differ slightly, at a high-level they describe three comparable levels of 
integration. Based on these levels, three population strategies can be identified in integrated 
care (see Figure 6). 
 
 38 
Figure 6: Population strategies in integrated care  
 
 
Whole population: While the care settings included may vary, macro integrated care models 
are developed for an entire population. These programmes are system-wide approaches to 
link up different care providers and settings. For example, integrated care organisations such 
as Kaiser Permanente provide an integrated service for their entire covered population. 
 
Subpopulation: Meso-level integration focuses on a specific subpopulation of patients, and 
provides them with integrated services specific to their needs. This may be condition specific 
care, such as COPD or diabetes care, or care services tailored to older people. By integrating 
care for a defined subpopulation, specialist services required by that group can be included in 
the integrated care package. Bundled payments in the Netherlands are an example of meso-
level integration.
32
 These payments are capitated, and intended to cover all disease-specific 
care needed to manage a patient’s condition over a set period of time.  
 
High-risk population: By identifying high-need or high-risk individuals, care integration can 
be provided to those who need it most. Micro-level integrated care does not make systematic 
changes to the way care is provided, but rather integrates on a case-by-case basis by 
providing coordination services and case management. An example is the NHS in England, 
where risk stratification is used in primary care to identify high-needs patients, who are then 
provided with care planning and coordination.
64
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The majority of integrated care programmes in England focus on a subpopulation (see Table 
7). Among the programmes in the Integrated Care Pilots scheme, a two-year initiative started 
in 2009 by the Department of Health,
65
 and in the Integrated Care Pioneers scheme, 
launched by Monitor to identify local best practices,
31
 common subpopulations include older 
people and people with long-term conditions, specifically COPD and dementia. Of the three 
whole population integrated care models, only one specifies a population segmentation 
approach to better understand variations in care needs within the population.  
 
Table 7: Population strategies of selected integrated care models in England 
Organisation Population strategy     Specific groups targeted  
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Barnsley
20, 2
 Subpopulation              I 
Bournemouth & Poole
65
 Subpopulation ✓              
Cambridge Assura
65
 Subpopulation  ✓             
Cheshire
31
 Subpopulation             ✓ II 
Church View, Sunderland
65
 
Subpopulation & 
High-risk population 
   ✓        ✓  
 
Cornwall & the Isles of Scilly
31
 
Subpopulation & 
High-risk population 
   ✓        ✓  
 
North Cornwall
65
 Subpopulation     ✓          
Cumbria
65
 High-risk population            ✓   
Durham Dales
65
 Whole population              I 
Greenwich
31
 
Subpopulation & 
High-risk population 
   ✓        ✓ ✓ 
III 
Islington
31
 Subpopulation    ✓ ✓ ✓     ✓    
Kent
31
 Subpopulation      ✓         
Leeds
31
 Subpopulation    ✓  ✓         
Nene
65
 High-risk population            ✓   
Newquay
65
 Subpopulation ✓              
Norfolk
65
 Subpopulation      ✓         
North West London
12, 31
 Whole population ✓  ✓ ✓ ✓ ✓    ✓    IV 
Northumbria
65
 Subpopulation       ✓        
Principia, Nottinghamshire
65
 
Subpopulation & 
High-risk population 
      ✓     ✓  
 
Southend
31
 Subpopulation    ✓  ✓         
South Devon & Torbay
31
 Subpopulation  ✓     ✓   ✓ ✓  ✓ V 
Staffordshire & Stoke on Trent
31
 Subpopulation  ✓ ✓            
Tameside & Glossop
65
 Subpopulation        ✓       
Torbay
65
 Subpopulation ✓   ✓   ✓ ✓    ✓   
Tower Hamlets
65
 Subpopulation         ✓      
North Tyneside
65
 Subpopulation    ✓           
South Tyneside
31
 High-risk population            ✓   
Wakefield
65
 Subpopulation             ✓ VI 
Waltham Forest, East London & City
31
 High-risk population            ✓   
Worcestershire
31, 66
 Whole population              I 
I. No population explicitly defined  
II. Other: Families with complex needs 
III. Other: People with physical disabilities 
IV. Whole population was segmented, some groups indicated in table 
V. Other: Frequent A&E with alcohol problems 
VI. Other: Substance misusers 
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3.3 A FRAMEWORK FOR POPULATION SEGMENTATION IN PATIENT-
CENTRED INTEGRATED CARE 
As described above, three types of population strategies can be identified for integrated care 
models: whole population, subpopulation or high-risk population. For each of these three 
population strategies, data-driven population segmentation can be used to identify patients 
with similar needs through descriptive segmentation analysis (see Figure 7). In addition, when 
high-risk patients are identified using data-driven risk stratification, this is a form of predictive 
segmentation. 
 
Figure 7: Framework for population segmentation in patient-centred integrated care 
 
 
3.3.1 Segmentation of a whole population 
Macro-level integrated care models include a whole population, from healthy young people to 
older patients with multimorbidity. Understanding differences between these groups, and 
providing patient-centred care fitting their specific needs, is crucial. Segmentation can help 
understand the different patient types in a population and provide a framework to develop 
tailored care plans and interventions. 
 
This type of segmentation was used in the Delaware State and London Health Commission 
case studies in chapter 2.
13, 40
 The Better Health for London report makes the case for the 
application of segmentation to provide patient-centred, needs-based care for everyone, and 
segments the entire London population into 15 patient groups. 
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3.3.2 Segmentation of a subpopulation 
Similar to whole population, segmentation can also help understand differences within a 
subpopulation. While care needs for a specific subgroup, such as older patients or patients 
with diabetes, will not diverge as much as for an entire population, there will still be significant 
variation which is important to understand and address.  
 
The case study on Kaiser Permanente's Senior Segmentation Algorithm described a 
subpopulation segmentation.
42
 They observed that the care needs of older patients are 
variable, ranging from prevention and screening to advanced illness and end-of-life care. The 
Algorithm identifies four groups of older patients with distinct needs, for which tailored policies 
and treatment plans were developed. 
 
3.3.3 Segmentation of a high-risk population 
Risk stratification only provides a one-dimensional view of the population, for example risk of 
an emergency hospitalisation. Within the high-risk group, there may be different types of 
patients with varying risk, needs and characteristics. Further segmenting this population can 
help to understand who the identified high-risk patients are and what care they use across 
different settings.  
 
An example of segmentation of a high-risk population is the ValCrònic programme.
45, 46
 In 
addition to using risk stratification, the risk levels are further segmented by disease profiles. 
This is used to deliver tailored, condition-specific interventions.  
 
3.3.4 Risk stratification 
Integrated care programmes can use data to predict a patient's risk of a certain adverse 
event. When this information is used to stratify the population, this is a form of data-driven 
segmentation. This approach allows policymakers to predict which patients are at highest risk 
of a specific outcome. 
 
In the English NHS, risk stratification is used extensively for a range of micro-level integrated 
care initiatives and programmes.
49
 In most cases, administrative data is used to predict the 
risk of an emergency hospitalisation. Primary care-led case management is then provided to 
high-risk patients to improve coordination and integration with other care settings. 
 
3.4 CONCLUSION 
In each of the three population strategies that exist in integrated care, descriptive 
segmentation can be used to better understand the selected population and tailor care. In the 
case of whole population integrated care, segmentation can be used at a population level to 
plan services and design programmes (whole population segmentation will be further 
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explored in chapter 6). Subpopulation segmentation can be used to develop differentiated 
policies or to design tailored interventions (subpopulation segmentation will be further 
explored in chapter 7). For programmes focusing on high-risk patients, segmentation can be 
used for case finding and tailoring interventions (high-risk population segmentation will be 
further explored in chapter 8). In addition, risk stratification can be seen as a form of 
predictive segmentation (risk stratification will be further explored in chapter 9). 
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CHAPTER 4: SCOPING THE POTENTIAL OF USING DATA-
DRIVEN SEGMENTATION ANALYSIS IN HEALTHCARE - A 
SYSTEMATIC REVIEW 
 
This chapter presents the results of a systematic review that explores the use of data-driven 
segmentation methods in healthcare. It identifies the methods that are used to segment 
patient populations, and describes the applications of such analyses. It shows that data-
driven segmentation is being used in healthcare research, but not often for large 
administrative databases or to develop new care models. It identifies k-means as an efficient 
method for large databases, and hierarchical clustering as a method to identify the optimal 
number of clusters. 
 
 
4.1 INTRODUCTION 
There exist a wide range of data-driven segmentation methods, which all have their benefits 
and limitations. These have been extensively reviewed and described for use in marketing.
3, 5, 
6, 27
 However, segmentation is not a well-established concept in the field of healthcare. Few 
papers exist that explore population segmentation in healthcare and the methods that are 
applicable for this purpose. 
 
Nevertheless, there exist studies that implicitly conduct segmentation analysis, as they use 
clustering methods to better understand patient populations. Reviewing these papers can 
provide insight into the different healthcare topics that can be analysed using segmentation, 
as well as the methods that can be applied to healthcare data. 
 
This chapter explores the potential of using data-driven population segmentation analysis in 
designing patient-centred healthcare. The first objective is to understand in what areas data-
driven segmentation analysis can be used to design patient-centred healthcare, by identifying 
existing population segmentation studies and their applications. The second objective is to 
understand what methods are used for population segmentation analyses. 
 
4.2 METHODS 
A systematic search of the literature was conducted on 1
st
 April 2015, following PRISMA 
guidelines,
67
 to find healthcare segmentation studies. Science Citation Index Expanded (Web 
of Science), MEDLINE, and Scopus were reviewed using the search term ‘(“cluster analysis” 
OR segmentation) AND health AND care AND population’, published since 2000 in the 
English language. The results were supplemented with targeted searches and a review of the 
reference list of each paper, conducted from 1
st
 April until 8
th
 of May 2015. 
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Segmentation was defined as: a systematic effort to allocate an entire patient population to 
multiple, homogeneous groups, based on the patient’s characteristics, for the purpose of 
understanding or influencing these groups as an entity. Therefore, studies were excluded if 
individual patients were allocated to groups on a case-by-case basis rather than 
systematically; a single subgroup was selected from the main population; patients were 
allocated to groups randomly, such as in a randomized trial; or where the patients in a 
segment were subsequently treated or analysed individually rather than as a group.  
 
In addition, this review focused on segmentation analyses that inform healthcare policy or 
services, excluding studies exploring clinical topics such as medical treatment and diagnosis 
methods. Only data-driven segmentation approaches were considered, and segmentation 
studies where the groups were presumed a priori rather than derived through data mining 
were excluded. 
 
Every paper was analysed to identify which country the patient population came from, the 
topic of the research, the methods used and the size of the population. For methods, only the 
techniques used to segment the population were considered, and not those used to prepare 
the data or analyse the segments post-hoc. Factor analysis and Principal Component 
Analysis (PCA) were therefore only included when they informed the patient clusters, and not 
if they were used to reduce the dimensions of the data before applying a different clustering 
method. To create an overview of potential practical applications of population segmentation 
analysis, each paper was reviewed for suggestions on potential uses of their results. 
 
Studies were also classified according to their segmentation base. A population can be 
segmented based on a range of characteristics, such as morbidities, age or care usage. Each 
segmentation base provides a different view of the population and can help answer a specific 
question.
2
 Since no classification was available for segmentation bases in healthcare, two 
marketing models were adapted to the healthcare setting. 
 
Tsiptsis and Chorianopoulos identified six segmentation bases, which could be applied to 
healthcare as described in Table 8.
3
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Table 8: Tsiptsis and Chorianopoulos’ segmentation bases 
Segmentation 
type
3
 
Description
3
 Marketing 
application 
example 
Healthcare 
analogy 
Healthcare 
application 
example 
Value  Segment 
customers 
based on the 
amount they 
spend in store 
Provide special 
customer 
service or 
promotions to 
high spending 
customers 
Segment patients 
based on the total 
cost of their 
healthcare 
Creating 
capitated 
payment 
budgets for 
specific 
segments with 
similar cost 
Behavioural Segment 
customers 
based on their 
behaviour and 
usage pattern 
Develop 
product offers 
tailored to the 
behavioural 
pattern of 
customers 
Segment patients 
based on their 
interactions with 
the healthcare 
system 
Create a care 
model for 
patients 
requiring 
frequent acute 
and primary 
care 
Propensity Segment 
customers 
based on their 
propensity 
towards a 
certain outcome 
Create groups 
of customers 
where cross-
selling is likely 
for the sales 
force to contact 
Segment patients 
based on their 
propensity 
towards an 
adverse outcome 
(e.g. emergency 
hospitalisation, 
readmission) 
Understand 
the patient 
groups at high 
risk of 
readmission to 
tailor 
interventions 
Loyalty Segment 
customers 
based on their 
loyalty to the 
company 
Create groups 
of customers at 
high risk of 
churning to 
target with 
promotions 
aimed at 
extending their 
contract 
Segment patients 
based on the 
provider they visit 
Understand 
which patients 
decide to go to 
hospitals 
outside their 
catchment 
zone 
Socio-
demographic 
and life-stage 
Segment 
customers 
based on 
characteristics 
like age, income 
and marital 
status 
Target new 
families with 
promotions for 
baby supplies 
Segment patients 
based on age or 
conditions 
Provide COPD 
patients with a 
tailored care 
service 
Needs/ 
attitudinal 
Segment 
customers 
based on their 
needs and 
wants 
Build inner-city 
shops that 
meet customer 
needs with 
respect to 
travel time 
Segment patients 
based on their 
healthcare 
attitudes and 
service 
requirements 
Create evening 
clinics for 
patients 
preferring out-
of-hours 
services 
 
Theoretically, all six approaches can be applied to healthcare. The loyalty aspect of this 
framework is less relevant for policymakers in a centralised, public system like the NHS. The 
terms ‘needs’ and ‘behaviours’ would generally be used differently in healthcare, where 
receiving care is more a need than a behaviour, while ‘needs’ as described above could be 
considered attitudes or preferences. 
 
Cooil et al. have defined four segmentation bases (see Table 9).
5
 In this approach, the 
behavioural and activity segmentations overlap for healthcare, as both look at utilisation of 
healthcare services. 
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Table 9: Cooil et al.’s segmentation bases 
Segmentation 
type
5
 
Description
5
 Marketing 
application 
example 
Healthcare 
analogy 
Healthcare 
application 
example 
Value  Segment 
customers 
based on their 
current and 
future 
profitability  
Provide special 
customer service 
or promotions to 
high spending 
customers 
Segment 
patients based 
on their 
current and 
future cost of 
their 
healthcare 
Creating 
targeted 
interventions for 
groups with high 
expected future 
cost 
Behavioural Segment 
customers 
based on their 
behaviour and 
usage pattern 
Develop product 
offers tailored to 
the behavioural 
pattern of 
customers 
Segment 
patients based 
on their 
interactions 
with the 
healthcare 
system 
Create an 
integrated care 
model for 
patients 
requiring 
frequent acute 
and primary care 
Lifestyle Segment 
customers a 
priori based on 
their likelihood 
to buy certain 
products 
Create different 
offers for 
‘gourmets’ and 
‘dieters’ 
Segment 
patients based 
on their 
likelihood to 
require certain 
care 
Create different 
care models for 
‘older people’ 
and ‘people with 
long term 
conditions’ 
Activity level Segment 
customers 
based on their 
purchase 
amount and 
frequency 
Target customers 
who migrate from 
‘active’ to ‘passive’ 
with marketing to 
re-engage them 
Segment 
patients based 
on their 
healthcare 
utilisation 
Target A&E 
frequent flyers 
with 
interventions 
through primary 
care 
 
For this systematic review, “patient attitudes” segmentation included preferences as well as 
actual actions or choices, as these two are often related and would be hard to differentiate 
(see Table 10). A study exploring screening behaviour will likely analyse patients’ preferences 
for testing. Similarly, a study looking at patient preferences may do so with the aim of 
changing behaviours. Patient needs are considered in a narrow sense, focusing on actual 
utilization and specific care activities. While looking at chronic disease patterns may be 
reflective of patient needs, these are considered patient type segmentation unless they 
explicitly use data related to care usage. 
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Table 10: Classification of segmentation bases for healthcare 
Segmentation 
base 
Analogue to Tsiptsis 
and Chorianopoulos 
Analogue to 
Cooil et al.  
Description 
Patient type Socio-demographics Lifestyle Segmentation based on patient 
characteristics, such as age or 
chronic conditions 
Patient 
attitudes 
Needs and attitudes; 
Loyalty 
 Segmentation based on 
conscious and subconscious 
patient choices, opinions, and 
preferences 
Patient needs Purchasing behaviour Purchasing 
behaviour; 
activity 
Segmentation based on patient 
care needs; as reflected in 
volume and type of healthcare 
utilisation  
Patient 
outcomes 
Propensity  Segmentation based on 
patients’ propensity or risk for 
specific health outcomes, such 
as readmissions or 
complications 
Patient costs Value Value Segmentation based on the 
healthcare costs of the patient 
 
 
4.3 RESULTS 
4.3.1 Population segmentation studies 
Through the database search, 199 records were found, and 39 papers were added through 
additional targeted searches (see Figure 8). The majority of studies excluded from the 
analysis were not segmentation studies, but used clustering methods for other purposes such 
as image processing. Other papers were segmentation studies, but applied to medical 
treatments, diagnostic tools, disease presentations or phenotypes rather than healthcare 
policy or delivery; focused on segmenting providers, staff or events rather than the patient 
population; or defined their segments a priori rather than through data mining methods. A 
total of 86 studies were included in the review (see appendix I for an overview). 
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Figure 8: PRISMA flow chart 
 
 
The plurality of papers (41) were patient attitudes segmentations, with patient type coming 
second with 23 papers. Needs, outcomes and cost studies were scarcer, with 11, nine and 
two papers respectively. The studies came from a range of countries (see Figure 9). English-
speaking countries such as the US and Australia contributed a large number of papers, which 
is to be expected based on the English search terms. Nevertheless, there were a 
considerable number of studies from other countries as well, such as Sweden, Italy, Spain, 
and Taiwan. 
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Figure 9: Geographical distribution of papers included in the review 
 
 
For each segmentation base, common research topics could be identified (see Figure 10). 
Within patient type studies, a large number of papers looked at patterns of multimorbidity as 
well as different types of older patients. Patient attitude studies explored patients’ preferences 
for services and a range of risk-related behaviours such as diet, lifestyle, screening decisions, 
and substance use. For patient outcomes studies there were two broad categories: risk 
studies, which looked at what type of patients are at risk of developing a condition or 
experiencing an adverse event; and outcome studies, which distinguished groups of patients 
with different outcomes following a treatment or event. Patient needs and cost were more 
homogenous, with no clear differentiating topics. 
 
1 >10?
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Figure 10: Overview of research topics by segmentation base 
 
 
4.3.2 Practical applications of segmentation in healthcare 
By reviewing the papers for applications suggested by their respective authors, nine broad 
categories were identified describing how segmentation analysis could be used in practice 
(see Figure 11). 
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Figure 11: Applications of data-driven segmentation in patient-centred healthcare 
 
 
 
At a health system level, segmentation of patient needs can inform the design of new patient-
centred care models. For example, Kendig et al. explored community and home care needs 
among older people, by clustering the type and volume of care used.
68
 Of the nine care needs 
segments identified, three groups had highly complex needs and used more than five 
different services. To meet the needs of these patients, coordinated care models were 
recommended to link up health and welfare services. Segmentation can also support more 
detailed planning and budgeting. Tibi-Lévy et al. segmented palliative care patients based on 
their cost, making the case for differentiated tariffs that take into account the patient’s degree 
of dependency, age, and cancer status.
69
  
 
In public health, segmentation can support the design of patient-centred interventions, 
screening programs and communication by tailoring them to patient attitudes. Many of these 
studies segment patients based on risk behaviours such as treatment and screening 
decisions,
70-74
 diet and lifestyle,
75-81
 or substance use.
82-85
 For example, Mathijssen et al. 
analysed questionnaire data on adolescents’ attitudes toward alcohol, and identified 
segments such as “consciously sobers”, “high spirits” and “socials”, which require different 
prevention programmes.
84
 
 
For care providers, segmentation of patient preferences can provide information to improve 
patient experience. Rudman at al. surveyed Swedish women on their experiences with 
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postnatal care, asking them to rate interpersonal care, time spent on checking the baby and 
maternal health, on information and support, and on breast feeding.
86
 Through cluster 
analysis they identified eight patient groups with varying profiles of satisfaction, which 
providers can use to improve the care experience for different patients. Care providers can 
also use patient type segmentation to support differentiated guidelines and protocols, and to 
deliver personalized care plans. Kidachi et al. conducted a survey of dialysis patients to 
understand their personality and coping style.
87
 They identify four types of patients, and 
recommend patient-centred care plans for “sensitive” and “submissive” types that include a 
mental health component.  
 
Finally, pharmaceutical companies can use patient attitudes segmentation to guide the design 
of more user-friendly or suitable products. Basen-Engquist et al. had patients rate cervical 
cancer testing scenarios, and identified four distinct groups with different priorities in terms of 
specificity, sensitivity, timing and pain.
88
  
 
4.3.3 Segmentation methods used in healthcare 
K-means and hierarchical clustering, two clustering approaches widely applied in customer 
segmentation analyses,
3, 89
 are the most commonly used methods in healthcare as well (see 
Figure 12). Latent class analysis is not generally included in traditional data mining texts,
3, 36, 
89
 but is often used for segmentation analyses in healthcare. Latent class analysis has gained 
popularity as a clustering method due to the increase in computing power of the last decades 
and the availability of specialised software.
90
 There was no clear relation between 
segmentation types and the methods used. 
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Figure 12: Methods used for population segmentation 
 
 
The average population size of the studies in this review is 15,894, but there is strong 
variation between data mining methods. Hierarchical clustering methods are known to 
struggle with datasets containing more than a thousand observations, while k-means can 
handle large datasets.
3, 91
 This is reflected in the results, as the average and maximum 
population sizes for hierarchical studies are significantly smaller than for k-means. However, 
the limitation of k-means is that the number of clusters (k) needs be decided manually, 
whereas for hierarchical methods it can be derived from the results.
92
 A number of papers 
have therefore combined the two, using hierarchical methods on a subset of the data to 
identify the optimal number of clusters, which can then be used for a k-means analysis of the 
whole dataset. As a result, the maximum population size for these papers is higher than for 
studies using only hierarchical methods. 
 
Another method that has been used for larger datasets is factor analysis. Factor analysis 
analyses the correlation between variables, and replaces them with a lower number of new 
variables (factors). All of the papers in this review that use factor analysis look at 
multimorbidity, which is the presence of multiple chronic conditions in a patient.
93-95
 In these 
studies, factor analysis is applied to find clusters of diseases that co-occur, which can then be 
used to group patients who have two or more diagnoses from the same cluster. Since this 
approach segments the population based on correlations between variables rather than 
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observations, the population size becomes less of an issue. In the studies identified, this 
method is therefore applied to large administrative datasets.  
 
One hierarchical cluster study used a related approach to deal with large datasets, by 
applying hierarchical clustering to a heat map of correlations between morbidity variables 
rather than individual patients.
96
 However, since the clustering technique is not being applied 
to the original population dataset, this study has been excluded from the reported population 
sizes (see note 1 in Figure 12). 
 
Contrary to the other clustering techniques, decision trees are a supervised method. This 
means that patients are compared and grouped based on a predefined outcome variable. 
One study used a decision tree to create clusters of patients with similar costs based on 
characteristics such as age and morbidities.
69
 Other studies identified groups of patients with 
homogeneous physical activity levels,
97
 quality of life,
98
 and likelihood of completing a 
colorectal cancer screening test or follow-up examination.
70, 72
 
 
4.4 DISCUSSION 
4.4.1 General findings 
While segmentation in healthcare is not a well-established discipline in itself, a large number 
of healthcare studies were identified that apply segmentation methods. These studies cover a 
breadth of topics and have applications at all levels of healthcare services and policy. The 
results suggest that segmentation is a flexible tool that can be applied to a wide range of 
healthcare purposes. 
 
The majority of segmentations are based on patient attitudes or patient type, with only a few 
studies looking at patient needs, outcomes or cost. This may be due to the fact that for 
understanding the latter three, there are established quantitative metrics such as utilization, 
readmissions, or total cost, respectively. Patient attitudes or types on the other hand are more 
fluid concepts, which cluster analysis can help to quantify. Nevertheless, patient needs 
studies could support more tailored care delivery models - in particular patient-centred 
integrated care programmes - and further research should be done to explore opportunities in 
this area.  
 
The methods used in the studies, such as hierarchical clustering and K-means analysis, are 
techniques commonly using for customer segmentation in marketing.
3, 89
 This shows the 
technical feasibility of applying marketing methods in a healthcare setting. Population size is a 
major driver in the choice of segmentation method, as well as whether a single outcome is 
available for a supervised analysis.  
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4.4.2 Implications for policymakers 
While this chapter suggests nine areas of practical applications for segmentation in patient-
centred care, these should not be considered restrictive uses but rather an indication of the 
wide-ranging potential. The diversity in research topics in this review shows how 
segmentation methods can be adapted to many different healthcare studies. Moreover, since 
this review limits the potential applications of each paper to those specifically mentioned by 
the respective authors, the examples presented here are likely only a small subset of the 
broad spectrum of possibilities. Regardless of the topic or field, any healthcare professional 
looking to develop patient-centred solutions should consider using segmentation analysis to 
understand their patients and tailor their approach accordingly. 
 
Overall, the population sizes of the studies are relatively small, considering that data mining is 
popular for analysing big data. This leaves significant scope to expand the use of these 
methods to larger datasets. Routine, administrative healthcare datasets are a readily 
available source of information on large numbers of patients.
99
 They contain a great amount 
of information that can be used to explore a range of research questions on patient-centred 
care. However, access to these datasets for research is limited. To advance the use of 
segmentation methods and other vital health services research, policymakers should support 
and advocate the availability of healthcare data.
60
 
 
4.4.3 Limitations 
An important limitation of this research is the lack of a clear concept or definition of 
segmentation in healthcare, complicating the use of search terms for the systematic search. 
Ad-hoc searches and reference list reviews were done to mitigate this issue and added a 
large number of studies. The results cover a wide range of topics highlighting the versatility of 
segmentation, and any additional studies would have provided further support of this. The 
complexity of the search term also forced the limitation to English language studies. However, 
the studies identified cover a large geographic range despite this restriction. 
 
Another limitation is the lack of an established classification for segmentation bases. Two 
models used in marketing were adapted to the healthcare setting, however there are 
important differences between the two industries that affect this classification. The terms 
‘needs’ and ‘behaviours’, as used in marketing,
3, 5
 would generally be used differently in 
healthcare. A customer purchasing a product is considered behaviour, while a patient 
receiving treatment reflects a care need. On the other hand, customer needs relate to their 
preferences, which would be considered patient attitudes in this study's classification. 
 
4.4.4 Conclusion 
Overall, the results show that there is significant potential for the use of data-driven 
population segmentation analysis in the design of patient-centred healthcare, both in terms of 
technical feasibility and practical applications. Healthcare professionals from policymakers to 
 56 
providers and pharmaceutical companies can use segmentation to increase their 
understanding of the patients they serve and to deliver care tailored to their needs. The most 
popular methods are k-means and hierarchical clustering, which each present with unique 
benefits. K-means can handle very large datasets, while hierarchical clustering can be used 
to identify the optimal number of clusters. 
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CHAPTER 5: METHODS FOR DATA-DRIVEN DESCRIPTIVE 
POPULATION SEGMENTATION IN HEALTHCARE - AN APPLIED 
REVIEW OF THE KNOWLEDGE DISCOVERY PROCESS  
 
Since this research is aimed at healthcare professionals and policymakers, it is important to 
outline the segmentation methods in detail rather than assume prior knowledge. This chapter 
describes the steps of the knowledge discovery process, the creation of the patient-level 
database, the different options available for descriptive segmentation analysis, and the 
methods chosen for the analyses in chapters 6, 7 and 8. Methods for predictive segmentation 
will be discussed in chapter 9. 
 
 
5.1 INTRODUCTION 
Over the past decades, the amount of healthcare data available has grown exponentially; and 
is expected to continue growing.
100
 This big data, driven by record keeping for patient care as 
well as regulation and financing, provides a major epidemiological research opportunity. 
Analysing trends, patterns and associations in healthcare data can inform all areas of 
healthcare, including developing new treatments, identifying high risk patients, informing 
healthcare policy and shedding new light on disease causes and pathophysiology. However, 
the analysis of these data sources is only at a nascent state,
100
 leaving the healthcare 
industry in a situation which is “data rich but information poor”
89
. 
 
Data mining is a discipline that has emerged as a result of the progress in digital data 
capturing and storage.
36
 It can be described as
36
: 
 
“The analysis of (often large) observational data sets to find unsuspected 
relationships and to summarize the data in novel ways that are both understandable 
and useful to the data owner” 
 
This definition highlights some of the important characteristics of data mining. First of all, data 
mining is primarily applied to large datasets. As the amount of available data increases 
rapidly, data mining as a tool gained popularity because of its ability to extract knowledge 
from big data.
89
 Secondly, data mining makes use of observational datasets. Data mining is 
sometimes called secondary data analysis, as it often uses datasets which have been 
collected for other purposes.
36
 Administrative datasets in healthcare fall in this same category, 
as they are usually collected for internal operational purposes such as financing and 
regulation rather than research. Thirdly, data mining techniques aim to find unsuspected 
relationships in the data. This refers to the fact that many data mining analyses are not 
hypothesis driven. While classical methods such as regression analysis rely on a hypothesis 
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made by the user (e.g. outcome A is dependent on B and C), data mining does not. This 
allows it to find ‘unsuspected’ patterns, or patterns that the user did not hypothesise. Finally, 
data mining is geared towards real-world applications, by generating outputs that are useful 
and understandable to the end-user. This is a crucial element, as it reflects the potential of 
data mining to be a practical tool used by healthcare professionals and policymakers, rather 
than just an academic tool used by statisticians. 
 
Within the range of data mining techniques, clustering methods can be used to perform 
descriptive segmentation analyses, as shown in Chapter 4. However, the actual segmentation 
analysis is only one step in the knowledge discovery process.
36, 89
 Han and Kamber
89
 
describe the process as data cleaning, data integration, data selection, data transformation, 
data mining, pattern evaluation and knowledge presentation. Under data transformation, they 
include aggregation, attribute construction, generalisation, normalisation and reduction.  
 
This chapter describes the stages in the data mining and knowledge discovery process, and 
lays out the various options and methods available for each step. It focuses on descriptive 
population segmentation through cluster analysis, and describes how this was applied going 
forward in this thesis. Predictive methods are explored in chapter 9. 
 
5.2 DATA COLLECTION 
5.2.1 Data sources 
In healthcare there exist a large number of routinely collected, administrative datasets that 
have significant potential to be used for secondary purposes such as research.
99, 101, 102
 While 
datasets collected one-off for a study in the form of questionnaires or trials can provide data 
more specific to the research question, routine data sources have a number of benefits
99
: 
 Data is available in a standardised, cleaned format 
 There is potential to perform retrospective analysis; as well as on-going monitoring 
and evaluation 
 The data is generally not limited to a subsample or study population, but collected for 
all patients 
 Obtaining data for research is easy and cheap as the data has already been collected 
 
This research focuses on using these readily available datasets, to illustrate how 
segmentation can be used in practice in healthcare. A linked dataset of primary and 
secondary care data was used, to understand care needs across these healthcare settings. 
The primary care data comes from the Clinical Practice Research Datalink (CPRD) (ISAC 
approved protocol 14_211RA). This data was provided by CPRD linked at the patient-level to 
Hospital Episode Statistics (HES), as well as the Townsend deprivation score. In addition, unit 
cost data were gathered from a range of sources. 
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CPRD collects patient-level medical records data from GP practices who have agreed to 
share their data, and who can be using any of the four major IT systems.
103
 Participating 
practices supply data on all their patients, with the exception of patients who have opted out 
of data sharing.
104
 
 
The CPRD database covers approximately 7% of the UK population.
104
 The population 
covered by CPRD data is broadly representative of the UK population in terms of age, sex 
and ethnicity. However, as CPRD is an administrative data source, the completeness of 
patients’ medical record can be limited – due to GPs not testing, not reporting or patients not 
presenting. 
  
The CPRD database contains 10 separate datasets. For the purpose of this study, the 
primary datasets that were used are: 
 Patient – for patient demographic information 
 Consultation – to determine care utilisation, by type of consultation 
 Clinical – for clinical information, including diagnoses 
 Therapy – to determine care utilisation in terms of prescriptions 
 
HES data is collected and published monthly by the NHS Information Centre for Health and 
Social Care, which has recently been renamed NHS Digital.
105
 The dataset contains 
information on all hospitalisations, outpatient and A&E attendances for NHS hospitals in 
England, at an episode level.  
 
CPRD has a linkage scheme to link the primary care data to other healthcare data sources, in 
which 58% of all CPRD practices have consented to participate.
104
 For this study, linked HES 
data was obtained through CPRD for the 300,000 patients in the sample. At the moment of 
protocol submission (14
th
 November 2014), no A&E data linkage was available. Therefore 
only inpatient and outpatient activity were included in the database. 
 
5.2.2 Study population 
From the CPRD database a random sample of 300,000 patients was obtained. Patients in the 
sample were required to have an active registration status over the entire study period, to 
ensure all care activities, or lack thereof, were recorded. Registration can be derived from the 
variables crd (date of current registration) and a potential tod (date transferred out) or 
deathdate (date of death). In addition, a link to the HES data needed to be available. This 
excluded 45% of CPRD patients who are ineligible for the linkage scheme (K. Chidwick, 
CPRD, personal communication, 13 November 2014). Besides these two requirements, a 
fully random sample was used, to include all possible patients that one would find in a real-
world population. 
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This research used a sample size of 300,000 patients. The aim of the analysis is to simulate 
real-world population level patterns, which requires a population-sized sample. In the English 
NHS a large number of population level decisions, such as commissioning of primary and 
secondary care and the development of care models, take place at the Clinical 
Commissioning Group (CCG) level, thus making this a useful unit for the analysis. CCG 
population sizes range from around 100,000 to 900,000, but the majority of CCGs have 
population of between 150,000 and 350,000.
106
 75% of CCGs have population sizes of less 
than 300,000, making it an acceptable sample size (see Figure 13).  
 
Figure 13: CCG population sizes 
 
Source: Office for National Statistics
106
 
 
5.2.3 Study period 
To obtain an accurate view of patient needs, and increase the chance of observing low 
frequency activity or historic diagnoses, five years of activity and diagnosis data were 
included in the database. The most recent HES data available at the time of protocol 
submission to CPRD was financial year 2012/13, therefore the study period was set as 2008 
up to and including 2012. 
 
5.2.4 Data integration 
Using the data from the CPRD, HES and Townsend databases, a dataset was constructed at 
the patient level, meaning that there is one observation, or row, for each patient. Each 
observation holds a range of variables for that patient, describing their personal details, 
healthcare activity and cost information. Figure 14 provides a high-level overview of the 
database structure. The different datasets can be linked based on an anonymised patient 
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identification number as generated by CPRD. This allows the creation of a patient-level 
database containing information from different datasets.  
 
Figure 14: Variables extracted from HES and CPRD for patient-level database 
 
 
5.3 DATA MANIPULATION: DEMOGRAPHIC DATA 
While some attributes could be obtained directly from the raw dataset, like gender, the 
majority of patient-level variables had to be constructed from care episode data. Based on 
existing literature, a large number of variables were created. Afterwards, they were further 
reviewed in the data cleaning, reduction and normalisation stages. 
 
Basic person data that can be extracted from administrative databases are age and gender. 
Age was recorded as at the end of the study period, as calculated from the year of birth. For 
this reason, the youngest age in the dataset was 5, reflecting new-borns included at the 
beginning of the five-year study period. Townsend 2001 deprivation score was also included 
in the demographic data, at a 5, 10 and 20-step scale. While the Index of Multiple Deprivation 
(IMD) score is also available linked to CPRD, Townsend was chosen because it does not 
include any predictors related to health.
107
 The IMD does include a health predictor - mortality 
- and could therefore overestimate the impact of deprivation on health outcomes. 
 
To supplement the person data, a range of clinical patient characteristics were deduced from 
healthcare data. Firstly, flags were created for the main chronic conditions of the patient. 
Per person:
Cost
Inpatient
Person Activity
• Long-term condition flags • # ELDCs
• # ELIPs
• # NEIPs
• # RAs
• ALoS ELIP
• ALoS NEIP
• Emergency admissions
• Non-emergency admissions
• Total cost ELDC
• Total cost ELIP
• Total cost NEIP
• Total cost RA
H
E
S
Patient
C
P
R
D
• Year of birth
• Age in 2012
• Age band
• Sex
• # GP surgery attendances
• # GP clinic attendances
• # GP telephone contacts 
• # GP home visits
• Total cost GP surgery
• Total cost GP clinic
• Total cost GP telephone
• Total cost GP home visits
Therapy
• # prescriptions
• # unique prescriptions
• Total prescription cost
Outpatient
• # OP appointments
• # unique OP specialties
• Total cost OP
• Total cost
ELDC: elective day case; ELIP: elective inpatient; NEIP: non-elective inpatient; RA: Regular attender; ALoS: average length of stay; OP: 
outpatient; GP: general practice/practitioner
Townsend
Combined
• Townsend 2001 5-scale
• Townsend 2001 10-scale
• Townsend 2001 20-scale
• # long term conditions
• Multimorbidity flag
• Risk score
• Residential care flag
Consultation
Clinical • Long-term condition flags
Database
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Secondly, the presence of selected mental health diagnoses was used to identify mental 
health conditions. Finally, learning disabilities were identified. Together these form the long-
term condition (LTCs) flags. 
 
5.3.1 Chronic conditions 
This study considers the impact of chronic conditions on the healthcare needs of the patient. 
To define a set of chronic conditions that significantly impact care needs, a comorbidity index 
was used. Comorbidity indices are based on a list of coexisting illnesses that may impact a 
patient’s prognosis. By combining the impact of these conditions in a single index, an overall 
score can be generated.
108
 These scores can be used to correct for case mix differences or to 
predict outcomes like mortality.
109
 There exist a large number of comorbidity indices, all based 
on different conditions and some providing weightings for specific diseases based on severity. 
However, not all indices can be derived from administrative data as used in this study, instead 
requiring case note review to determine severity or non-diagnosis based factors.  
 
HES uses the International Classification of Diseases (ICD) version 10. The Charlson Index 
has been proven to work using ICD-based diagnosis information from administrative data, 
and is one of the most widely used comorbidity indices.
109-112
 Moreover, while it is originally an 
index predicting mortality,
113
 it has been shown to also correlate with avoidable hospital 
admissions,
110
 health-related quality of life,
114
 and healthcare cost.
115
 The Charlson Index 
combines 16 conditions and assigns them a numerical standard weighting to create the 
overall score.
113
  
 
This study used the individual conditions specified by the Charlson Index as variables rather 
than their combined score, to enable the exploration of different patterns at the condition 
level. There exist different versions of ICD-10 translations of the original ICD-9 codes that 
were developed for this index (see Table 11).
110, 112, 116-119
 This research used the translation 
developed by Aylin and Bottle
119, 120
 because it has been adapted to English coding practices, 
and because the HSCIC includes it in statistical guidance to NHS institutions.
118
 In addition, a 
translation to Read codes has also been created specifically for use in primary care datasets 
like CPRD, which use Read codes rather than ICD-10.
121
 
 
For the purpose of this study, the condition rather than its state (e.g. diabetes, versus 
diabetes with complications) was used, as patient characteristics should be the same over 
time. Therefore ‘diabetes’ and ‘diabetes with complications’ were combined, as well as ‘mild 
liver disease’ and ‘severe liver disease’, and ‘cancer’ and ‘metastatic cancer’. 
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Table 11: Overview of Charlson comorbidity ICD coding  
 Deyo et al.
111
 ICD-9 adaptation Sundararajan et al.
112
 ICD-
10 translation 
Bottle and Aylin
120
 
English coding 
adaptation 
Condition ICD-9 codes ICD-10-AM codes ICD-10 codes 
Myocardial infarct 410-410.9 Acute myocardial infarction; 
412 Old myocardial infraction 
Acute myocardial infarction: 
I21, I22, I252 
I21, I22, I252, I258 
Congestive heart 
failure 
428-428.9 Heart failure I50 I50 
Peripheral vascular 
disease 
443.9 Peripheral vascular disease inc. 
intermittent claudication; 441-441.9 Aortic 
aneurysm; 785.4 Gangrene; V43.4 Blood 
vessel replaced by prosthesis; Procedure 
38.48 Resection and replacement of 
lower limb arteries 
I71, I739, I790, R02, Z958, 
Z959 
I71, I739, I790, R02, Z958, 
Z959 
Cerebrovascular 
disease 
430-438 Cerebrovascular disease G450-G452, G454, G458, 
G459, G46, I60-I66, I670-I672, 
I674-I679, I681, I682, I688, I69 
G450-G452, G454, G458, 
G459, G46, I60-I69 
Dementia 290-290.9 Senile and presenile dementia F00-F02, F051 F00-F03, F051 
Chronic pulmonary 
disease 
490-496 Chronic obstructive pulmonary 
disease; 500-505 Pneumoconioses; 506.4 
Chronic respiratory conditions due to 
fumes and vapours 
Pulmonary disease: J40-J42, 
J44-J47, J60-J67 
J40-J47, J60-J67 
Connective tissue 
disease 
Rheumatologic disease: 710.0 
Systematic lupus erythematosus; 710.1 
Systematic sclerosis; 710.4 Polymyositis; 
714.0-714.2 Adult rheumatoid arthritis; 
714.81 Rheumatoid lung; 725 
Polymyalgia rheumatica 
Connective tissue disorder: 
M050-M053, M058-M060, 
M063, M069, M32, M332, M34, 
M353  
M05, M060, M063, M069, 
M32, M332, M34, M353 
Ulcer disease Peptic ulcer disease: 531-534.9 Gastric, 
duodenal and gastrojejunal ulcers 
Peptic ulcer: K25-K28 K25-K28 
Mild liver disease 571.2 Alcoholic cirrhosis; 571.5 Cirrhosis 
without mention of alcohol; 571.6 Biliary 
cirrhosis; 571.4-571.49 Chronic hepatitis 
Liver disease: K702, K703, 
K717, K73, K740, K742-K746 
K702, K703, K717, K73, 
K74 
Diabetes 250-250.3 Diabetes with or without acute 
metabolic disturbances; 250.7 Diabetes 
with peripheral circulatory disorders 
E101, E105, E109, E111, 
E115, E119, E131, E135, 
E139, E141, E145, E149 
E101, E105, E106, E108, 
E109, E111, E115, E116, 
E118, E119, E131, E135, 
E136, E138, E139, E141, 
E145, E146, E148, E149 
Hemiplegia Hemiplegia or paraplegia: 344.1 
Paraplegia; 342-342.9 Hemiplegia 
Paraplegia: G041, G81, G820-
G822 
G041, G81, G820-G822 
Moderate or severe 
renal disease 
Renal failure: 582-582.9 Chronic 
glomerulonephritis; 583-583.7 Nephritis 
and nephropathy; 585 Chronic renal 
failure; 586 Renal failure, unspecified; 
588-588.9 Disorders resulting from 
impaired renal failure 
Renal disease: N01, N03, 
N052-N056, N072-N074, N18, 
N19, N25 
I12, I13, N01, N03, N052-
N056, N072-N074, N18, 
N19, N25 
Diabetes with end 
organ damage 
Diabetes with chronic complications: 
250.4-250.6 Diabetes with renal, 
ophthalmic, or neurological manifestation 
Diabetes complications: 
E102-E104, E112-E114, E132-
E134, E142-E144 
E102-E104, E107, E112-
E114, E117, E132-E134, 
E137, E142-E144, E147 
Any tumour Any malignancy, including leukaemia 
and lymphoma: 140-172.9 Malignant 
neoplasm; 174-195.8 Malignant 
neoplasm; 200-208.9 Leukaemia and 
lymphoma 
Cancer: C0-C3, C40, C41, 
C43, C45-C49, C5, C6, C70-
C76, C80-C85, C883, C887, 
C889-C901, C91-C93, C940-
C943, C9451, C947, C95, C96 
C00-C67, C80-C97 
Leukaemia 
Lymphoma 
Moderate or severe 
liver disease 
572.2-572.8 Hepatic coma, portal 
hypertension, other sequalae of chronic 
liver disease; 456.0-456.21 Esophageal 
varices 
Severe liver disease: K721, 
K729, K766, K767 
K721, K729, K766, K767 
Metastatic solid 
tumour 
196-199.1 Secondary malignant 
neoplasm of lymph nodes and other 
organs 
Metastatic cancer: C77-C80 C77-C79 
AIDS 042-044.9 HIV infection with related 
specified conditions 
HIV: B20-B24 B20-B24 
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5.3.2 Mental health  
While mental health conditions have not been included in the Charlson index, they have a 
significant impact on a patient's care needs, such as higher overall utilisation of care,
122
 more 
unplanned and potentially preventable hospital admissions,
123
 and more readmissions.
124
 
Moreover, patients with mental health conditions require a care model which integrates with 
mental health services.
125
 While this study did not have access to linked mental healthcare 
provider data, the physical healthcare needs of these patients were explored by creating a 
mental illness flag, similar to the chronic condition flags. 
 
There exists no standard classification for severe mental illness, however most studies 
include psychosis (including or limited to schizophrenia and schizoaffective disorders) and 
bipolar disorder (see Table 12). This research used the codes defined by White et al.,
126
 as it 
provides a wide definition for psychosis and bipolar disorders that includes the criteria set out 
by Chang et al.,
127
, while excluding drug-induced and depression-related psychosis that NHS 
England includes.
128
 The latter two may be temporary states rather than enduring mental 
illnesses and were therefore excluded. 
 
Table 12: Overview of severe mental illness definitions 
Source Definition  Conditions and ICD-10 codes 
White et al.
126
  Severe mental illness are 
“a range of serious and 
chronic conditions including 
schizophrenia, bipolar 
disorder and psychoses” 
Psychosis: F20-F29 
Bipolar disorder: F30-F31 
Chang et al. 
127
 
“SMI [Severe mental 
illness] which might include 
schizophrenia, 
schizoaffective disorder, 
bipolar disorder, and 
depressive psychosis” 
Schizophrenia: F20 
Schizoaffective disorders: F25 
Bipolar affective disorder: F31 
Substance use disorder: F10-F19 
Depressive episode: F32 
Recurrent depressive disorder: F33 
NHS 
England
128
  
Severe mental illness are 
“patients with psychoses, 
including schizophrenia 
and bipolar affective 
disorder” 
Psychosis: F20-F29 
Drug induced psychosis: F105, 
F115, F125, F135, F145, F155, 
F165, F195 
Bipolar disorder: F302, F312, F315 
Depressive episodes (with 
psychosis): F323 and F333 
HSCIC
129
 Mental health prevalence 
based on “people with 
schizophrenia, bipolar 
disorder and other 
psychoses” 
N/A 
 
5.3.3 Learning disabilities 
Learning disabilities is another group of conditions that significantly impacts a person’s care 
needs, but that is not included in general morbidity indices. Like mental health, it is included in 
the NHS Quality and Outcomes framework, however there are no specific conditions listed for 
this metric.
129
 While in England the term learning disabilities is common, the World Health 
   
 65 
Organisation uses “mental retardation”.
130
 This group of conditions is covered by ICD-10 
codes F70-F79,
131
 and was included as such in this research. 
 
5.3.4 Creating the LTC flags 
To create the chronic condition, mental health and learning disabilities flags in the acute 
dataset, all diagnosis fields in all inpatient hospital episodes during the study period were 
reviewed for the relevant ICD-10 codes. In primary care, where Read codes are used, the 
ICD codes for mental health and learning disabilities were mapped to Read codes according 
to the ICD-10/Read Cross Mapping (Version 3) created by the UK Terminology Centre.
132
 
CPRD uses Medcodes rather than Read codes in its databases, so the Read codes for the 
various conditions were translated to Medcodes using the CPRD Medical Dictionary.  
 
Some conditions can also be derived from fields other than diagnosis, for example diabetes 
from recorded HbA1c test scores. However, this is not true for all conditions, and therefore 
only diagnoses codes were used to avoid bias. If there was any diagnosis of the condition 
over the study period, in any dataset, the patient was given a flag for the condition. 
 
In addition to the various LTC flags, the database also included a metric specifying whether 
the patient had multiple LTCs and a count of LTCs, both based on the conditions specified 
above. 
 
5.3.5 Missing data 
For both acute and primary care, identifying chronic conditions will be subject to missing data. 
Doctors are more likely to record the chronic conditions they treat, rather than describing a 
patient’s full health status. However, it is likely that if a condition is related to any healthcare 
need, it will have been recorded in either dataset. If a patient technically has a chronic 
condition but never requires care, this does not affect the healthcare system and there will be 
little impact from not recording the condition. 
 
5.4 DATA MANIPULATION: ACTIVITY VARIABLES 
The care needs of a patient depend both on the type of care needed as well as the volume. 
The database therefore contained activity counts for the main types of care. Types of care 
were defined based on their setting rather than the specialism or procedure involved, to serve 
the purpose of informing the design of integrated care models that cut across settings. It 
follows the patient-centred approach, based on where the patient needs to go to receive care. 
Care utilisation was measured over five years, to reduce random variation in utilisation and 
increase the chance of observing low frequency activity. 
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5.4.1 Acute care activity 
In the inpatient acute dataset, activity was counted split by elective day cases, elective 
inpatient hospitalisations, non-elective inpatient hospitalisations and regular attenders, 
according to common NHS practice.
133, 134
 These variables were defined as detailed in Table 
13. 
 
Table 13: Definitions of inpatient care activity metrics 
Admission 
type 
Abbreviation Definition
133
 Coding in HES
133, 135
 
Elective 
day case 
ELDC “where the patient has a 
planned admission and is 
discharged on the same 
day” 
Patient classification is 
2 (Day case admission) 
Elective 
inpatient 
ELIP “where the patient has a 
planned admission to 
hospital with the 
expectation that they will 
remain in hospital for at 
least one night” 
Admission method is 
11 (Elective: from 
waiting list) or 12 
(Elective: booked) or 
13 (Elective: planned) 
& 
Patient classification is 
1 (Ordinary admission) 
Non-
elective 
inpatient 
NEIP “where the patient has an 
unplanned admission. 
Included emergency 
admissions and 
admissions for maternity, 
births, and non-emergency 
patient transfers from 
another hospital” 
Admission method is 
not 11 (Elective: from 
waiting list) or 12 
(Elective: booked) or 
13 (Elective: planned) 
& 
Patient classification is 
1 (Ordinary admission) 
Regular 
attender 
RA “patients admitted 
electively during the day or 
night, as part of a planned 
series of regular 
admissions for an on-going 
regime of broadly similar 
treatment and who are 
discharged the same day 
or next morning” 
Patient classification is 
3 (Regular day 
attender) and 4 
(Regular night 
attender) 
 
For every patient, a count of ELDs, ELIPs, NEIPs and RAs was calculated over the study 
period. In addition, the average length of stay (ALoS) in days for elective and non-elective 
inpatient stays were calculated to quantify healthcare needs further.  
 
Emergency hospitalisations – non-elective inpatient hospitalisations where the admission 
method was through A&E or an emergency referral by GP, consultant or other specialist – are 
monitored by the HSCIC on a monthly basis,
136
 and are often used for risk stratification 
analyses. They were therefore included in the database as an alternative measure to NEIPs. 
Nevertheless, the two are closely related, and 79% of NEIPs in the dataset could be defined 
as emergency hospitalisations (the remainder include hospital transfers, maternity 
admissions, babies born in the hospital and admissions where the method was unknown). 
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Emergency hospitalisations were defined according to NHS standard practice as detailed in 
Table 14. All other admissions were considered non-emergency hospitalisations. 
 
Table 14: Definition of emergency hospitalisations 
Name Definition  Coding in HES
136
 
Emergency 
hospitalisation 
“episodes with an 
admission method 
indicating the 
hospitalisation was an 
emergency” 
Admission method is 21 
(Emergency: via A&E services) or 
22 (Emergency: via GP) or 23 
(Emergency: via Bed Bureau) or 
24 (Emergency: via consultant 
outpatient clinic) or 25 
(Emergency: via Mental Health 
Crisis Resolution Team) or 28 
(Emergency: via other means) 
 
A count of outpatient appointments was also included in the dataset, as well as the number of 
unique specialties attended as an outpatient, as defined by the treatment specialty variable in 
HES. 
 
5.4.2 Primary care activity 
In the primary care dataset, activity counts were included for consultations and prescriptions. 
Consultations were classified as clinic consultations, surgery consultations, telephone 
contacts and home visits, as derived from the type of consultation “COT” code in CPRD (see 
Table 15). The study considers these activities separately as they require different levels of 
resources, and their unit cost are available from the Unit Cost of Health And Social Care 
study.
137
 Actions taken by the GP that do not involve direct patient contact were excluded 
from the patient activity counts. No distinction was made between patients visiting their own 
GP or a local rota or other service, as the subject of study is the patient and their needs rather 
than the provider. 
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Table 15: Definitions of primary care activity metrics 
Activity COT codes included 
Surgery 
consultation 
7 (Out of hours, Practice), 8 (Out of hours, Non Practice), 9 
(Surgery consultation), 18 (Emergency Consultation), 33 
(Triage), 34 (Walk-in Centre), 36 (Co-op Surgery 
Consultation), 38 (Minor Injury Service) 
Clinic 
consultation 
1 (Clinic) 
Home visit 2 (Night visit, Deputising service), 3 (Follow-up/routine visit), 
4 (Night visit, Local rota), 6 (Night visit, practice), 11 (Acute 
visit), 24 (Children's Home Visit), 27 (Home Visit), 28 (Hotel 
Visit), 30 (Nursing Home Visit), 31 (Residential Home Visit), 
32 (Twilight Visit), 37 (Co-op Home Visit), 50 (Night Visit) 
Telephone contact 10 (Telephone call from a patient), 21 (Telephone call to a 
patient), 35 (Co-op Telephone advice), 55 (Telephone 
Consultation) 
Excluded 0 (Data Not Entered), 5 (Mail from patient), 12 (Discharge 
details), 13 (Letter from Outpatients), 14 (Repeat Issue), 15 
(Other), 16 (Results recording), 17 (Mail to patient), 19 
(Administration), 20 (Casualty Attendance), 22 (Third Party 
Consultation), 23 (Hospital Admission), 25 (Day Case 
Report), 26 (GOS18 Report), 29 (NHS Direct Report), 39 
(Medicine Management), 40 (Community Clinic), 41 
(Community Nursing Note), 42 (Community Nursing Report), 
43 (Data Transferred from other system), 44 (Health Authority 
Entry), 45 (Health Visitor Note), 46 (Health Visitor Report), 47 
(Hospital Inpatient Report), 48 (Initial Post Discharge 
Review), 49 (Laboratory Request), 51 (Radiology Request), 
52 (Radiology Result), 53 (Referral Letter), 54 (Social 
Services Report), 56 (Template Entry), 57 (GP to GP 
communication transaction), 58 (Non-consultation medication 
data), 59 (Non-consultation data), 60 (ePharmacy message) 
 
For prescriptions this study counted both the total number of prescriptions, to reflect the 
volume of demand on the healthcare system, as well as the number of unique types of 
prescriptions, to reflect the variety of care needs. Unique prescriptions were defined based on 
the first 6 digits of the British National Formulary (BNF) code, the BNF Paragraph, which 
defines the type of drug product.
138
 
 
5.4.3 Patients in residential care 
Patients in residential care, such as care homes or nursing homes, receive additional care 
services that cannot be quantified from CPRD or HES data. Moreover, there is no indicator in 
either CPRD or HES that confirms a patient is in residential care. Therefore, this care type 
could not be included in the utilisation patterns. Nevertheless, the fact that these patients are 
in residential care will influence the volume and type of other care that is received. A 
residential care flag was therefore created, which was used to understand clusters post-hoc. 
 
To create the residential care flag, three different sources were used: admission source 
information from HES, Medcodes from CPRD, and consultation types from CPRD (see Table 
16). Admission source rather than discharge destination was used in HES, to pick up patients 
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who generally reside in a care or nursing home, and not those that get discharged there for 
temporary rehabilitation. To define the eligible Medcodes, the long-list was scanned for 
mentions of ‘care home’, ‘nursing home’ and ‘residential care’. Finally, patients were identified 
who had had a consultation classified as nursing home visit or residential home visits. 
Patients were flagged as receiving residential care if any of these three sources indicated 
residential care. 
 
Table 16: Definition of residential care flag 
Medcode Description 
7653 Seen in nursing home 
10993 Discharge to nursing home 
13359 Lives in a nursing home 
24828 Nursing home care 
27936 Delayed discharge to nursing home 
43915 Discharge to private nursing home 
73083 Nursing home visit note 
73321 Nursing home 
94070 Provision of continuing care in nursing home 
102230 Nursing home acquired pressure ulcer 
102493 Admission to nursing home 
102598 Discharge to nursing home 
46642 Other residential care homes managed by local authority 
49681 Lives in care home 
99148 Other residential care home man voluntary/private agents 
101078 Patient died in care home 
24816 Residential care 
53140 Local authority residential care 
Admission 
source code 
Description 
54 NHS run nursing home, residential care home or group home 
65 Local authority Part 3 residential accommodation: where care is 
provided (from 1996-97)  
85 Non-NHS (other than Local Authority) run residential care home 
(from 1996-97) 
86 Non-NHS (other than Local Authority) run nursing home (from 
1996-97 to 2006-07) 
88 Non-NHS (other than Local Authority) run hospice 
Activity type 
(COT) code 
Description 
30 Nursing Home Visit 
31 Residential Home Visit 
 
There are significant limitations to this approach. On the one hand, it is impossible to tell for 
how long the patient received residential care. Patients were flagged based on one time point 
where residential care was involved. This will overestimate the number of patients who 
actually permanently reside in a care home. On the other hand, this method is highly reliant 
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on proper coding by GPs and acute trusts. It will therefore likely miss a number of patients 
whose residential care status was not recorded in the notes. To verify the general accuracy of 
this method, residential care prevalence in this dataset was compared to national averages. 
This study flagged 3.0% of the population over 65 as residential care receivers, compared to 
3.2% as recorded by the Office for National Statistics,
139
 which is reasonably close. 
 
5.5 DATA MANIPULATION: COST VARIABLES 
The activity data for each patient was accompanied by cost estimates. The purpose of this is 
two-fold. Firstly, it provides a cost perspective to managers, policymakers and 
commissioners, which is important when making healthcare services decisions. Secondly, 
attributing cost to activity counts provides an automatic weighting. Comparing inpatient 
episodes with outpatient appointments and GP visits is meaningless when each requires a 
different intensity of care resources. Cost approximate the relative resources required, and 
therefore provide a way to weigh care needs and compare utilisation across care settings.  
 
Using unit costs multiplied by the relevant care activity, total cost of care was calculated per 
person. Where different versions existed for cost sources, the most recent version was used 
for all years, to reflect the cost of a patient in the current system. In the analysis, this total cost 
variable was used as a descriptor of the identified segments.  
 
5.5.1 Acute care 
The unit costs for acute care were derived from NHS Reference Costs 2011/12.
140
 While the 
actual cost of treating patients may vary by provider,
134, 141
 the aim is to give a relative 
indication of cost to identify high-cost individuals. The Reference Costs provide a national 
average cost based on the Healthcare Resource Group (HRG) code for the hospitalisation, 
taking into account the type of admission (day case, elective, non-elective or regular 
attender). Non-elective cases were assigned different cost for short stays (less than 2 days) 
and long stays (2 days or longer).
142
 For hospitalisations without an HRG code in the 
database – hospitalisations from 2008 before the introduction of HRG version 4.0, and regular 
attender visits – a weighted average cost was calculated for each activity type from the NHS 
Reference Costs. Cost for outpatient appointments were based on a weighted average from 
the NHS Reference Cost, calculated and allocated per treatment specialty. 
 
5.5.2 Prescribing 
Similar to acute care, prescriptions cost were based on Net Ingredient Cost (NIC) rather than 
actual cost, disregarding any local fees or discounts. The CPRD database holds information 
on the BNF code for each prescription. However, these differ slightly from those used by the 
Health and Social Care Information Centre (HSCIC) at the 5
th
, 6
th
 and 7
th
 digit (H. Strongman, 
CPRD, personal communication, 21 April 2015).  
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To estimate the NIC for each prescription, Prescription Cost Analysis (PCA) data for 2012 
from the HSCIC was used.
138
 This dataset contains cost and volume information on drugs 
prescribed in England for each 15-digit BNF code. The data was aggregated at both the 6-
digit and 4-digit level, calculating weighted average cost for each. If no 6-digit BNF code 
match was available in the CPRD dataset due to coding differences, a 4-digit match would 
provide the unit cost instead. 
 
5.5.3 Primary care 
For primary care activities unit cost were obtained from the Unit Cost of Health and Social 
Care report.
137
 The Unit Cost report calculates cost for GP services by comparing salary, 
overheads and other cost for the practice to the activities performed, taking into account the 
amount of time each activity takes. Separate unit costs for clinic, surgery, and telephone 
consultations, as well as home visits, were available and were used in the analyses. 
 
5.6 EXPLORATORY DATA ANALYSIS 
It is important to understand the characteristics of the variables in the dataset through 
exploratory data analysis before attempting any data mining.
143
 For the cluster analysis, 
various utilisation variables were used. Therefore, a clear understanding was needed of their 
type, range and distribution, as this would influence decisions in the cluster analysis. 
 
All variables that were used for the segmentation analysis were numeric, which simplifies the 
approach. While there are methods to deal with categorical, binary or even mixed datasets, 
this research focuses on numerical approaches only. The ranges of the variables were very 
different (see   
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Table 17). Elective inpatient admissions varied from 0 to 75, while GP surgery visits went as 
high as 855. 
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Table 17: Minima, percentiles and maxima for utilisation variables 
 
A critical aspect of healthcare utilisation is that it is highly skewed. The percentiles showed 
that for most variables over half of the patients have a count of 0, while the higher percentiles 
strongly increase in value (note that   
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Min 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
10th 0 0 0 0 0 0 0 0 0 2 0 0 1 1 
20th 0 0 0 0 0 0 0 0 0 5 0 0 2 3 
30th 0 0 0 0 0 0 0 0 0 8 0 0 3 6 
40th 0 0 0 0 1 1 0 0 0 11 0 0 5 11 
50th 0 0 0 0 2 1 0 0 0 15 0 0 6 18 
60th 0 0 0 0 4 2 0 0 1 20 0 1 8 32 
70th 0 0 0 0 7 2 0 0 2 26 0 1 11 61 
80th 1 0 1 0 11 3 0 1 4 35 0 2 14 122 
90th 1 1 1 0 20 4 1 2 9 52 0 5 20 247 
95th 2 1 2 0 31 6 3 5 15 71 1 9 25 379 
99th 6 3 5 0 63 9 8 16 33 125 8 23 39 727 
Max 168 75 119 765 1166 26 3491 2340 323 855 424 307 109 11978 
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Table 17 uses a different scale in percentile steps for the last two categories). As the 
variables are based on count data, the data is more likely to follow a Poisson distribution 
rather than a Normal distribution.
144
 While Poisson distributions may approximate a Normal 
distribution if the average rate or mean count is large, in this case the mean was less than 
one for most variables and the variables were therefore not Normally distributed. For regular 
Poisson distributions, the variance is roughly equal to the mean. However, in this dataset the 
variance (the square of standard deviation) was significantly larger than the mean for all 
activity variables. This indicates that the data is highly overdispersed. 
 
This skewedness, as well as the different ranges of the variables, has important 
consequences for the analysis. It complicates finding a distance measure, and puts more 
weight on larger numbers. In addition, it restricts the use of common tests for significance, 
such as t-tests and ANOVA analysis, which are based on an assumption of Normality.
144
 This 
will be further discussed later in this chapter. 
 
5.7 DATA CLEANING 
The data, as obtained from CPRD and HES, is pre-cleaned to serve research purposes. 
However, there may still be some observations with missing data. In this dataset, the 
exploratory data analysis showed no missing values for critical variables such as age or 
gender. Ethnicity and marital status however had large numbers of ‘unknown’ values, 65% 
and 83% respectively. Therefore these variables were not used for analysis. 
 
Outlier analysis is an important aspect of data mining, as extreme values can significantly 
affect the outcomes of clustering analyses.
3
 The exploratory data analysis of the utilisation 
variables showed very large values in the data, with the top 0.1% of patients presenting 
values several orders of magnitude larger than the mean. A common approach to identify 
whether large values are within range or outliers is a box-whisker plot (see Figure 15).
16, 144
 
This approach is based on the box width, also known as the interquartile range, and assumes 
that any value 1.5 times the interquartile range higher than the upper quartile is an outlier.  
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Figure 15: Using box-and-whisker plots to identify outliers 
 
 
However, this approach is not useful for the highly skewed patient data. For many variables 
the upper quartile (>75%) was zero, making the box width also zero and anything higher an 
outlier. Even for the variables with non-zero 75% values, such as GP surgery visits and 
prescriptions, using the box-whisker approach would have identified around 5% of the data as 
an outlier. As these ‘outliers’ may not be in the same patient across variables, this approach 
could have excluded a large portion of the sample. Moreover, it is the high utilisation patients 
that are important for health systems, as they are costly and may benefit from better 
coordination of their wide spectrum of care needs. 
 
Though high utilisation patients are of interest, extreme values would negatively affect the 
results of the cluster analyses. Moreover, risk stratification studies have suggested that 
focusing on the top 0.5% high risk patients may not be the right approach, as they would 
require very intensive care management to reduce hospitalisations, may have already be 
identified as high risk and their care optimised, and only account for a small number of 
hospitalisations as compared to larger population strata.
49, 145
 In this research's dataset, 
removing the top 0.05% patients with the highest rate for each variable would cut out the most 
extreme values (see Table 18). This was particularly important for the whole population 
segmentation (Chapter 6), where the variation between patients is greatest. When this rule 
was applied across all utilisation variables, 0.52% of the population (1,568 people) was 
excluded from the analysis; an acceptable level for a whole-population segmentation model 
and in line with the 0.5% usually excluded in risk models.  
 
Outliers: Values are more than 
1.5x box widths from the upper 
edge of the box
Maximum: Highest value still 
within 1.5x box widths from the 
upper edge of the box
Median
Upper quartile
Lower quartile
1.5x 
box width
Variable 
value
Interquartile
 range = box 
width
Illustrative
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Table 18: Outliers in utilisation variables 
 
5.8 DATA REDUCTION 
5.8.1 Data reduction methods 
Traditionally, data mining methods recommend a data reduction step before applying 
clustering techniques to the data, to simplify and enhance the clustering process.
3, 89
 
Particularly in traditional customer segmentation situations, where there are great amounts of 
sales and customer variables to process, this is an essential step. There are a number of 
strategies for data reduction
89
: 
 Data cube aggregation – in this research, aggregation of data was applied when 
creating the variables, for example by taking counts of activity rather than individual 
activity observations. Further aggregation may be needed if there is significant 
correlation between variables. 
 Dimensionality reduction – removing variables unrelated to the outcome from the 
dataset. In this study, this happens at point of analysis. For example, when analysing 
patient needs, patient characteristics, cost and outcomes will be excluded. 
 Data compression – reducing the number of variables by replacing them with a 
smaller number of variables, each reflecting several others. This not only reduces the 
size of the dataset, but also reduces the correlation between variables, ensuring that 
clusters are not based on confounding variables. 
 
5.8.2 Data compression methods 
A data compression technique well-established in the literature,
3, 89
 and often applied in 
practice for data mining analyses in healthcare,
146-148
 is principal component analysis (PCA). 
PCA aims to create new attributes that replace a larger number of original attributes, while 
preserving their information.
3, 89
 PCA is based on an analysis of linear correlations between 
variables, replacing them with a smaller number of composite variables.
3
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Mean 0.5 0.2 0.4 0.1 7.3 1.7 0.5 1.0 3.0 22.8 0.4 1.9 8.6 83.1 
Top 10% 1 1 1 0 20 4 1 3 9 52 0 5 20 247 
Top 5% 2 1 2 0 31 6 3 5 15 71 1 9 25 379 
Top 1% 6 3 5 0 63 9 8 16 33 125 8 23 39 727 
Top 0.5% 9 3 7 0 82 10 12 24 44 153 15 31 44 930 
Top 0.1% 23 6 13 11 140 13 37 54 82 235 41 59 58 1966 
Top 0.05% 32 8 16 24 183 14 61 71 101 281 57 75 63 2498 
Max 168 75 119 765 1166 26 3491 2340 323 855 424 307 109 11978 
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Another commonly used data compression method is factor analysis, PCA’s “twin brother”.
149
 
This technique is also commonly applied in healthcare data mining studies, especially those 
based on survey data.
29, 84, 150-152
 PCA and factor analysis are similar techniques and 
generally produce comparable results.
3
 The difference is that factor analysis assumes the 
existence of latent, underlying factors driving the results of multiple other variables, while PCA 
merely aims to reduce the number of variables. Therefore, factor analysis is often applied to 
questionnaire or survey data, where an underlying opinion or belief (e.g. “I won’t get colorectal 
cancer”) can influence the results of multiple survey questions (e.g. “I don't see the need to 
get screened” and “I do not worry about colorectal cancer”). Moreover, factor analysis 
explicitly excludes variability that is unique to only one variable.
143
 This has as a benefit that 
the resulting variables have reduced noise and are smoothed, but may also result in a loss of 
information. 
 
As conducting PCA and factor analysis follows a similar approach, PCA is used here as an 
example. PCA reduces the number of variables in the dataset by replacing them with principal 
components. When using the same number of principal components as there are variables, 
all the original information in the dataset is fully captured and the cumulative variance is 
100%.
3
 However, this would defeat PCA’s purpose of reducing the data. Therefore selection 
criteria are needed to decide on the optimal number of components to retain sufficient 
information while reducing the size of the dataset.  
 
A simple, commonly used way of deciding on the number of components is by selecting only 
those with an eigenvalue of over 1 (see Figure 16).
3, 84, 89, 152
 An eigenvalue represents the 
proportion of total variance explained by the component as a function of the total number of 
variables. If the eigenvalue is less than one, this means that a single variable would retain 
more information than the component.
3
 A method for evaluating the overall performance of 
the reduced model is to look at the percentage of variance from the original model the 
components represent. The cut off depends on the situation, but generally a value above 60-
65% is desired.  
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Figure 16: Interpreting the results of PCA analysis 
 
Adapted from: Tsiptsis et al.
3
 
 
For the new variables to be useful for population segmentation, the components need to be 
interpretable and understandable.
3
 A component combining hospitalisation and prescription 
count has no direct meaning, and segments based on this component will be difficult to 
interpret. The “meaning” of the identified components can be interpreted using a rotated 
component matrix, which displays the original variables and their correlation to the 
components. By suppressing lower correlations (<0.3 recommended,
3
 or <0.1, default option 
given in SPSS
153
), this table gives an overview of which variables are represented by which 
component. Based on this, the components can be interpreted and named. The Varimax 
rotation is a popular method which produces transparent components.
3
 
 
Lastly, the model needs to be reviewed in relation to each individual original variable, to 
ensure all variables are accurately reflected in the new model. A communality table shows for 
each variable the amount of variance that is accounted for by the combination of all 
components (rather than per component as in the rotation table). Typically, a value of at least 
0.5 is required for the model to be accepted.
3
 
 
5.8.3 Data reduction for population segmentation 
The initial data reduction step in this research was to identify whether the utilisation variables 
correlated, which would indicate that there is an opportunity to reduce the number of 
variables. A correlation matrix, based on pair-wise correlation analysis between the variable, 
Components Eigenvalue % of total 
variance
Cumulative % 
of variance
1 2.2 22 22
2 1.8 18 40
3 1.7 17 57
4 1.5 15 72
5 1.3 13 85
6 0.5 5 90
7 0.4 4 94
8 0.4 4 98
9 0.1 1 99
10 0.1 1 100
Eigenvalue criterion: The sixth 
component has an eigenvalue of 
less than 1, and is excluded
Model cut off for 
components
Percentage of variance  
criterion: The model 
represents more than 
60-65% of variance
All components together 
represent 100% of 
variance
Illustrative
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showed that there existed significant correlation between all variables, albeit of different 
magnitudes (see Table 19).  
 
Table 19: Correlation matrix of Pearson correlation coefficients for utilisation variables  
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0.31 0.17 0.09 0.42 0.44 0.19 0.12 0.14 0.28 0.08 0.16 0.24 0.33 
elip_# 0.31 
 
0.21 0.09 0.44 0.42 0.56 0.16 0.13 0.26 0.10 0.17 0.23 0.31 
neip_# 0.17 0.21 
 
0.04 0.36 0.40 0.18 0.45 0.14 0.31 0.24 0.22 0.28 0.38 
ra_# 0.09 0.09 0.04 
 
0.09 0.07 0.06 0.03 0.01 0.04 0.01 0.01 0.02 0.04 
op_# 0.42 0.44 0.36 0.09 
 
0.76 0.30 0.25 0.21 0.43 0.14 0.25 0.40 0.52 
op_unique 0.44 0.42 0.40 0.07 0.76 
 
0.31 0.27 0.25 0.53 0.16 0.29 0.43 0.61 
elip_alos 0.19 0.56 0.18 0.06 0.30 0.31 
 
0.21 0.10 0.20 0.13 0.14 0.22 0.26 
neip_alos 0.12 0.16 0.45 0.03 0.25 0.27 0.21 
 
0.11 0.22 0.27 0.17 0.28 0.30 
gpclinic_# 0.14 0.13 0.14 0.01 0.21 0.25 0.10 0.11 
 
0.18 0.07 0.13 0.30 0.35 
gpsurgery_# 0.28 0.26 0.31 0.04 0.43 0.53 0.20 0.22 0.18 
 
0.16 0.32 0.54 0.75 
gphomevisit_# 0.08 0.10 0.24 0.01 0.14 0.16 0.13 0.27 0.07 0.16 
 
0.29 0.32 0.29 
gptelephone_# 0.16 0.17 0.22 0.01 0.25 0.29 0.14 0.17 0.13 0.32 0.29 
 
0.29 0.41 
prescriptions_# 0.24 0.23 0.28 0.02 0.40 0.43 0.22 0.28 0.30 0.54 0.32 0.29 
 
0.70 
prescriptions_unique 0.33 0.31 0.38 0.04 0.52 0.61 0.26 0.30 0.35 0.75 0.29 0.41 0.70 
 
Note: all correlation are significant at p<0.001; colouring reflective of size of the correlation 
 
PCA and factor analysis rely on the assumption that there exist linear correlations between 
the attributes,
3
 which the correlation matrix showed to be the case. However, since there are 
clear real-world relations between the variables, data reduction may oversimplify the data and 
hide differences between groups that may not be relevant mathematically but are in real life.
36
 
To avoid losing potentially important information, PCA was used, which aims to retain the 
maximum amount of variance, rather than factor analysis, which retains only common 
variance. 
 
PCA analysis in SPSS of the utilisation variables with a Varimax rotation resulted in the 
extraction of three components, together accounting for 54% of total variance in the model. 
This is below the generally accepted minimum of 60 to 65%, which means that a large 
proportion of information would be lost if the three components were used instead of the 
original variables. 
 
Looking at the rotated component matrix for the utilisation variables, some interesting 
observations could be made (see Table 20). Component 2 included high loadings for 
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variables related to elective day cases, elective inpatient visits and outpatient appointments, 
and could therefore be interpreted as an elective specialist care variable. Component 3 
included non-elective care, as well as home visits, and could be reflective of complex need 
patients. However, component 1 did not have a clear interpretation. A lot of detail regarding 
the use of different care settings would be lost in these three components, and this data 
reduction was therefore not used for the final dataset. 
 
Table 20: Rotated component matrix 
 Component 1 Component 2 Component 3 
eldc_# 0.361 0.491  
elip_#  0.788  
neip_#   0.622 
ra_#    
op_# 0.554 0.564  
op_unique 0.644 0.504  
elip_alos  0.705  
neip_alos   0.732 
gpclinic_# 0.473   
gpsurgery_# 0.817   
gphomevisit_#   0.71 
gptelephone_# 0.408  0.384 
prescriptions_# 0.652  0.347 
prescriptions_unique 0.837   
Note: loadings below 0.3 are suppressed for easier interpretation 
 
Instead of using PCA, the number of variables was manually reduced, based on their 
correlation as well as their real-life relations. This allowed the combination of variables into 
clinically logical higher-level metrics, instead of calculating components solely from 
mathematical correlation. The first step was to identify metrics with a strong correlation from 
the correlation matrix (see Table 19). The decision on which variables to include, combine or 
exclude was based on logical judgement.  
 
 High correlation between OP_# and OP_unique 
 Use only OP_# for the cluster analysis 
 High correlation between prescriptions_# and prescriptions_unique 
 Use only prescriptions_# for cluster analysis 
 High correlation between GPsurgery_# and OP_unique (and OP_# to a lesser 
extend) 
 Partially solved by excluding OP_unique 
 High correlation between GPsurgery_# and prescriptions_unique (and 
prescriptions_# to a lesser extend) 
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 Partially solved by excluding prescriptions_unique 
 High correlation between OP_unique and prescriptions_unique 
 Solved by excluding both 
 High correlation of ELIP_ALoS and NEIP_ALoS with ELIP_# and NEIP_#, 
respectively 
 Use only ELIP_# and NEIP_#, respectively 
 
This initial set of clustering variables got further amended when conducting the research, 
based on the results of the analyses. During the whole population segmentation, the decision 
was made to exclude the GP telephone variable. It caused a single cluster to form around 
high values for this variable, which was otherwise similar to other groups. Cluster profiling and 
interpretation also revealed that elective (overnight) inpatient hospitalisations, day cases and 
regular attender visits all reflect similar patient characteristics. The same applied to GP 
surgery and clinic visits. As a result, these were combined into ‘elective inpatient 
hospitalisations’ and ‘GP practice visits’, respectively.  
 
For the subpopulation and risk stratification analyses in chapters 7 and 8, the number of 
clustering variables was further reduced as the samples were smaller. No distinction was 
made between GP visit types, such as home visits or practice visits. Moreover, emergency 
and non-emergency care was used rather than non-elective and elective care, to correspond 
with the emergency hospitalisations that are used to define the subpopulations studied in 
those analyses. 
 
Table 21: Final utilisation variables used for the descriptive segmentation analyses 
Chapter Analysis Utilisation variables included 
6 Whole population Non-elective inpatient 
hospitalisations 
Elective inpatient hospitalisations 
Outpatient appointments 
GP practice visits 
GP home visits 
Prescriptions 
7 & 8 Subpopulation & 
High-risk population 
Emergency hospitalisations 
Non-emergency hospitalisations 
Outpatient appointments 
GP visits 
 
 
5.9 DATA NORMALISATION 
5.9.1 Data normalisation methods 
When applying data mining techniques that rely on distance calculations, such as clustering 
techniques, it is essential to normalise the metrics in the database.
3, 89
 Metrics with different 
scales cannot be directly compared. In this study for example, patients are likely to have a 
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larger number of GP visits than inpatient hospitalisations. When distances are calculated 
between patients, the absolute difference between patients as measured in GP visits will 
therefore be larger than as measured in inpatient hospitalisations. Because of this, metrics 
with a larger scale will be overrepresented in the cluster formation.
3
 A solution to this issue is 
to normalise all metrics, and plot them on the same scale. Two common approaches to 
standardising data are the min-max and the z-score methods,
3, 89
 and another approach is 
based on ranking observations.
154
 
 
Min-max normalisation: Values v for attribute A are normalised to v’ by mapping the current 
position of value v in relation to the minimum and maximum value of A, to the new range of 
attribute A, new_maxA and new_minA. A new range of 0 to 1 is commonly used. 
 
𝑣′ =
𝑣 −𝑚𝑖𝑛𝐴
𝑚𝑎𝑥𝐴 −𝑚𝑖𝑛𝐴
(𝑛𝑒𝑤_𝑚𝑎𝑥𝐴 − 𝑛𝑒𝑤_𝑚𝑖𝑛𝐴) + 𝑛𝑒𝑤_𝑚𝑖𝑛𝐴 
 
z-Score normalisation: Values v for attribute A are normalised to new v’ by subtracting the 
average value of attribute A, Ā, and dividing by the standard deviation of A, σA. This method 
can be used when the data contains outliers that create an extreme minimum and/or 
maximum. 
𝑣′ =
𝑣 − ?̅?
𝜎𝐴
 
 
Ranking methods: Another method to transform data into standardised intervals is based on 
a ranking approach.
154
 This non-parametric transformation is particularly good for dealing with 
outliers. Ranking can be done absolute, by assigning each observation a rank and creating a 
range equal to n-1, or it can be based on percentiles. While this method provides a very 
strong adjustment to outliers and high values, it does lead to a significant loss of information. 
 
5.9.2 Data normalisation for population segmentation 
For some clustering methods, like the TwoStep cluster analysis in SPSS, the software has an 
integrated function for normalisation; therefore no manual data manipulation in the database 
is necessary. In other cases the distance measure produces values between 0 and 1 by 
default, and no normalisation is needed (see section on distance measures). However, for 
some cluster approaches, such as k-means with a Euclidean distance, the clustering 
variables need to be normalised. 
 
The z-score normalisation can handle extreme maximums. However, since the data used in 
this study does not follow a Normal distribution, the mean and standard deviation that are 
used to calculate the z-score are not reflective of the underlying data.  
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A ranking approach would also address the extremes in the data used for this research. 
However, the data contains a very large number of 0 and 1 counts, and a tail of various higher 
counts. This complicates ranking normalisation, as it creates a larger difference between 
common values than uncommon values. If 1,000 patients have a count of 0, they are all 
assigned a rank of 1. The 1,000 patients with a count of 1 will all be ranked 1001. If all counts 
higher than 1 are unique, ranking will continue increasing by 1 for each patient, for example 
1002, 1003 etc. This means that the distance between patients with a 0 and 1 count is 1000, 
while the distance between patients with a count of 2 and 3 is only 1. 
 
The strongly skewed data similarly prevents the use of percentile ranking, as multiple 
percentiles will be zero. Instead, it is possible to use non-zero percentiles.
68
 This would avoid 
the issue of several quartiles being zero, and divide the care users into distinguishable 
utilisation levels. However, in the highly skewed data even non-zero quartiles are not useful 
as the large majority of patients would still have a count of 1, taking up several percentile 
groups. 
 
The min-max approach is sensitive to outliers,
154
 and therefore not ideal for a highly skewed 
dataset. However, a logarithmic transformation can be used to reduce the differences 
between variables at the extreme end. Combining a logarithmic transformation with a min-
max standardisation therefore reduces the skewedness of the data, and was chosen as the 
approach for this study. 
 
5.10 DATA MINING 
There exist a large number of data mining algorithms and methods that can be applied to 
segment a patient population, as shown in chapter 4. They consist of predictive methods, 
which group observations based on a specific classifier or outcome variable, and descriptive 
methods, which compare the similarity of observations across a range of variables. 
 
5.10.1 Predictive methods 
Predictive or classification methods try to allocate observations to different groups based on a 
set of rules.
89
 This is a supervised method, where a specific attribute is defined as the 
classifier.
3
 Traditional linear or logistic regression analyses fall under this group.
3, 36, 89
 Other 
commonly used methods for prediction in data mining are decision trees, neural networks and 
Bayesian networks. 
 
Decision trees: Decision tree methods continuously split the population into subgroups 
based on predictor variables, so that the internal variation of the selected outcome in each 
subgroup is as low as possible.
3
 The resulting splits can be displayed as a tree, where at 
each split (a node) new subgroups emerge (the branches) until there are no more significant 
splits and the tree finishes with a number of subpopulations (the leaves). A major benefit of 
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decision trees as a data mining method is their interpretability. Especially when displayed in a 
tree-like diagram, decision trees can be easily understood even without statistical knowledge.  
 
A commonly used algorithm for decisions trees is CART (Classification and Regression Tree), 
which can be used for classification of binary attributes as well as regression of continuous 
attributes.
36
 However, it is a binary procedure and only produces two branches at every node 
of the tree. Another popular method is CHAID (Chi-square Automatic Interaction Detector), 
which uses a Chi-square test to analyse the statistical independence of categories.
3
 At every 
node, the attribute with the greatest interaction with the outcome is selected to split the tree 
further. CHAID allows more than two branches to be created at each node. For this method, 
all continuous variables need to be transformed into intervals to create discrete values.
155
  
 
Artificial neural networks: Artificial neural networks were originally developed by 
neurobiologists to create a computational method based on the way neurons operate.
89
 
Neural networks are a set of connected input and output units, which ‘learn’ their weighting 
through backpropagation.
36, 89
 This learning phase is an iterative process during which the 
weightings at each unit get adjusted to better predict the final outcome.
89
 Limitations of neural 
networks are their long learning time, making them unsuitable for large datasets, as well as 
their limited interpretability.
3, 89
 Where the outputs of a decision tree can be easily understood, 
neural networks are a black box and provide no explanation for their predictions.
3
 This 
method is discussed in more detail in chapter 9. 
 
Bayesian models: Bayesian models use Bayes theorem to calculate the likelihood of an 
observation belonging to a certain class.
3, 89
 Bayes theorem can be written as: 
 
𝑃(ℎ|𝐷) =
𝑃(𝐷|ℎ)𝑃(ℎ)
𝑃(𝐷)
 
 
This theorem shows that the probability P of hypothesis h being true, given dataset D, 
increases with probability P that dataset D is observed if hypothesis h was true, and with the 
probability P that hypothesis h is true regardless of the data. This P(h) is not dependent on 
the dataset and reflects a prior probability for hypothesis h that is based on any background 
knowledge the researchers may have.
156
 It also states that hypothesis h is less likely to be 
true if the probability P of observing dataset D regardless of h is higher. Bayesian methods 
are a key example of machine learning, as they are able to take into account prior knowledge 
and can calculate the probability for a hypothesis, rather than either confirming or refuting it.  
 
5.10.2 Descriptive methods 
Descriptive cluster analysis is an unsupervised grouping method, where no single outcome 
variable is specified. Instead, observations are grouped based on their overall similarity, 
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following the principle of “maximizing the intraclass similarity and minimizing the interclass 
similarity”
89
. This method creates descriptive rather than predictive models. Commonly used 
cluster analyses are non-hierarchical partitioning methods such as k-means and k-medians, 
hierarchical clustering and the TwoStep algorithm.
3, 89
 While not traditionally included, latent 
class analysis can also be considered a form of cluster analysis.
90
 
 
K-means: K-means is a non-hierarchical method to partition data into a predefined number of 
groups, so that all groups have at least one observation, and all observations belong to only 
one group.
89
 After an initial allocation, the mean values for each cluster are calculated. 
Observations are then allocated to the cluster with the closest mean following an iterative 
process, repeating the calculation of means and reallocation. In addition to its simplicity, k-
means is one of the most popular clustering methods because it is efficient, fast and can 
handle large datasets. K-means refers to the number of groups to be defined by the user, k, 
and the fact that the clusters are expressed as means of the clustering variables. It only works 
for continuous, numerical variables.
3, 91
 
 
K-medians: The k-means method, being based on mean values, is sensitive to outliers in the 
data. Similar to using the median instead of the mean in descriptive statistics to deal with 
outliers, it is possible to use k-medians instead of k-means.
143
 In this method the median is 
calculated for each cluster to guide the iterative process. However, this is a computationally 
intensive approach for larger datasets. 
 
Hierarchical clustering: Hierarchical clustering creates groups of observations following an 
iterative top-down or bottom-up approach.
89
 The top-down, or divisive, approach starts with 
the full population in one cluster and splits the clusters further at each step. The bottom-up, or 
agglomerative, approach starts with each observation in its own cluster, and combines 
clusters to create larger ones. The results can be displayed as a dendogram, a tree-like plot 
detailing each hierarchical step in the model.
3, 91
 This method has become somewhat 
outdated as it struggles to handle datasets with more than a thousand observations. 
 
The TwoStep algorithm: To solve the problem of data size for hierarchical models, the 
TwoStep algorithm available in SPSS incorporates a pre-clustering step before applying 
agglomerative hierarchical clustering to refine the clusters.
3
 The initial step assigns the 
observations to a large number of clusters. Observations are matched to the cluster with the 
closest mean values of the clustering attributes, but if the predefined distance target is not 
met the observation will form a new cluster. The numerous primary clusters are then merged 
following an agglomerative approach to form the final clusters. The algorithm can handle 
continuous and categorical variables.
3, 91
 However, the only options for distance measures are 
log-likelihood, which assumes a Normal distribution of the variables, and Euclidean.
91
 
 
   
 86 
Latent class analysis: Latent class analysis is not generally included in traditional data 
mining texts,
3, 36, 89
 but is commonly used for segmentation analyses in healthcare.
29, 75, 82, 84, 
157
 With the increase in computing power of the last decades and the availability of 
specialised software, latent class analysis has gained popularity as a clustering method.
90
 
The name derives from the fact that the model assumes there to be a latent class that drives 
the results of certain variables, be they continuous or categorical. The main difference with 
other clustering approaches is that latent class analysis is a model approach, and can 
calculate probabilities for observations to belong to a certain segment. 
 
5.10.3 Data mining for descriptive population segmentation 
The initial consideration in choosing a segmentation method is whether the analysis will be 
predictive, requiring a classification approach, or descriptive, using a cluster analysis. This will 
depend on the practical application of the population segmentation. If the purpose is to better 
understand a certain outcome, such as emergency hospitalisation, total cost or a high number 
of prescriptions, a predictive method should be used. The outcome metric will guide the 
creation of clusters, and each segment will contain patients with similar results. These 
predictive methods will be discussed in more detail in chapter 9, while this chapter focuses on 
descriptive methods as used in chapters 6,7 and 8. 
 
To analyse care needs across different settings, a cluster analysis is more appropriate. While 
total cost could be used to reflect the overall level of care needs, it gives no information on the 
type of care required. A cluster analysis can analyse utilisation profiles, consisting of a range 
of care utilisation variables, and compare this to other patients. Clusters can then be formed 
containing patients with a similar profile of care utilisation. 
 
To decide between the range of cluster methods available, a number of factors need to be 
taken into account
3
:  
 Applicability: The methods should be able to handle large amounts of administrative 
data, as well as the skewedness of the data 
 Understandability: The process of segmentation and the results should be easily 
understood by policymakers or healthcare professionals 
 Ease of use: The analysis can be conducted by healthcare analysts without requiring 
advanced statistical knowledge or software 
 
Hierarchical analysis cannot be used for population segmentation in this study, as the number 
of observations far exceeds the limit for this algorithm (see Table 22). The TwoStep 
programme, which incorporates hierarchical modelling in a more efficient algorithm, can 
handle larger datasets. However, the incorporation of multiple steps into one black-box 
programme makes the process less transparent. A k-medians analysis would be useful for 
skewed data but requires significant computational power and does not produce useful results 
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for variables with a median of zero. Latent class analysis requires specialised software, and is 
less intuitive as it is model based. The k-means method is a very popular and efficient 
method, and was selected for the analyses. 
 
Table 22: Overview of data mining methods for unsupervised segmentation purposes 
Method Applicability Understandability Ease of use 
K-means Continuous data only; 
very efficient method for 
large datasets; sensitive 
to outliers 
Outputs (cluster means) easy 
to interpret, calculation is 
simple and intuitive 
Included in most 
statistical packages
1
; 
requires number of 
clusters to be chosen 
K-medians Continuous data only; 
less efficient method than 
k-means but also less 
sensitive to outliers 
Outputs (cluster median) 
easy to interpret, calculation 
is simple and intuitive 
Included in some 
statistical packages
2
; 
requires number of 
clusters to be chosen 
Hierarchical 
clustering 
Continuous or binary 
data; struggles with 
dataset with more than 
1,000 observations 
Process easy to understand 
and produces visual results in 
the form of a dendogram 
Included in most 
statistical packages
1
; 
provides information on 
the number of clusters 
TwoStep Continuous and 
categorical data; efficient 
method for large datasets 
Process more complex due 
to two steps conducted in 
‘black box’ 
Included in some 
statistical packages
3
; 
decides automatically on 
the number of clusters 
Latent class 
analysis 
Continuous and 
categorical data; efficient 
method for large datasets 
Process less intuitive; results 
are probability based 
Requires specialist 
software
4
 
1. Available in SPSS & STATA 
2. Available in STATA 
3. Available in SPSS 
4. Available in neither SPSS nor STATA 
 
5.11 DISTANCE MEASURES 
5.11.1 Types of distance measures 
The distance measure is of crucial importance in cluster analysis, as it is used to determine 
how close observations are to each other, and therefore what cluster they belong in.
92
 There 
exist a large number of distance measures that can be used for cluster analysis. The most 
popular ones are the Euclidean and Manhattan distances, both a form of Minkowski distance 
measures.
89
 These are general distance measures, calculating the absolute difference 
between observations. The Canberra distance is a weighted version of the Manhattan 
distance.
92
 Another approach is to use correlation coefficients to measure dissimilarity, such 
as the Pearson correlation.
92
 
 
Euclidean distance: The Euclidean distance is the most commonly used distance 
measure.
89, 92
 It is a straightforward approach based on the sum of the physical distance for 
each variable. To calculate the distance dij between observation i and j, both consisting of p 
variables, the distance between the two observations i and j is calculated for each variable k 
by subtracting the two values xik and xjk. This approach deals with negative distances by 
calculating the square of the distances, and subsequently taking the square root of the sum. 
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𝑑𝑖𝑗 = [∑(𝑥𝑖𝑘 − 𝑥𝑗𝑘)
2
𝑝
𝑘=1
]
1/2
 
 
Manhattan or city block distance: The Manhattan distance, also known as the city block or 
taxicab distance, is similar to the Euclidean distance except it uses a rectilinear configuration, 
like traveling along a grid street plan.
89, 92
 As such it uses the absolute value of intervariable 
distances rather than the square/square root approach. 
 
𝑑𝑖𝑗 = ∑|𝑥𝑖𝑘 − 𝑥𝑗𝑘|
𝑝
𝑘=1
 
 
Both the Euclidean and Manhattan distance measures require the different variables to be 
normalised to avoid over-representing variables with a larger scale.
89
 For example, when 
patients are compared based on their number of prescriptions and number of A&E visits, 
values for the former would generally be larger than for the second. Therefore, the distances 
calculated for prescriptions are on average going to be larger than for A&E visits, and the sum 
of distances between two observations would depend mostly on the difference in 
prescriptions. By normalising each variable to the same scale (e.g. 0 to 1), each variable will 
have an equal weight in the overall distance measure. 
 
Canberra distance: The Canberra distance measure is similar to the Manhattan distance, 
but the difference of the observations is divided by the sum of the observations.
92
 
 
𝑑𝑖𝑗 = ∑|𝑥𝑖𝑘 − 𝑥𝑗𝑘|/(|𝑥𝑖𝑘| + |𝑥𝑗𝑘|)
𝑝
𝑘=1
 
 
This adjustment to the distance provides a weighting based on the absolute size of the 
observation, therefore making the results more sensitive to difference between smaller 
values. The measure produces distance values between 0 (where the two observations are 
equal) and 1 (where the difference between the two variables approaches their sum value). 
Therefore, this method requires no prior normalisation of variables. 
 
Pearson correlation: Correlation coefficients, such as the Pearson correlation, produce 
values between -1 and 1 which measure the correlation of variables between two groups.
92
 
By transforming the Pearson correlation coefficient between observations i and j, Φij, into a 
value ranging from 0 to 1 as shown below, a dissimilarity measure δij can be created. 
 
𝛿𝑖𝑗 = (1 − 𝜙𝑖𝑗)/2 
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The use of correlation coefficients to measure distances for cluster analysis is not always 
appropriate. Instead of standardising the values within each variable as required for Euclidean 
and Manhattan distance measures, correlation requires the standardisation of values within 
each observation. The standardised values lose information on actual size, and someone with 
2 prescriptions and 1 A&E visit (2:1) will be considered identical to someone with 10 
prescriptions and 5 A&E visits (10:5, or 2:1).  
 
5.11.2 Distance measures for population segmentation 
As described above, the Pearson correlation measure is not applicable to healthcare 
utilisation variables, as the size of the variables is important to the analysis. The Canberra 
distance adjusts for the relative size of the variable, and is therefore more sensitive to smaller 
values and less affected by high outliers. For a patient dataset where the majority of values 
are 0 or low counts, with a small number of very high outliers, this distance measure is most 
appropriate. However, during initial analysis this computationally intensive method struggled 
when the number of clusters got larger than four. 
 
The Minkowski distance measures – Euclidean and Manhattan – calculate the absolute 
difference between two variables. This puts more weight on the higher values, as these will 
produce larger differences, which is an issue for the skewed patient data. In addition, the 
distance between a patient with 1 or 5 hospitalisations will be the same as for patients with 
101 or 105, while in reality the latter pair can be considered much more similar than the 
former. However, the logarithmic transformation of the variables during normalisation partially 
mitigates these issues. The Euclidean distance is easy to understand as it reflects the 
physical distance between variables, and was therefore selected for this research.
91
 
 
5.12 EVALUATING THE RESULTS 
There exist a large number of data mining methods, and even within one method several 
different settings can be applied. While some choices for methods can be made upfront 
based on computational fit with the data and the type of outputs required, as discussed in the 
previous sections, others can only be decided after evaluation of the results.  
 
There are a number of quantitative tests that can be run after the cluster analysis to evaluate 
the quality of the results. However, it is important to keep in mind that, in cluster analysis, 
there is no ‘right’ answer.
16
 Grouping a deck of cards based on suit is no more right than 
based on colour. As such, evaluating cluster quality largely depends on the application of the 
segmentation. There are a number of qualitative aspects to take into consideration when 
evaluating the clustering results, in addition to any quantitative tests. Some of the aspects to 
consider in evaluating the segments are interpretability, actionability and ease of use.
3
 In the 
case of segmentation for healthcare, this means:  
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 Interpretability: The different segments can intuitively be understood by 
policymakers and healthcare professionals 
 Actionability: The people in each segment can be identified and targeted in practice 
with interventions, campaigns or care models 
 Ease of use: The segmentation can be applied and used in practice without the need 
for expert analysis 
 
5.12.1 Evaluating the number of clusters 
A k-means analysis requires the user to specify the number of clusters. This can be decided 
based on the desired number of segments, or by analysing the data for the optimal number of 
clusters. The aim of segmentation is to allocate observations to a number of groups which 
maximise the similarity between clusters and minimize the similarity within a cluster.
89
 The 
optimal number of groups will therefore depend on patterns in the data.  
 
One way to identify the optimal number of clusters is by running a series of k-means analyses 
with different numbers of clusters, and calculating the pseudo-F statistic for each. The 
pseudo-F statistic, as defined by Calinski and Harabasz,
158
 was identified as the best criterion 
to determine the number of clusters,
92
 and has been widely used in healthcare cluster 
analysis studies.
68, 159-162
 It measures the separation between clusters, taking into account the 
variation explained by the groupings, the number of clusters and the number of 
observations.
161
 A higher value indicates a greater separation between clusters, and therefore 
a better solution. 
 
Another option is to use other clustering techniques which do determine the number of 
clusters automatically, such a hierarchical clustering methods.
3, 143
 By applying these methods 
to a subset of the data, the optimal number of clusters can be derived. This number can then 
be used for a k-means clustering analysis of the full dataset. Commonly used hierarchical 
methods for this purpose are Ward’s method,
79, 146, 163, 164
 average linkage,
152
 and weighted 
average linkage.
162, 165, 166
 Average linkage is based on the average distance between the 
observations in two clusters.
143
 Weighted average linkage increases the weight of 
observations in smaller clusters, and should therefore be used if some small clusters are 
expected.
92, 165
 Ward’s method is based on minimising the total sum of squared deviations 
from the mean.
143
 This is analogous to k-means, and they are therefore often used 
together.
79, 146, 163
 
 
To determine the optimal number of clusters in an hierarchical clustering model, the two 
stopping rules that perform best and are used most often are the pseudo-F statistic, and the 
Duda and Hart Je(2)/Je(1) index.
92, 162, 165, 166
 The Je(2)/Je(1) index uses the within-cluster 
sum of squared distances from the mean to compare a current cluster to a potential further 
split.
92
 A higher value of the Je(2)/Je(1) index indicates that the current solution (Je(1)) has a 
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relatively low sum of squared distances and is homogeneous, and no further splits are 
required. Stata presents Duda/Hart’s index with a pseudo-T squared value.
167
 A rule of thumb 
for deciding on the number of clusters is to look for a clustering solution with a high 
Je(2)/Je(1) index and a corresponding low pseudo-T squared value with high pseudo-T 
squared values on either side. 
  
These methods give an indication of the mathematical fit of the clustering solution to the 
dataset. However, the number of clusters also needs to meet the practical requirements 
described before, for the segmentation to be useful. In terms of interpretability, a large 
number of segments may become difficult to oversee. On the other hand, if there are only two 
groups they will likely be more general, and therefore difficult to profile. Actionability will 
depend on how the segmentation is used, but splitting the population into two segments is 
likely to provide little actionable information, while a hundred segments would be 
unmanageable in practice. Ease of use again depends on the purpose of the segmentation, 
but generally means that the number of segments is manageable without requiring additional 
analysis for every new situation. Overall, the ideal number and size of segments will depend 
on the research question. 
 
5.12.2 Evaluating cluster stability 
K-fold cross validation and holdout or split-sample validation are two methods that determine 
a supervised model’s accuracy in predicting an outcome.
89, 155
 While unsupervised cluster 
analysis does not have a right answer to check the model against, it is possible to review how 
stable the identified clusters are. The split-sample validation method partitions the data into 
two datasets. By running the same analysis on both samples and comparing the resulting 
clusters in terms of size and characteristics, the segment stability can be compared. If similar 
segments are found in the two unique samples, the results are more likely to reflect actual 
patterns of care rather than incidental variations in the data.  
 
5.12.3 Evaluating cluster profiles 
An important aspect of evaluating a segmentation model is the interpretability and 
actionability of the segments. The segments can be profiled by comparing the mean values 
for the clustering variable to the population as a whole.
3
 For example, a segment with higher 
than average use of GP and prescribing services can be profiled as a ‘high primary care 
needs’ segment.  
 
Further profiling can also be based on non-clustering variables, like age, morbidities and 
outcomes.
3
 While these variables are not necessarily different across segments (since they 
were not included in the cluster analysis), they can provide additional insights into the created 
segments. Based on all variables, cluster profiles can be derived such as ‘older patients with 
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high primary care needs for multiple long-term conditions, at risk of emergency 
hospitalisations’. Creating these profiles allows for a qualitative review of the results. 
 
Quantitatively, clustering and non-clustering variables can be analysed to identify whether 
they are statistically different across segments. Commonly used parametric statistical tests, 
such as the Student t-test and ANOVA, rely on an assumption of Normality. However, the 
Central Limit Theorem states that if the sample is large enough, the sampling distribution of 
the mean will become Normal, no matter what the actual distribution is.
168
 
 
For some non-Normal variables, a sample of 15 may be large enough to be able to use 
parametric tests.
168
 However, the healthcare utilisation data in this research is significantly 
non-Normal and will thus require a larger sample. An analysis of similarly highly skewed 
healthcare cost data found that samples over 500 were large enough to not require the 
Normality assumption to be met.
169
 In this research, the overall sample size, and the sample 
sizes of individual clusters, are much greater, and they can therefore be compared using 
parametric tests such as t-tests and ANOVA. 
 
The alternative to a t-test or ANOVA would have been a non-parametric test such as the 
Mann-Whitney U test. Non-parametric tests compare distributions and rankings, and the 
median would therefore have been more appropriate for reporting cluster values than the 
mean. However, due to the skewedness of the data used in this research, using the median 
to measure utilisation would not expose many differences between segments. This was 
another reason to use parametric tests instead. 
 
An ANOVA test was used to compare continuous variables across multiple groups 
(segments), including age and the utilisation variables; and a Chi square test to analyse 
proportions for the LTC flags and the Townsend scores.
144, 170
 Variables that were found to be 
significantly different across segments were compared in a pair-wise fashion between 
individual clusters, to identify which clusters are different from others. This required the two-
sample equivalents of the tests mentioned above: t-tests, and z-tests respectively. 
 
Performing pair-wise tests between multiple clusters creates a multiplicity problem, where the 
chance of a false positive increases which each additional test.
171
 Therefore the significance 
level was adjusted. A commonly used adjustment is the Bonferroni method.
171-173
 This 
approach divides the normal significance level, usually 0.05, by the number of tests.
173
 For a 
4-cluster solution, requiring 6 pairwise comparisons, this would result in a significance level of 
0.05/6 = 0.0083.  
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5.13 CONCLUSION 
This research uses a random sample of 300,000 patients, reflecting the size of a typical CCG. 
Primary care data from CPRD and secondary care data from HES was linked at the patient-
level, to understand care needs across these settings and inform integrated care design. 
However, applying segmentation methods to these datasets is far from a straightforward 
process. Extensive data manipulation was needed to transform the administrative datasets 
into variables for analysis. 
 
For the whole population analysis, six utilisation variables were selected: non-elective 
inpatient hospitalisations, elective inpatient hospitalisations, outpatient appointments, GP 
practice visits, GP home visits and prescriptions. For the subpopulation and risk stratification 
analyses, which use smaller populations, the number of clustering variables was reduced. 
Moreover, emergency and non-emergency care were used rather than non-elective and 
elective care, to correspond with the emergency hospitalisations used in those studies to 
define the subpopulations. 
 
The non-Normal, highly skewed nature of healthcare utilisation complicates many of the 
analyses. The variables were therefore logarithmically transformed, and standardised using a 
min-max standardisation. Even the transformed values were non-Normal, but the sample size 
was large enough that t-tests and other tests relying on Normality could still be used. 
 
For the descriptive segmentation analyses in this research the k-means method was selected, 
as it is a simple and efficient method. This was combined with a Euclidean distance measure, 
which is easy to understand and not too computationally taxing. 
 
As opposed to traditional statistics, there are no right answers in segmentation and the results 
need to be evaluated based on both mathematical fit and practical usefulness. There exist a 
number of evaluation methods, which were applied as they fit with the different analyses.  
 
While this chapter aims to describe the choices made for this specific study, anyone wanting 
to apply these methods will need to tailor their approach to the research question and data at 
hand.
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CHAPTER 6: DEVELOPING A QUANTITATIVE EVIDENCE BASE 
FOR POPULATION HEALTH - A SEGMENTATION ANALYSIS OF A 
GENERAL PATIENT POPULATION 
 
This chapter presents the results of a segmentation analysis of a whole population. It shows 
how different care user types can be identified, and how these segments cut across traditional 
population groups. It describes how the results can be used as a quantitative evidence base 
for population health initiatives. 
 
A paper based on this research was published in Population Health Metrics journal:  
Vuik SI, Mayer E, Darzi A. A quantitative evidence base for population health: applying 
utilization-based cluster analysis to segment a patient population. Population Health Metrics. 
2016;14(1):44. 
 
Results from this research were presented at the International Conference for Integrated 
Care, 23-25th May 2016, Barcelona (Nominated for the 2016 Integrated Care Award) and an 
abstract of this presentation was published in the International Journal of Integrated Care: 
Vuik SI, Mayer E, Darzi A. Understanding population health needs: How data-driven 
population segmentation can support the planning of integrated care. Int J Integr Care. 
2016;16(6):A170. 
 
 
6.1 INTRODUCTION 
Internationally, there has been a growing focus among integrated care organisations and 
health systems on population health.
174-176
 Population health approaches aim to improve the 
overall health of an entire population.
4, 177
 They consider health and diseases across the care 
pathway, from primary prevention to acute management and recovery, to identify care 
priorities for a population at all stages.
177
 With a rising chronic disease burden, understanding 
the determinants of health and intervening early will only become more important for health 
systems trying to control cost. 
 
To be able to improve the health of a population, it is crucial to understand the specific needs 
of different groups within that population, and organise care around these groups.
13, 38, 175
 A 
common approach to divide the population is based on risk scores, where care priorities are 
set for different risks levels.
175, 178
 Counties Manukau in New Zealand use risks stratification to 
differentiate their services from preventive education for low-risk individuals to active case 
management for high-risk patients.
175
 While risk stratification can theoretically create any 
number and size of strata, the pyramid approach – which creates a small number of high-risk 
patients and a larger base of low-risk patients – is common.
55, 179, 180
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An alternative approach to understanding the care needs of a population is segmenting 
people based on characteristics such as age and long-term conditions.
12, 13
 The Whole 
Systems Integrated Care programme in North West London segments the entire population 
into groups based on their morbidities, and separates older people from adults.
12
 This 
approach allows care priorities to be identified for specific diseases and age groups. 
 
Although both approaches provide an indication of overall care needs, they do not reflect 
actual care utilisation across different care settings. Since population health often aims to 
reduce acute care in favour of primary care, insight into the use of both primary and 
secondary care services is necessary. In addition, when existing conditions are used to 
predict risk or allocate a segment, people without chronic conditions are left without 
differentiation. Yet as the primary target for prevention, this is a key population group to 
understand. 
 
An alternative that does consider different care settings, and differentiates patients regardless 
of chronic disease status, is segmentation based on care utilisation. The aim of this chapter is 
to explore the potential application of utilisation-based cluster analysis to segment a general 
patient population. This was achieved by, firstly, assessing whether utilisation-based cluster 
analysis could distinguish different groups of care users with unique health needs, and, 
secondly, by comparing the cluster results to the traditional segmentation methods described 
above.  
 
6.2 METHODS 
6.2.1 Data 
A database was constructed by linking English primary care records from CPRD, acute care 
information from HES, and the Townsend Index of Deprivation 2001, at a patient-level. The 
study used a random sample of 300,000 patients to reflect a general local population. The 
0.52% of patients with the most extreme utilisation rates were removed as this could produce 
noise in the cluster analysis, leaving 298,432 patients in the final dataset. For each patient, 
six care utilisation variables were calculated, reflecting different types of care. In addition, 
patient characteristics including long-term conditions, age, deprivation, cost and risk scores 
were extracted or calculated. For further details on the construction of the database and the 
variables in it, please refer to chapter 5. For details on the risk score, please refer to chapter 
8. 
 
6.2.2 Segmentation analysis 
A k-means cluster approach with an Euclidean distance was used for the cluster analysis, as 
it is efficient, fast and can handle large datasets.
89
 However, k-means requires the number of 
clusters (k) to be determined by the user. Hierarchical methods on the other hand can be 
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analysed for the optimal cluster number, but struggle with large datasets.
3
 Therefore 
hierarchical cluster analysis was applied to ten random samples of 3,000 patients using Stata 
14 software.
181
 Ward’s method was used as it aims to minimise the cluster sum of squares 
and can therefore be considered a hierarchical analogue for k-means.
143
 
 
For each of the ten samples the pseudo-F statistic,
158
 and the Duda and Hart Je(2)/Je(1) 
index with pseudo-T squared value,
92
 were calculated for 4- to 12-cluster solutions. While the 
pseudo-F statistic showed a gradual decrease for increasing cluster numbers without any 
discernable peaks, low pseudo-T statistics with corresponding high Je(2)/Je(1) values were 
found for 7- to 10-cluster solutions.  
 
Ward's method is sensitive to outliers,
92
 which may have caused the varying results across 
samples. Despite the log-normalisation of the clustering variables, there still were a large 
number of outliers (see Figure 17). Especially in the smaller samples used for the hierarchical 
clustering, these outliers could have changed the resulting clusters. 
 
Figure 17: Box plots of the standardised, log-normalised clustering variables 
 
 
While the quantitative analysis of the optimal number of clusters did not produce a definite 
answer, it suggested the presence of between 7 and 10 clusters. Therefore, the k-means 
method was applied to the whole population for 7, 8, 9 and 10 clusters using SPSS Statistics 
23.
182
 The results of these cluster analyses were then compared qualitatively.  
 
The 8-cluster solution improved on the 7-cluster model, by splitting a high-needs cluster into 
two distinctive groups: one with, and one without non-elective hospitalisations (see Figure 
18). Practically, these two groups are very different as one appears to have acute 
complications or exacerbations, while the other group seems to manage their complex care 
needs with elective and primary care. The 9-cluster solution however did not create any 
clinically relevant additional segments, instead identifying an additional group of patients with 
lower to average care needs. These patients did not form a distinct subgroup of one of the 8-
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cluster groups. The 10-cluster solution could therefore also be disregarded. Based on these 
analyses, the 8-cluster solution was selected. 
 
Figure 18: Qualitative comparison of the 7-, 8- and 9-cluster solutions 
 
 
6.2.3 Statistical analysis 
The segments were reviewed and profiled based on the utilisation variables, as well as other 
characteristics such as age and morbidities. The variables were analysed to identify whether 
they were statistically different across segments using ANOVA tests for continuous variables, 
and a Chi square test for the LTC flags and the Townsend scores. Variables found to differ 
significantly were then explored pair-wise between segments using t-tests and z-tests 
respectively. The significance level of 0.05 was adjusted for the pair-wise tests using the 
commonly used Bonferroni method, to account for the multiplicity problem that occurs when 
comparing multiple clusters.
171, 173
 
 
6.2.4 Cluster stability 
To understand whether the identified clusters did in fact reflect underlying patterns of care 
utilisation, or whether they were a chance observation, a split-sample validation was used. 
The total population was divided randomly into two groups, and the same cluster analysis was 
run on each half. The resulting segments were compared to each other, and to the segments 
extracted from the overall population. 
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6.3 RESULTS 
The dataset of 298,432 patients (50.5% female and 49.5% male) had an average age of 45 
years. Deprivation in the sample was lower than the national average, with 25% of people in 
the most affluent national quintile and only 12% in the lowest. The k-means cluster analysis 
produced eight clusters based on patient care utilisation patterns (see Table 23). The cluster 
analysis aims to maximise the distance between the clustering variables, and the results 
show that all utilisation variables were statistically different across segments. In addition, all 
non-clustering variables, which were not used to define the segments, were also found to 
differ significantly. Pairwise comparisons between segments showed that for some variables, 
including deprivation, this difference was caused by only one or two segments. 
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Table 23: Cluster characteristics 
 
 Cluster 
Total 
popu-
lation   1   2   3   4   5   6   7   8   
Care utilisation (clustering variables)                 
Number of non-elective inpatient 
hospitalisations per year, mean 
0.01 * 0.01 * 0.34 *** 0.00 *** 0.01 * 0.44 *** 0.00 *** 0.45 *** 0.08 
Number of elective inpatient 
hospitalisations per year, mean 
0.01 ** 0.01 ** 0.07 *** 0.13 *** 0.02 *** 0.58 *** 0.38 *** 0.34 *** 0.13 
Number of outpatient 
appointments per year, mean 
0.16 *** 0.09 *** 1.90 *** 1.65 *** 0.29 *** 5.58 *** 3.60 *** 3.99 *** 1.43 
Number of GP practice visits per 
year, mean 
0.38 *** 2.13 *** 5.54 *** 3.40 *** 6.40 *** 13.24 *** 10.06 *** 12.14 *** 5.07 
Number of GP home visits per 
year, mean 
0.00 ** 0.01 * 0.02 ** 0.01 ** 0.03 ** 0.06 *** 0.05 *** 1.94 *** 0.06 
Number of prescriptions per year, 
mean 
0.17 *** 1.66 *** 7.40 *** 3.04 *** 21.21 *** 55.62 *** 39.78 *** 86.96 *** 15.93 
Patient characteristics                  
Age at end of study period, mean 36.0 *** 34.4 *** 37.8 *** 39.1 *** 53.0 *** 61.4 *** 62.1 *** 77.1 *** 45.1 
Number of long-term conditions, 
mean 
0.0 *** 0.1 *** 0.3 *** 0.1 *** 0.3 *** 1.3 *** 0.7 *** 1.7 *** 0.3 
Proportion in residential care, % 0.0 *** 0.0 *** 1.0 *** 0.0 *** 1.0 *** 2.0 *** 2.0 *** 16.0 *** 1.0 
Predicted risk of an emergency 
hospitalisation in 2012, % 
2.7 ** 2.8 ** 5.3 *** 3.2 *** 4.3 *** 16.2 *** 6.7 *** 22.3 *** 5.2 
Townsend Deprivation Index, %  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 (affluent) 24.1 ** 26.7 *** 21.7 * 25.2 ** 25.8 ** 20.9 * 24.1 ** 21.1 * 24.7 
2 22.0 * 22.9  21.0 * 23.7  23.8  22.0  24.1  22.4  23.0 
3 21.1  20.9  20.8  20.7  20.9  21.2  21.6  22.2  21.0 
4 19.3  18.1  20.9 * 18.7  18.3  21.0 * 18.6  20.9  19.0 
5 (deprived) 13.4 ** 11.3  15.7 ** 11.7  11.3  14.9 * 11.6  13.4 * 12.4 
Disease prevalence                  
Prevalence of AMI, % 0.0 * 0.0 * 1.7 ** 0.0 * 0.5 *** 13.3 ** 1.9 ** 14.0 ** 1.7 
Prevalence of asthma, % 0.4 *** 3.9 *** 12.0 *** 5.6 *** 15.0 *** 23.6 *** 16.8 *** 20.6 *** 9.6 
Prevalence of cancer, % 0.1 ** 0.2 ** 1.7 *** 2.8 *** 1.0 *** 14.7 ** 10.9 *** 14.0 ** 3.5 
Prevalence of cerebrovascular 
disease, % 
0.0 * 0.1 * 2.1 *** 0.1 * 0.7 *** 8.9 *** 1.5 *** 15.9 *** 1.5 
Prevalence of congestive heart 
failure, % 
0.0 * 0.0 * 0.5 *** 0.0 * 0.2 *** 6.8 *** 0.8 *** 11.9 *** 0.9 
Prevalence of COPD, % 0.1 ** 0.1 ** 1.3 *** 0.4 *** 0.9 *** 10.4 *** 3.1 *** 15.1 *** 1.8 
Prevalence of dementia, % 0.0 ** 0.0 ** 0.3 ** 0.0 *** 0.2 ** 1.7 *** 0.6 *** 10.5 *** 0.5 
Prevalence of diabetes, % 0.0 *** 0.3 *** 2.5 *** 0.6 *** 8.4 *** 19.4 ** 15.4 *** 20.8 ** 5.6 
Prevalence of HIV/AIDS, % 0.0  0.0  0.0  0.0  0.0  0.0  0.0  0.0  0.0 
Prevalence of learning 
disabilities, % 
0.0  0.0  0.0  0.0  0.0  0.2 ** 0.1  0.3 ** 0.0 
Prevalence of liver disease, % 0.0 * 0.0 ** 0.2 ** 0.1 ** 0.0 * 1.0 *** 0.4 * 0.6 ** 0.2 
Prevalence of mental health 
conditions, % 
0.0 * 0.0 * 0.7 *** 0.1  0.1 ** 1.9 ** 0.4 *** 1.8 ** 0.3 
Prevalence of paraplegia, % 0.0 * 0.0 ** 0.2 ** 0.0 * 0.0 ** 1.3 *** 0.1 ** 3.1 *** 0.2 
Prevalence of peptic ulcer, % 0.0 ** 0.0 ** 0.5 *** 0.1 ** 0.2 ** 2.8 ** 0.9 *** 2.7 ** 0.5 
Prevalence of peripheral vascular 
disease, % 
0.0 ** 0.0 ** 0.6 *** 0.1 *** 0.3 *** 5.4 *** 1.7 *** 7.5 *** 0.9 
Prevalence of renal disease, % 0.0 *** 0.2 *** 1.3 *** 0.6 *** 4.0 *** 13.9 *** 8.5 *** 24.3 *** 3.5 
Prevalence of rheumatic disease, 
% 
0.0 *** 0.1 *** 0.6 ** 0.3 *** 0.7 ** 5.4 *** 3.8 *** 6.6 *** 1.2 
***: Significantly different from all 7 other clusters; 
**: Significantly different from 6 other clusters; 
*: Significantly different from 5 other clusters;  
All at 0.05/7=0.007 significance level (Bonferroni adjustment). 
All variables are significantly different across clusters at a <0.001 significance level using ANOVA or Chi Square tests 
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6.3.1 Care user segment profiles 
By comparing the average cluster values to the overall population mean, cluster profiles were 
created that describe distinct care user segments (see Figure 19).  
 
Figure 19: Care user segment profiles 
 
Segment size and cost as a proportion of the total population; Segment cost split by care type (NEIP: 
Non-elective inpatient; ELIP: Elective inpatient; OP: Outpatient; GP practice visits, GP home visits and 
prescribing); Relative care utilisation (percentage difference from the overall population mean (Pop. 
mean) – y-axes vary); Average segment age (based on age at the end of the study period); Average risk 
score (risk of an emergency hospitalisation in 2012 as a percentage, as predicted based on 2008-2011 
data); Percentage of segment with any care home use; Distribution of the number of long-term 
conditions (LTCs) among patients in the segment 
 
Segment 1: Very low overall care use 
Segment one, containing 15% of the population, is made up of young people with few chronic 
conditions. This segment has a very low utilisation, and had little to no contacts with the 
healthcare system over the five-year period. As a result they only account for 1% of the total 
healthcare cost.  
 
Segment 2: Low primary care use 
Segment two consists of young, relatively affluent people with low care needs. There is some 
use of primary care services, corresponding to a small number of people with a long-term 
condition. Asthma dominates the disease profile, a condition more common in young people. 
Segment two contains nearly a quarter of the entire population, but only accounts for 4% of 
total healthcare cost, consisting mostly of GP care.  
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Segment 3: High emergency care use 
Segment three consists of younger people with a relatively high deprivation, who have a high 
use of emergency care. While all other utilisation variables are around the population mean, 
non-elective hospitalisations are very high. Common morbidities for this group are asthma, 
cerebrovascular disease, and diabetes. The high use of non-elective care drives the overall 
cost of this segment up to 12% of the population total.  
 
Segment 4: Specialist care use 
The people in segment four are relatively low users of primary and non-elective care, but 
require more outpatient and elective care services than average. Cancer and asthma make 
up the majority of the disease burden. While this segment has a relatively low number of long-
term conditions as defined by this study, they may have other less common conditions for 
which specialist care is required. The healthcare costs for this segment are primarily for 
elective inpatient, outpatient and GP care.  
 
Segment 5: High primary care use 
The people in segment five use less acute care than average, but see their GP often and 
require more prescriptions. This is the second largest segment with 17% of the population. 
These primary care needs are likely related to their disease profile, which is dominated by 
ambulatory care sensitive conditions such as asthma and diabetes. Despite the higher than 
average use of primary care services, the prevalence of multimorbidity as well as non-elective 
hospitalisations in this segment are low. GP care and prescriptions account for the large 
majority of cost for this segment. 
 
Segment 6: Very high needs and high emergency care use 
People in segment six are older than segments one to five, with an average age of 61. The 
care needs for this segment are significantly higher, with all utilisation variables far above the 
population average. In addition, multimorbidity is common in this segment and all conditions 
are prevalent. Compared to segment seven, which is of a similar age, segment six has a high 
burden of cardiovascular conditions such as AMI, CHF and cerebrovascular disease. The 
number of non-elective hospitalisations for this segment is five times the population average, 
indicating a very high risk of acute events or complications. While this segment is the second 
smallest at 7% of the population, it accounts for over a quarter of the total cost.  
 
Segment 7: High needs but low emergency care use 
Segment seven has a higher than average usage of primary and elective care services, 
similar to segment six. However, there is a marked difference, as this group has a very low 
number of non-elective hospitalisations. They have a considerable disease burden, with 0.7 
long-term conditions on average, but fewer multimorbid patients than segment six. Cancer 
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and ambulatory conditions such as asthma and diabetes are relatively prevalent. The high 
care needs of segment seven are reflected in the high cost, made up of primary and elective 
care. 
 
Segment 8: High needs, emergency and home care use 
With an average age of 77, segment eight has the oldest patients. While all morbidities are 
more common for this group than in the average population, organic brain conditions such as 
dementia and cerebrovascular disease are particularly prevalent. Patients in segment eight 
have a large number of emergency hospitalisations, reflecting their risk of complications and 
deterioration, and a large number of prescriptions, increasing the risk of adverse drug 
reactions. In addition, they are the principal segment requiring home visits and residential 
care, which may be indicative of frailty or reduced mobility. While the segment is very small 
and only contains 2% of the population, it accounts for 9% of the total cost. 
 
6.3.2 Care user segments compared to traditional segmentation methods 
Care user segments compared to age group segments 
Segmenting a population based on age, by creating age groups, results in roughly equally 
sized segments (see Figure 20). However, each age group segment is made up of a large 
variety of care user types, as defined by the utilisation-based cluster analysis. Even in the 
older segments, where overall high care needs would be expected, all eight care user 
segments are represented. In the younger age groups, high-needs segments such as six, 
seven and eight are less common. However, this does not mean that care needs are uniform. 
Instead, the younger age groups consist of a variety of different lower needs segments. 
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Figure 20: Age group segments versus care user segments 
 
 
Care user segments compared to long-term condition segments 
Segmenting a population based on the number of long-term conditions can be considered a 
proxy for care needs, and the data confirms this (see Figure 21). Patients with two long-term 
conditions are predominantly of care user type six, seven or eight, all of which are high-needs 
segments. For the segment with three or more long-term conditions this effect is even 
stronger, with over 90% of patients in one of the high-needs segments. However, for the large 
majority of the population, segmenting on long-term condition count provides little 
differentiation. In this population, 78% of people do not have a long-term condition, and end 
up in one large segment. The care user type segmentation shows however that the patients in 
this large segment do not have homogenous care needs, but span across all eight care user 
types. 
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Figure 21: Long-term condition segments versus care user segments 
 
 
Care user segments compared to risk strata 
When using a pyramid approach to risk stratification, the sizes of the strata are per definition 
uneven (see Figure 22). The large low-risk stratum, accounting for 80% of the total 
population, consists of a wide variety of lower-needs care user types. However, even the 
smaller medium risk group is heterogeneous in terms of care needs, consisting of all care 
user segments. The top 5% of patients with the greatest risk of an emergency hospitalisation 
are predominantly in high-needs segments. However, risk stratification does not differentiate 
between different types of high-needs segments. 
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Figure 22: Risk strata versus care user segments 
 
 
6.3.3 Cluster stability 
The analysis of the split population showed that in the two split samples, which were 
completely independent of each other, the same groups of care users existed (see Figure 23). 
These segments also corresponded to the ones found in the overall population.  
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Figure 23: Cluster stability analysis 
 
 
6.4 DISCUSSION 
6.4.1 Using utilisation-based cluster to create distinct patient segments 
Eight unique care user types were identified by applying a cluster analysis to utilisation 
variables in a large patient database. The same segments were found in two unique 
populations, indicating that they reflect actual care utilisation patterns, and are not a random 
manifestation. Although the segments were defined based only on utilisation patterns, they 
each presented with unique disease patterns and demographic characteristics. This 
demonstrates that specific population health and care priorities can be identified using such 
an approach.  
 
Segments one and two both have a low long-term disease burden, making preventive care a 
key priority to maintain their health and avoid future cost. However, since people in segment 
one have little to no contact with the health system, they will need to be targeted via non-
healthcare routes. For segment three the focus should be on prevention of acute episodes, 
potentially using specialised risk prediction models that can identify patients in this segment. 
Segment four may benefit from multispecialty community providers as defined in the NHS 
Five Year Forward View,
183
 to shift some of their outpatient care to an ambulatory setting. 
Systematic care and support planning could improve outcomes for patients with chronic 
conditions in segment five.
184
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Segments six, seven and eight all require integrated care to coordinate the different care 
services they use. Case managers can also educate patients on self-management, which is 
complicated by the high rates of multimorbidity in these segments.
185
 For segments six and 
eight, preventing further complications and emergency hospitalisations is crucial. Segment 
seven however has very few emergency hospitalisations, and interventions for this group 
should focus on maintaining vitality.
186
 In addition, segment eight could benefit from 
comprehensive geriatric assessments,
187
 and medicines optimisation to avoid adverse drug 
reactions from their large number of prescritions.
188
 However, the reduced mobility and care 
home residency of this cluster should be considered for the delivery of these interventions. 
 
6.4.2 Comparing utilisation-based cluster analysis to traditional segmentation methods 
Comparing the segments identified through cluster analysis to traditional methods showed 
some high-level trends. Increasing age, long-term condition count and risk score were all 
associated with higher-needs segments. The segments with 3 or more long-term conditions, 
the highest risk scores, and over 80 year olds, consisted mainly of the high-needs segments 
six, seven and eight. Similarly, at the other end of the population, lower-needs segments were 
more common. 
 
Nevertheless, two important advantages of utilisation-based segmentation can be observed. 
Firstly, segmentation based on utilisation can identify differences between lower-needs 
population groups. While risk scores or long-term conditions allow policymakers and providers 
to identify a small group of high-needs patients, they do not provide useful information at the 
other end of the spectrum. There exists a great diversity of care needs in the lower risk strata 
and in people without multimorbidity, to which these traditional segmentation methods provide 
little insight. Although the high-needs patient are very costly, the lower needs segments make 
up around 80% of the population and are the prime target for prevention programmes. It is 
therefore crucial that a population health strategy is able to consider the disparate care 
priorities of this large group. 
 
Secondly, the care user types identified by utilisation-based segmentation provide a 
perspective on cross-setting care needs. At a high level, traditional methods correspond with 
low- and high-needs segments, but they fail to differentiate between different types of needs. 
Segment seven’s lower use of emergency care corresponds with a lower risk score, and the 
majority of these patients end up in the medium or low risk strata. However, across all other 
care settings they are high-needs patients. Segmenting based on long-term conditions 
recognises a need for care, but not how this is being delivered. Segment three and five have 
similar LTC counts, but while segment five manages their conditions with primary care 
services, segment three has a very high chance of needing emergency hospital care. These 
different types of care users have different requirements in terms of disease management, 
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prevention and education. While utilisation is still only a proxy for actual needs, it provides 
more detailed insight into the care requirements of the different population groups. 
 
6.4.3 Implications for policymakers 
A data-driven population segmentation as demonstrated in this chapter can produce novel 
insights that support evidence-based decisions on population health. Policymakers can use 
this type of analysis to develop a population health strategy that considers both care and 
prevention, includes the entire population, and delivers interventions tailored to the segment’s 
needs.  
 
In addition to providing an evidence base for population health, planning at a segment level 
rather than for specific diseases or providers can also help the integration of care. When 
policies or budgets are set by care setting, or for specific conditions, care models that aim to 
integrate care delivery across these silos will be obstructed. Instead, plans and budgets 
should be based around segments of patients with similar needs, measured across care 
settings and regardless of the type of condition, to enable integration. 
 
While this chapter focuses on the advantages of utilisation-based segmentation compared to 
other approaches, they can be used to complement traditional methods. For example, 
combining disease-based segmentation with an utilisation cluster analysis can provide in-
depth insights into condition-specific care needs, and inform capitated payment schemes or 
care plans. Alternatively, segmenting a high-risk population based on utilisation can support 
the design of more tailored interventions. 
 
Importantly, for any segmentation to be used in practice, linked healthcare datasets need to 
be available. To make informed decisions on population health, patient-level information is 
needed for each setting to understand the patient pathway across the care continuum. 
Unfortunately, access to these types of datasets is still limited.
60
 Policymakers should 
encourage and facilitate the use of data in healthcare. In addition, they could support adoption 
of these methods by investing in developing and disseminating technological guidance or 
software. 
 
6.4.4 Limitations and further research 
An important limitation of this research, in addition to the well-documented general limitations 
of using administrative data,
99, 102
 is its limited scope in terms of care settings. Knowledge 
about A&E utilisation plays an important part in understanding patient pathways from primary 
to secondary care, but data for this care setting was not yet available linked to CPRD primary 
care data. In addition, data on mental health services could significantly improve the 
understanding of overall care needs. A relatively high prevalence of mental health conditions 
in segment three suggests the use of acute hospital care for mental health emergencies, but 
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more detailed data is required to explore this further. Furthermore, if social care data could be 
linked to medical care records, segmentation could provide an evidence base to support the 
widespread move to integrate the two. 
 
Another limitation of this research is that it is based on a random selection of GP registered 
patients from across England. While GP registration is close to universal in England,
189
 this 
does leave some population groups out of scope. In addition, the results presented here may 
not be reflective of local patterns. This applies in particular to more deprived populations, 
which may see significantly higher rates of multimorbidity.
190
 Analysis of local population 
datasets would likely show different segment sizes and possibly even different segment 
types, depending on the health status of the community. While the segments detailed in this 
chapter can be used for high-level strategy decisions, it is recommend that local healthcare 
commissioners and providers run their own analyses for detailed planning. 
 
6.4.5 Conclusion 
This analysis shows how population segmentation, and in particular a data-driven approach 
based on utilisation variables, can provide a quantitative overview of a population’s care 
needs to support population health strategies. Segmenting the population based on a cluster 
analysis of utilisation variables creates a multidimensional picture of care needs, cutting 
across traditional silos such as care settings and disease groups. Long-term condition counts, 
age groups and risk scores can be used to identify the small group of high-needs patients in a 
population, but provide little useful information for primary and secondary prevention. 
Utilisation-based cluster analysis on the other hand segments the entire population into 
meaningful groups with unique care priorities, creating an evidence-base for whole population 
health strategies and integrated care models.
   
 110 
CHAPTER 7: UNDERSTANDING CARE UTILISATION PATTERNS 
PRIOR TO ACSC HOSPITALISATION - A SEGMENTATION 
ANALYSIS OF A SUBPOPULATION 
 
This chapter presents the results of a segmentation analysis of a subpopulation: patients with 
hospitalisations for ACSCs. It first shows that traditional methods, which focus only on 
primary care and overall averages, provide little insight into the drivers of ACSC 
hospitalisation. It then demonstrates how segmentation can help to identify patterns of care 
across different settings, and allows policymakers to tailor their interventions. 
 
A paper based on this research was published in the BMJ Open: Vuik SI, Fontana G, Mayer 
E, et al Do hospitalisations for ambulatory care sensitive conditions reflect low access to 
primary care? An observational cohort study of primary care usage prior to hospitalisation 
BMJ Open 2017;7:e015704. 
 
Another paper based on this research is currently under review with PLOS ONE journal 
(revisions submitted): Vuik SI, Mayer E, Darzi A. Understanding care utilisation patterns prior 
to ACSC hospitalisation: A cluster analysis. 
 
 
7.1 INTRODUCTION 
Ambulatory care sensitive conditions (ACSCs) are conditions that are generally cared for and 
managed in the community, such as diabetes, COPD and angina.
191-193
 If managed correctly, 
hospitalisations for these conditions are considered partially avoidable.
191, 194
 For this reason, 
the rate of ACSC hospitalisation has been widely used to measure the quality of primary care, 
for example by national organisations in the UK, the USA, Canada and Australia.
195-198
  
 
Despite the widespread use of these metrics, empirical review of their effectiveness is 
limited.
199
 The original list of conditions was developed by a panel of six doctors,
193
 rather 
than through data analysis, and researchers have subsequently continued to use this set of 
conditions.
199
 While studies have looked for and found correlations between ACSC 
hospitalisation rates and various predictor variables, there has been little research on the 
metrics' face validity.
199, 200
 
 
In particular, ACSC hospitalisations are considered a reflection of access to primary care.
191, 
201-207
 Whether and to what extent improved access to primary care can indeed prevent 
hospitalisations for ACSCs remains unclear.
199, 208
 Various studies have identified low access 
to primary care doctors to be related to higher rates of ACSC hospitalisation.
201-205, 207, 209
 
However, these are often ecological studies using high-level proxies for primary care access, 
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such as the density of primary care doctors in a certain region.
201-203, 209
 Other studies have 
found no relation between primary care access and ACSC hospitalisation rates.
210, 211
 
 
In addition to focusing only on access, it is debateable whether the responsibility for 
preventing ACSC hospitalisations lies solely with primary care. Integrating primary and 
secondary care, or integrating health and social care, has been shown to reduce emergency 
hospitalisations.
208, 212
 The care needs of patients with hospitalisations for ACSCs may extend 
beyond primary care, and this should be taken into account in any intervention for this 
population. 
 
Understanding what drives hospitalisations for ACSCs is the first step in developing effective 
policies to address the issue. This chapter shows how segmentation analysis can be used to 
guide the design of patient-centred integrated care programmes for this subpopulation. 
Firstly, it establishes whether there exists a patient-level, time-dependent relation between 
low access to primary care, as reflected in the number of GP contacts, and higher rates of 
ACSC hospitalisations. Secondly, it will explore how utilisation of other care providers relates 
to ACSC hospitalisations, by identifying utilisation patterns across multiple care settings.  
 
7.2 METHODS 
7.2.1 Study design 
While it is difficult to measure 'potential' care access, which includes unmet needs, 'realised' 
care access can be measured in terms of care utilisation rates.
213
 Utilisation rates were 
measured for primary care by counting the number of GP contacts, including home visits and 
telephone calls. 
 
To understand the general, long-term levels of primary care utilisation in patients with ACSC 
hospitalisations, the average number of GP contacts per six months was calculated from the 
full five years of data. To contextualise this utilisation rate and determine whether it is low or 
high, it was compared to the utilisation rates of two reference populations: patients without 
any diagnosed ACSCs, and patients with diagnosed ACSCs but no qualifying emergency 
hospitalisations. (Note that, for simplicity, the second group is called 'patients with ACSCs but 
no hospitalisations'. This only refers to qualifying emergency hospitalisations for ACSCs as 
defined below. Patients in this group may still have had elective hospitalisations, or 
emergency hospitalisations for non-ACSC causes). 
 
To explore whether a temporary lack of primary care contributes to ACSC hospitalisations, 
GP utilisation in the six months directly prior to the hospitalisation was also calculated. In 
addition, GP utilisation rates for six consecutive 30-day intervals were calculated to study 
changes in care leading up to an ACSC hospitalisation.  
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Finally, to understand how access to other care services impacts ACSC hospitalisations, 
utilisation across care settings was explored. Using a cluster analysis, different utilisation 
patterns prior to ACSC hospitalisation were identified. 
 
7.2.2 Data 
Using the CPRD and HES datasets, a database containing 300,000 patients and their five-
year (2008-2012) care activities was created. In the HES data, ACSC hospitalisations were 
identified following the definitions below. For each ACSC hospitalisation, the patient's care 
utilisation rates in the six months prior to the date of admission were calculated. This meant 
that only ACSC hospitalisations in the final 4.5 years were selected, in order to have a full six 
months of prior care activities. 
 
Utilisation rates were measured for primary care (number of GP contacts, including home 
visits and telephone calls), outpatient specialist care (number of appointments), non-
emergency inpatient care (number of non-emergency hospitalisations), and emergency 
inpatient care (number of emergency hospitalisations). 
 
The standard list of ACSCs includes both chronic and acute conditions.
214
 This study focuses 
on chronic ACSCs only, as it is interested in long-term disease management. In addition, this 
allows the comparison of care utilisation prior to an ACSC hospitalisation to the average 
utilisation of people with similar chronic conditions. A variety of ACSC conditions and coding 
practices exists,
214
 and this research used the definitions as employed in the NHS England 
Outcomes Framework,
195
 as they are specific to English administrative data (see Table 24). 
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Table 24: Definitions of ACSCs 
Condition ICD-10 and OPCS codes  
Chronic viral hepatitis If primary diagnosis is B180 or B181; and all diagnoses fields do 
not contain D57 
Asthma If primary diagnosis is J45 or J46X 
Congestive heart failure If primary diagnosis is I110, J81x, I130 or I50; and all procedure 
fields do not contain K0-K4 or K50, K52, K55-57, K60, K61, K66-
69 or K71  
Diabetes If primary diagnosis is E10-E14 
Chronic obstructive 
pulmonary disease 
If primary diagnosis is J41, J43, J44, J42X or J47X; or primary 
diagnosis is J20 and other diagnosis contain J41, J42, J43, J44 
or J47  
Angina If primary diagnosis is I20 or I25; and all procedure fields do not 
contain A-T, V, W, X0-X5 
Anaemia If primary diagnosis is D51, D52, D501, D508 or D509 
Hypertension If primary diagnosis is I10X or I119; and all procedure fields do 
not contain K0-K4, K50, K55-57, K60, K61, K66-K69 or K71 
Epilepsy If primary diagnosis is G40, G41 
Dementia If primary diagnosis is F00-F03 
Atrial fibrillation If primary diagnosis is I48X 
General criteria  
Admission method is 21-25 or 28 (emergency admission) 
Episode order is 1 (only considering the first episode in the spell, with the initial reason for 
admission) 
Patient classification is 1 (only ordinary admissions, excluding day cases and regular 
attenders)  
Episode type is 1 (no births or deliveries or mental health) 
Admission source is not 51, 52 or 53 (transfers) 
Source: NHS England
195
 
 
The diagnosis codes for ACSC hospitalisations were also used to identify patients in the 
overall population who have a diagnosis for an ACSC. The ICD-10 codes used in HES were 
translated to Read and Medcodes used in CPRD according to the TRUD translation 
mapping.
132
 Patients' disease profiles were based on a combination of both datasets, with any 
diagnosis at any point in time being considered as a positive flag for that condition. 
 
7.2.3 Analyses 
An independent t-test was used to compare the utilisation rates in the population with ACSCs 
hospitalisations to the population with diagnosed ACSCs but no hospitalisations. A general 
linear model for repeated measures was used to compare the different utilisation rates in the 
six 30-day intervals leading up to an ACSC hospitalisation. These intervals were compared 
pair-wise as well, adjusting the significance level for multiple tests using a Bonferroni 
correction.  
 
A k-means algorithm was used to cluster the utilisation patterns preceding ACSC 
hospitalisations. To determine the optimal number of clusters, the pseudo-F statistic was 
calculated for a range of solutions from 2 to 8 clusters. After the cluster analysis, statistical 
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tests for multiple groups (ANOVA and Chi) were used to identify differences between the 
clusters. 
 
7.3 RESULTS 
7,467 hospitalisations for ACSCs were identified in the sample of 300,000 people over 4.5 
years. This equates to an ACSC hospitalisation rate of 553 per 100,000 people per year. This 
is in line with crude ACSC hospitalisation rates for CCGs in 2014/15, which range from 137 to 
1,384 per 100,000.
215
 The most common ACSC hospitalisations were for angina, atrial 
fibrillation and COPD (see Table 25). 
 
Table 25: Frequency of ACSC hospitalisations 
 N % 
Anaemia 195 2.6 
Angina 1337 17.9 
Asthma 1033 13.8 
Atrial fibrillation 1285 17.2 
CHF 634 8.5 
COPD 1553 20.8 
Dementia 66 0.9 
Diabetes 682 9.1 
Epilepsy 523 7.0 
Hepatitis B 0 0 
Hypertension 159 2.1 
 
Nearly a quarter of people in the population (70,369) had one or more ACSCs (see Table 26). 
Of these, 5,190 people (7%) had one or more hospitalisations for their ACSCs, with on 
average 1.44 hospitalisations per person over the 4.5-year observation time. 
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Table 26: Sample characteristics for the three population groups 
 
People with 
no diagnosed 
ACSCs 
People with 
diagnosed 
ACSCs but no 
hospitalisations 
People with 
hospitalisations 
for ACSCs 
Total 
population 
N 229,631 65,179 5,190 300,000 
Age (average) 41 58 63 45 
Gender      
Female (%) 50% 53% 50% 51% 
Male (%) 50% 47% 50% 49% 
Number of 
diagnosed ACSCs 
(average) 
0 1.47 2.60 0.36 
Number of 
hospitalisations for 
ACSCs over 4.5 
years (average) 
0 0 1.44 0.02 
 
7.3.1 Long-term primary care utilisation 
During the study period of five years, patients with ACSC hospitalisations had significantly 
(p<0.001) more GP contacts (7.48) than people with similar conditions who did not require 
hospitalisation (5.15). 
 
People with ACSC hospitalisations also had a higher number of diagnosed ACSCs compared 
to people without hospitalisations. This can be expected to contribute to their higher utilisation 
of primacy care. To explore this effect, Figure 24 shows utilisation rates broken down by the 
number of diagnosed ACSCs. It shows similar primary care utilisation rates for people with 
ACSC hospitalisations and people with ACSCs but no hospitalisations. For the lower ACSC 
count groups, which contain larger numbers of patients, the slightly higher number of GP 
contacts for people with ACSC hospitalisations was found to be significantly different from 
people without ACSC hospitalisations. However, for people with 4 or more ACSCs there was 
no significant difference between the two groups. 
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Figure 24: Primary care utilisation split by number of diagnosed ACSCs 
 
7.3.2 Primary care utilisation prior to ACSC hospitalisation 
People with ACSC hospitalisations appear to use the same levels of GP care over the long-
term as people with similar disease profiles. However, it is possible that short-term, temporary 
lower access to primary care contributes to ACSC hospitalisations. To explore this, Table 27 
compares the average long-term utilisation rates of the three populations to the utilisation rate 
immediately prior to an ACSC hospitalisation. Rather than a decrease in care, patients with 
ACSC hospitalisations saw their GP more often in the six months preceding a hospitalisation 
(8.19 times) than their average six-month utilisation (7.48 times). 
 
Table 27: Primary care utilisation rates 
 Number of GP contacts 
over six months 
Average for people with no ACSCs 2.04  
Average for people with ACSCs but no hospitalisations 5.15  
Average for people with hospitalisations for ACSCs 7.48  
Prior to an ACSC hospitalisation 8.19 
 
To explore changes in primary care use leading up to an ACSC hospitalisation, the utilisation 
rates of six consecutive 30-day intervals were calculated. GP contacts are skewed towards 
the months closer to the hospitalisation date (see Figure 25). A repeated measures general 
linear model showed that the mean number of GP contacts is significant different (p<0.001) 
across the six 30-day intervals. Pairwise comparisons show that the peak in GP contacts in 
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the final 30 days prior to hospitalisation is significantly different from each of the five 
preceding months. (Note: the sum of these intervals (8.11) is slightly less than the six-month 
utilisation (8.19), as the latter is calculated over 182 days rather than 180; to reflect 6 
calendar months and allow comparison to the 5-year utilisation rates). 
 
Figure 25: Primary care utilisation prior to ACSC hospitalisation 
 
 
7.3.3 Utilisation patterns across care settings prior to ACSC hospitalisation 
Since no direct relation between access to primary care and ACSC hospitalisations was 
observed, other care settings were considered. To understand the different patterns of 
utilisation across care settings prior to a hospitalisation for an ACSC, a cluster analysis was 
conducted on the 7,467 hospitalisations. Peaks in the pseudo-F statistic were observed for a 
two- and a four-cluster solution (see Figure 26). The four-cluster solution was chosen as it 
provides more detail on care utilisation patterns than a two-way split. 
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Figure 26: Pseudo-F statistic for 2- to 8-cluster solutions 
 
 
Each cluster was profiled to understand its characteristics, and the differences between 
clusters were tested for statistical significance (see Table 28). All utilisation variables and 
other characteristics were significantly different across clusters, indicating unique and distinct 
patient groups.  
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Table 28: Cluster characteristics 
 
Cluster 
1 
Cluster 
2 
Cluster 
3 
Cluster 
4 
ANOVA/ 
Chi 
square 
Number of ACSCs 1680 1705 2211 1871  
Percentage of ACSCs 22% 23% 30% 25%  
Care utilisation in six months prior to hospitalisation (cluster variables) 
Average number of GP contacts 13.1 10.1 8.7 1.5 <0.001 
Average number of outpatient 
appointments 
5.6 5.3 0.3 0.6 <0.001 
Average number of emergency 
hospitalisations 
2.1 0.0 0.3 0.2 <0.001 
Average number of non-emergency 
hospitalisations 
0.7 0.7 0.1 0.1 <0.001 
Characteristics of unique patients in the cluster 
Number of unique patients 1028 1533 1884 1639  
Average number of diagnosed ACSCs 
per patient 
3.4 2.9 2.7 2.0 <0.001 
Average number of hospitalisations for 
ACSCs per patient 
2.5 1.7 1.6 1.5 <0.001 
Gender     <0.001 
Female (%) 48% 54% 55% 42%  
Male (%) 52% 46% 45% 58%  
Characteristics of the hospitalisations in the cluster 
Average age at admission (years) 64.2 64.3 64.7 50.5 <0.001 
Average duration of hospitalisation 
(days) 
6.7 5.5 5.0 4.1 <0.001 
Type of ACSC hospitalisation (percentage of total in cluster) <0.001 
Anaemia 2% 3% 3% 3%  
Angina 16% 18% 19% 18%  
Asthma 9% 10% 16% 20%  
Atrial fibrillation 14% 20% 18% 17%  
CHF 12% 10% 9% 4%  
COPD 28% 21% 22% 13%  
Dementia 1% 1% 1% 1%  
Diabetes 10% 10% 5% 12%  
Epilepsy 7% 5% 5% 10%  
Hypertension 1% 2% 2% 3%  
 
By comparing the utilisation rate of each cluster to the mean across ACSC hospitalisations, 
distinctive utilisation patterns could be identified (see Figure 27). Cluster one had a higher 
than average utilisation across all care settings, including a high risk of emergency 
hospitalisations, and people in this group could be characterised as 'High use, more 
emergencies' patients. Cluster two had above average care utilisation for all settings except 
emergency hospitalisations, which were rare in this group. They could therefore be described 
as 'High use, few emergencies' patients. Patients in cluster three mainly used GP services, 
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making them 'Primary care use' patients. Finally, cluster four had a lower than average 
utilisation of all care settings, and could be characterised as 'Low care use' patients. 
 
Figure 27: Utilisation patterns for the four clusters 
 
 
The clusters represent different utilisation patterns prior to an ACCS hospitalisation. Figure 28 
compares the utilisation rates of the identified clusters to the average utilisation rates of the 
three populations, to understand whether there is over- or underuse. There are clusters of 
hospitalisations that appear to be preceded by a shortage of care. For cluster four the 
average GP contact rate is even lower than in the population without ACSCs, despite ACSCs 
per definition requiring primary care. On the other hand however, the utilisation rates of 
cluster one are considerably higher than the average for the population with ACSC 
hospitalisations across all care settings. Cluster two has an above average utilisation of all 
services, but a number of emergency hospitalisations similar to people without ACSCs.  
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Figure 28: Utilisation rates of the four clusters compared to the three population groups 
 
 
7.4 DISCUSSION 
7.4.1 General findings 
The first objective of this study was to explore whether low access to primary care is related 
to hospitalisations for ACSCs. No evidence was found of low primary care utilisation either 
over the long term, which could affect the on-going management of the condition, or in the 
short term, prior to an ACSC hospitalisation. The results show that, over five years, patients 
with an ACSC hospitalisation in fact use more GP services compared to other patients with 
similar conditions. Even when standardising for the number of ACSC conditions, there 
appears to be no long-term lower access to GP services.  
 
Neither does there seem to be a temporary drop in utilisation. In the six months immediately 
prior to an ACSC hospitalisation, utilisation is higher than on average over the five years. In 
addition, utilisation increases every month nearer to the hospitalisation, with a significant peak 
in the last 30 days prior to hospitalisation. While there may be other aspects of primary care 
that contribute to ACSC hospitalisation rates, this research finds no evidence that low access 
to GP services is the primary driver. 
 
The next question is whether access to other care settings plays a role in ACSC 
hospitalisations. The results of the segmentation analysis show that there is not one pattern 
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of care utilisation preceding a hospitalisation. Four groups of patients, with very different care 
utilisation across care settings, were identified: 'High use, more emergencies', 'High use, few 
emergencies', 'Primary care use' and 'Low care use' patients. The clusters also exhibit 
different demographic and clinical characteristics, indicating that they represent distinct 
patient types. For example, 'Low care use' patients are more often male than female, and on 
average younger than the other patient groups. One-third of ACSC hospitalisations in 'High 
use, more emergencies' patients are for COPD, while asthma hospitalisations are more 
common for 'Primary care use' and 'Low care use' patients.  
 
Overall, there does not appear to be a single, linear relationship between access to care and 
ACSC hospitalisations. Four different groups of patients were identified; all with different 
utilisation rates across care settings. This suggests that access to care, let alone access to 
primary care specifically, is not a linear predictor of ACSC hospitalisations. Instead, much 
more complex patterns of care exist, reflecting different care needs. Interventions will need to 
be tailored to address these varying needs. 
 
7.4.2 Implications for policymakers 
The results presented here have important implications for healthcare professionals and 
policymakers. Firstly, this study suggests that low access to primary care is not a main cause 
of ACSC hospitalisations, contrary to common belief. Policymakers and clinicians trying to 
reduce emergency hospitalisations should therefore expand their focus to include other 
areas. 
 
Secondly, the heterogeneity of the care utilisation patterns prior to an ACSC hospitalisation 
shows that tailored interventions are needed to address the issue. The considerable 
differences in utilisation rates between clusters reflect varying needs, which require different 
care and prevention plans. Segmentation analysis can help to understand these patterns, and 
develop patient-centred interventions.  
 
Finally, the results presented here make the case for focusing on integrated care, rather than 
singling out primary care. The two high use clusters have high utilisation rates across a range 
of care settings, demonstrating that the responsibility of preventing ACSC hospitalisations 
cannot be put solely on the GP. For these two patient groups - which account for nearly half 
of all ACSC hospitalisations - care integration and coordination is needed across care 
settings. 
 
7.4.3 Strengths and limitations 
An important strength of this study is the use of linked, administrative data at the patient level. 
Rather than using population-level proxies for access, as has been done in previous studies 
of this topic,
201-203, 209
 this study looked at actual care utilisation immediately preceding an 
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ACSC hospitalisation. Using patient-level data, this approach can explore the direct, temporal 
relation between a patient's access to care and ACSC hospitalisation. Moreover, where 
previous studies have focused only on primary care and its role in preventing ACSC 
hospitalisations,
209-211, 216, 217
 this research includes data from a range of care settings. 
 
The research has a number of limitations. Firstly, while utilisation approximates access to 
care at the patient-level, it is still only a proxy. No differentiation can be made between low 
utilisation due to difficulty accessing services and other causes such as patients not seeking 
care. Moreover, it ignores any unmet needs. Patients may have required more care than they 
received.  
 
Secondly, access is only one aspect of care effectiveness. The fact that there appears to be 
no relation between access to primary care and ACSC hospitalisations does not mean that 
primary care has no role to play in preventing them. This paper only explores the relation 
between access to care and ACSC hospitalisations, and does not look at any other causes. 
There remain many other aspects of care quality, such as efficiency, safety, appropriateness 
and continuity,
218
 that should to be explored for their relation to ACSC hospitalisations. These 
should be considered across care settings, rather than for one setting in isolation, as nearly 
half of the ACSC hospitalisations are preceded by contacts with different care providers. 
 
7.4.4 Conclusion 
This research found no patient-level, temporal relation between low access to primary care 
services and hospitalisations for ACSCs. Instead, it identified four different patterns of care 
utilisation across various care settings. These patterns include utilisation rates that far exceed 
the average for patients with ACSCs, and others that are lower than the average for the 
general population. This heterogeneity indicates that there does not exist a single access-
related cause of ACSC hospitalisations. Instead, tailored interventions are needed that span 
different care settings. Segmentation of the subpopulation of patients with ACSC 
hospitalisations can help identify groups of patients around whom integrated care 
programmes should be developed. 
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CHAPTER 8: ENHANCING RISK STRATIFICATION FOR USE IN 
INTEGRATED CARE THROUGH POPULATION SEGMENTATION - A 
SEGMENTATION ANALYSIS OF A HIGH-RISK POPULATION 
 
This chapter presents the results of a segmentation analysis of a high-risk population. It 
shows that, while the high-risk population has higher utilisation rates overall across all care 
settings, there exist different utilisation patterns within this population. It describes how 
policymakers can use segmentation in addition to risk stratification, to better understand the 
high-risk population and tailor their interventions. 
 
A paper based on this research was published in BMJ Open journal: 
Vuik SI, Mayer E, Darzi A. Enhancing risk stratification for use in integrated care: a cluster 
analysis of high-risk patients in a retrospective cohort study. BMJ Open. 2016;6(12). 
 
Results from this research were presented as "Using Segmentation Analysis To Understand 
Utilisation Across The Care Continuum In The High-risk Population" at ISQua’s 33rd 
International Conference, 16-19th Oct 2016, Tokyo 
 
 
8.1 INTRODUCTION 
Risk stratification is seen as a core process to achieve integrated, personalised care.
49, 219
 For 
each stratum, a specific care model can be developed which addresses the needs of those 
patients. Interventions for lower-risk patients can focus on maintaining their health and 
preventing illness, while high-risk patients can be targeted with intensive care management. 
(For more details on risk stratification please refer to chapter 9). 
 
In practice in England, integrated care programmes have mainly focused on the high-risk 
patients, and provided them with primary care-led case management programmes.
51
 An 
example of such a programme is the ‘virtual wards’ model, where patients with a high risk are 
flagged on a specialised IT system (‘admitted to the virtual ward’).
51, 52
 They consequently 
receive coordinated care from multidisciplinary teams which may include GPs, social workers, 
community matrons and specialists. Another initiative is the NHS Enhanced Service 
Specification on avoiding unplanned admissions, which required GP practices to create a 
register of the top 2% of patients with the highest risk, and offer them proactive care, 
increased practice availability and improved coordination around hospital discharge (though 
this programme was cancelled in 2017).
64
 
 
However, for the purpose of integrated care, risk stratification has important limitations. 
Firstly, risk stratification only looks at one element of care: emergency hospitalisations. While 
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this can be expected to correlate with overall use of emergency acute care, utilisation of other 
care services may vary. For example, patients may require emergency acute care for a 
complex condition for which they also see a GP and specialist regularly, or they may be 
admitted as an emergency due to a complication of a long-term condition for which no primary 
care was received. To design appropriate integrated care programmes that address the 
underlying issues, understanding care use across the continuum is crucial. 
 
Secondly, while risk prediction models such as the Combined Predictive Model include 
utilisation of non-acute care settings as predictive variables, this detail is lost in the 
stratification. The same goes for other important predictors such as age, morbidities and 
socio-economic status. As a result, all patients who end up in the top stratum have high risk 
scores, but the characteristics driving this high score can be very different. When developing 
interventions, these differences should be taken into account to understand which patients 
are most likely to respond to different interventions.
178, 220
 
 
The aim of this chapter is to explore how utilisation-based segmentation can enhance risk 
stratification tools for use in patient-centred integrated care. It shows how segmentation takes 
into account care utilisation across multiple care settings, and provides insight into the 
characteristics of different patient groups within the high-risk stratum. 
 
8.2 METHODS 
8.2.1 Study design 
To show how segmentation can augment risk stratification, both methods were applied to a 
large patient database. First, a risk prediction model was trained to generate a risk score for 
each patient. Based on these risk scores, the high-risk population was identified. For this 
group, a cluster analysis was applied to four utilisation variables. The different clusters were 
analysed and profiled to understand the different patient types that exist within the high-risk 
stratum.  
 
8.2.2 Data 
The analyses were conducted for hypothetical “historic” (2008-2011) and “future” (2012) 
datasets. The historic dataset reflected the information that would be available to healthcare 
professionals conducting risk stratification at the end of 2011, while the future dataset was 
used to understand how accurately the models predicted actual utilisation in the following 
year. 
 
Both datasets were constructed from CPRD and HES data. They included patient 
demographics, long-term condition diagnoses and utilisation variables. Four high-level 
utilisation variables were selected for this analysis: emergency hospitalisations, non-
emergency hospitalisations, outpatient appointments and GP visits, to reflect different care 
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settings. Emergency and non-emergency care was used rather than non-elective and elective 
care, to correspond with the risk stratification, which is based on emergency hospitalisations.  
 
8.2.3 Risk scoring and stratification 
The PARR and the Combined Predictive Model used to be commonly applied risk prediction 
methods in England.
50, 55, 221, 222
 (see also chapter 9) However, since the discontinuation of 
national updates for both models in 2011, a wide array of tools are now being used in the 
NHS, provided by the CCGs, CSUs or commercial providers.
223
 It is therefore not possible to 
use an algorithm directly reflective of typical practice in the NHS. Moreover, the PARR tool is 
no longer publicly available and uses only acute data, and the Combined Predictive Model 
requires data from A&E, which was not available for this research. 
 
Therefore, a risk prediction score was created based on a range of predictor variables from 
PARR, the Combined Predictive Model and other risk prediction algorithms (see appendix II). 
The risk model was trained to predict emergency hospitalisations in 2012, using a stepwise 
logistic regression,
186, 224
 with the number of emergency hospitalisations in 2011 as one of the 
predictor variables, as well as the other variables detailed in appendix II.  
 
To validate the model, a split sample validation method was used, with half of the sample 
functioning as the training set and the other half as the test set. Only the test dataset was 
used for the analyses in this paper. The population was stratified into three groups, which are 
comprised of the top 5% highest risk patients (“High risk”), the top 5-20% (“Medium risk”) and 
the remaining 80% of the population (“Low risk”). 
 
8.2.4 Analyses 
For the segmentation analysis a k-means algorithm was used to cluster patients based on 
care needs, as represented by the utilisation variables. Clustering solutions ranging from 2 to 
8 clusters were explored for the high-risk stratum. To identify the optimal number of clusters, 
the pseudo-F statistic was calculated for all the clustering solutions.  
 
To create profiles for the segments, the utilisation variables as well as demographic 
characteristics were analysed to see if they differed significantly across segments. For the 
continuous variables, an ANOVA test was used, and for the binary LTC flags and the 2012 
emergency hospitalisation flag a Chi square test. Where these tests found significant 
differences across segments, the results were explored pair-wise to identify which segment or 
segments were significantly different from the others. Here, t-tests, and z-tests were used, 
respectively. To account for the multiplicity problem that occurs when performing multiple 
tests, the Bonferroni method was used to adjust the significance level.
171-173
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8.3 RESULTS 
8.3.1 Risk stratification 
The regression model only considered observations with no missing values. Since the 
Townsend deprivation score was missing for some people, the final dataset included 298,111 
people. This dataset was randomly split into a 148,791 observations training set and a 
149,320 observations test set. Of the variables originally included in the model, a number of 
diagnoses were excluded after step-wise elimination, as well as the over 75+ flag (see 
appendix II). The area under the receiver operating characteristic (ROC) curve for the test set 
was 0.75, which is in line with other risk prediction studies, which range from 0.55 to 0.83.
225, 
226
 
 
When using the risk score to stratify the population into three groups, risk predictive variables 
such as age and long-term conditions can all be seen to increase with each risk stratum (see 
Table 29). Both historic utilisation and future utilisation of all care types increase consistently 
with the risk strata (see Figure 29).  
 
Table 29: Strata characteristics 
  High risk Medium 
risk 
Low risk Total 
population 
Number of people 7,466 22,398 119,456 149,320 
Predicted proportion with any 
emergency hospitalisations in 2012 
27% 9% 3% 5% 
Actual proportion with any 
emergency hospitalisations in 2012 
27% 11% 3% 5% 
Age at end of study period, mean 75 65 40 45 
Number of long-term conditions, 
mean 
1.7 0.7 0.1 0.3 
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Figure 29: Care utilisation per risk stratum, compared to the overall population mean 
 
 
8.3.2 Segmentation of high-risk patients 
For the high-risk population, k-means cluster analyses were performed for 2- to 8-cluster 
solutions and the pseudo-F statistic was obtained for each solution (see Figure 30). A peak 
can be observed around the 3- and 4-cluster solutions. 
 
Figure 30: Pseudo-F statistic for 2- to 8-cluster solutions 
 
 
Exploring these two sets of clusters qualitatively, the 4-cluster solution included an additional, 
contrasting utilisation pattern and was therefore selected (see Figure 31). 
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Figure 31: Qualitative comparison of the 3- and 4-cluster solutions 
 
 
The clusters for the high-risk population are based on four historic care utilisation variables 
measured over 2008-2011. The clustering algorithm aims to optimise the distance between 
groups for these variables, and statistical tests confirm that historic utilisation is significantly 
different across segments (see Table 30). In addition, non-clustering variables, including 
future care utilisation, age, number of long-term conditions and most disease prevalence 
rates, also differ significantly across the clusters. 
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Table 30: Clusters within the high-risk population 
 Cluster ANOVA/ Chi 
square test 
 
1 
 
2 
 
3 
 
4 
 
Number of people 1967 
 
1807 
 
1831 
 
1861 
  
Clustering variables          
Number of emergency hospitalisations per 
year (historic), mean 
0.1 ** 0.9 *** 0.2 ** 0.8 *** An: <0.001 
Number of non-emergency hospitalisations 
per year (historic), mean 
1.0 *** 1.1 *** 0.1 ** 0.1 ** An: <0.001 
Number of outpatient appointments per 
year (historic), mean 
7.9 *** 9.3 *** 2.5 *** 3.3 *** An: <0.001 
Number of GP visits per year (historic), 
mean 
17.6 *** 16.7 ** 15.9 ** 12.5 *** An: <0.001 
Non-clustering variables          
Predicted proportion with any emergency 
hospitalisations in 2012 (based on average 
risk score), %  
21 *** 38 *** 20 *** 31 *** An: <0.001 
Actual proportion with any emergency 
hospitalisations in 2012, % 
19 ** 35 ** 21 ** 34 ** Chi: <0.001 
Age at end of study period, mean 79 *** 67 *** 83 *** 71 *** An: <0.001 
Number of long-term conditions, mean 1.8 *** 2.0 *** 1.4 *** 1.7 *** An: <0.001 
Proportion in residential care, % 5.6 * 6.8 * 5.8 * 9.3 *** Chi: <0.001 
Number of emergency hospitalisations per 
year (future), mean 
0.3 ** 0.6 ** 0.3 ** 0.6 ** An: <0.001 
Number of non-emergency hospitalisations 
per year (future), mean 
0.7 *** 0.9 *** 0.3 ** 0.3 ** An: <0.001 
Number of outpatient appointments per 
year (future), mean 
7.7 *** 9.1 *** 3.4 *** 4.2 *** An: <0.001 
Number of GP visits per year (future), 
mean 
18.5 * 17.9 * 17.5 * 14.2 *** An: <0.001 
Prevalence of AMI, % 15 *** 23 *** 10 *** 19 *** Chi: <0.001 
Prevalence of asthma, % 28 * 26 
 
24 * 25 
 
Chi: 0.028 
Prevalence of cancer, % 26 *** 22 *** 8 *** 5 *** Chi: <0.001 
Prevalence of cerebrovascular disease, % 9 ** 15 ** 10 ** 18 ** Chi: <0.001 
Prevalence of congestive heart failure, % 8 *** 13 ** 5 *** 13 ** Chi: <0.001 
Prevalence of COPD, % 18 * 17 * 13 *** 18 * Chi: <0.001 
Prevalence of dementia, % 3 ** 3 ** 5 ** 7 ** Chi: <0.001 
Prevalence of diabetes, % 28 ** 22 ** 28 ** 22 ** Chi: <0.001 
Prevalence of HIV/AIDS, % 0 
 
0 
 
0 
 
0 
 
Chi: 0.39 
Prevalence of learning disabilities, % 0 * 0 * 0 
 
0 
 
Chi: 0.032 
Prevalence of liver disease, % 1 
 
1 * 0 ** 1 * Chi: <0.001 
Prevalence of mental health conditions, % 2 * 3 * 2 * 5 *** Chi: <0.001 
Prevalence of paraplegia, % 1 ** 3 ** 1 ** 3 ** Chi: <0.001 
Prevalence of peptic ulcer, % 4 * 4 * 2 ** 3 
 
Chi: <0.001 
Prevalence of peripheral vascular disease, 
% 
8 *** 11 *** 4 ** 6 ** Chi: <0.001 
Prevalence of renal disease, % 23 * 23 * 24 * 18 *** Chi: <0.001 
Prevalence of rheumatic disease, % 10 ** 8 * 6 * 5 ** Chi: <0.001 
          ***: Significantly different from all 3 other clusters; **: significantly different from 2 other clusters; *: significantly 
different from 1 other clusters; all at 0.05/4=0.0125 significance level (Bonferroni adjustment) 
 
Risk stratification is used as a predictive tool, to understand future care utilisation. As shown 
before, the future utilisation rates for all care settings increases with each risk stratum. 
However, within the high-risk stratum, great variation in future utilisation rate can be observed 
(see Figure 32). Emergency care utilisation, which defines high-risk patients, is high for all 
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clusters. Nevertheless, clusters 1 and 3 have utilisation rates that lie closer to the average of 
the medium risk stratum. Non-emergency hospitalisations and outpatient appointments for 
clusters 3 and 4 are at or even below the medium risk stratum rate. GP care on the other 
hand is more homogenous, with the rates for each cluster closer to the high-risk average. 
 
Figure 32: Mean future care utilisation for the risk strata and high-risk clusters  
 Note: High (H), Medium (M) and Low (L) - and the four high-risk clusters: 1, 2, 3 and 4 
 
Each cluster has a unique pattern of care utilisation (see Figure 33). Cluster 1 has high 
utilisation across most care settings, with the exception of emergency care. Cluster 4 has the 
opposite pattern, with high emergency care use but low utilisation of other care settings. 
Clusters 2 and 3 have high and low utilisations across all settings, respectively. The 
difference between the clusters is strongest for historic care utilisation, upon which the cluster 
analysis is based. However, each cluster exhibits the same pattern of utilisation for future 
care as well. 
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Figure 33: Patterns of utilisation for the four high-risk clusters  
 
Note: Emergency care hospitalisations (Emg), Non-emergency hospitalisations (NEmg), 
Outpatient appointments (OP) and GP visits (GP) versus the high-risk population mean  
 
8.4 DISCUSSION 
8.4.1 General findings 
At a high level, the different risk strata correlate with care utilisation. The high-risk stratum has 
the highest historic and future utilisation of all care settings, and the medium-risk stratum has 
higher utilisation than the low-risk group. However, within the high-risk stratum there is 
significant variation in actual care needs, risk and LTC burden. 
 
The high-risk group can be split into four segments with varying care utilisation rates across 
the different care settings. Some of the high-risk clusters far exceed the average high-risk 
utilisation rate, while others are actually closer to the medium-risk stratum. There exist 
patients with low emergency care utilisation despite being high-risk, and patients with high 
emergency care needs who use very few other care services. 
 
Comparing historic and future utilisation for the four clusters, similar patterns can be 
observed, indicating that cluster analysis of historic data can help predict future needs. The 
future utilisation rates were closer to the group mean for all clusters and all care settings. This 
can be at least partially explained by regression to the mean (RTM), which is known to affect 
care utilisation predictions.
50, 145, 178
 RTM describes the phenomenon where relatively high or 
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low observations tend to be followed by less extreme observations in repeated 
measurements.
227
 This effect is compounded if subjects are stratified based on baseline 
measurements, which is the case when patients are clustered based on their 2008-2011 
utilisation. Because of RTM, the means of each cluster are expected to be closer to the 
population average in the follow-up measurement in 2012.  
 
8.4.2 Implications for policymakers 
The results illustrate the heterogeneity of the high-risk population. While many integrated care 
and case management initiatives are indiscriminately aimed at high-risk patients, the actual 
needs of these patients vary widely. Segmenting the high-risk stratum using cluster analysis 
can help tailor the approach for these different patient groups. Each cluster of high-risk 
patients presents with a unique care pattern, morbidities and demographics, which should be 
taken into account when designing interventions. 
 
Cluster 1 uses relatively few emergency care services, but has a high utilisation of non-
emergency and outpatient care. This may partially be linked to their significantly higher 
prevalence of cancer, which requires specialist, elective hospital care. Patients in this 
segment may not be the best target for primary care-led interventions aimed at reducing 
emergency hospitalisations, as their overall usage of emergency care is low and they may 
already be under the management of a specialist.  
 
Cluster 2 has the highest utilisation rates, the highest risk score and the most LTCs. 
Surprisingly, this segment is also the youngest of the four, with an average age of 67. Overall 
high care utilisation makes this cluster a worthwhile target for interventions aimed at reducing 
the need for emergency care use. As patients in this cluster have extensive care needs 
across different settings, they would likely benefit from case management and integrated care 
initiatives. 
 
Cluster 3 is at 83 years the oldest segment. Despite their old age, disease prevalence among 
the patients in this cluster is generally lower. This is reflected in their lower than average care 
use across all settings. This segment shows that while interventions often focus on older 
patients,
145, 175
 this population group does not necessarily have the highest care usage. 
 
Cluster 4 has one of the highest utilisation rates for emergency care, combined with a lower 
use of all other care services. Even GP care, which varies little for the other clusters, is well 
below average for this group. This could indicate a lack of preventative, primary care: patients 
in this cluster have on average 1.7 LTCs, but their lower usage of primary care could be 
causing complications which require emergency care. This would make cluster 4 a prime 
target for primary care interventions focused on preventing complications and emergency 
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hospitalisations. However, patients in this cluster are also more likely to be in residential care, 
where they receive in-house care that may have lowered their use of GP services. 
 
8.4.3 Limitations and future work 
There exist several limitations to this work. Firstly, the analysis only considers GP, outpatient 
and inpatient care, since no patient-level linked data was available for other settings such as 
A&E, mental health and social care. If risk stratification is used for integrated care 
programmes, including these care settings will provide a more comprehensive view of 
patients’ needs. Future research should be done using more extensive datasets where these 
settings are available. 
 
Secondly, the data is based on a random sample of patients in England. Local populations 
may see different sizes or types of segments within their risk strata. Especially if providers are 
using a risk prediction model that is considerably different from the one presented in this 
paper, they are encouraged to replicate the analysis using their own data and risk strata. 
 
In the high-risk population, clusters were identified that had a low use of emergency care, 
reflecting methodological limitations of current risk prediction methodologies. However, these 
segments comprised distinct populations with homogenous care needs and characteristics, 
indicating that the error is not random but caused by real-life factors. Further research should 
be done to identify whether segmentation methods and their results can be used to improve 
risk-scoring algorithms.  
 
8.4.4 Conclusion 
This chapter shows that, while risk stratification based on emergency hospitalisations can 
predict care usage at a high level, within the high-risk stratum there exist four very different 
patient types. These four segments have different patterns of utilisation across care settings, 
which has important implications for designing patient-centred integrated care. Interventions 
or care models targeted at high-risk patients should understand these differences and tailor 
their approach accordingly. 
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CHAPTER 9: PREDICTION METHODS AND THEIR APPLICATION 
AS A SEGMENTATION TOOL - A RISK STRATIFICATION 
ANALYSIS FOR POLICYMAKERS 
 
This chapter explores risk stratification as a segmentation method, and analyses how 
different risk prediction methods influence its perfomance. It compares traditional regression 
to more advanced ANN models. It concludes that, while there are minor differences between 
the two methods, neither has a high predictive power at the population level. Policymakers 
using risk stratification should be aware of these limitations. 
 
 
9.1 INTRODUCTION 
9.1.1 Risk stratification 
In healthcare, a small number of patients account for a disproportionally large share of 
healthcare utilisation.
228
 Identifying and targeting this group can be done through risk 
stratification. NHS England defines risk stratification as: “A systematic process that can be 
used for commissioning as it divides a population into different strata of risk for a specified 
outcome, e.g. unscheduled admission to hospital”
49
, and considers it essential to providing 
integrated services.
49
  
 
Risk stratification uses a risk score to stratify the population. An example of risk stratification 
is shown in Figure 34. Rather than pre-defined value cut-offs, the strata are generally defined 
based on population percentiles. In this example, the top stratum, ‘high risk’, includes the top 
5% of the population with the highest risk scores. The middle stratum covers the next 15% of 
the population, while the large majority of the population, 80%, falls in the low risk category. 
Due to this uneven distribution, risk stratifications are often depicted as pyramids.
179, 180, 228
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Figure 34: Risk stratification pyramid 
 
Adapted from: Wennberg
180
; Department of Health
179
; and Lewis
55
 
 
Unplanned hospitalisations, including readmissions, are often used as an outcome metric for 
this analysis as they are very costly for a health system.
55, 221
 In addition to cost, these 
hospitalisations may also indicate potentially low quality care and a poor patient 
experience.
221
 As such, unplanned hospitalisations are reflective of all elements of the triple 
aim of healthcare – quality of care, patient experience and cost
229
 – and can be considered a 
‘triple fail event’.
221
 
 
Risk stratification requires each patient to be assigned a risk score, which can be calculated 
in different ways. The majority of risk prediction models use traditional regression methods.
180, 
186, 225, 230
 The two predictive models that were widely used in the NHS for population-level 
commissioning purposes are PARR and the Combined Predictive Model, both of which were 
nationally commissioned and funded by the Department of Health up until 2011.
50, 55, 221, 222
  
 
9.1.2 PARR 
The Patients At Risk of Re-hospitalisation (PARR) algorithm was developed by strategic 
health authorities, the NHS and the Department of Health as a case finding tool.
186, 230
 The 
algorithm is based on four years of hospital data: it uses the three years prior to a triggering 
emergency hospitalisation to create a set of predictive variables, and one year after the 
triggering hospitalisation to identify any emergency re-hospitalisations.  
 
There exist two versions of the 12-month forward looking PARR score: PARR1 and 
PARR2.
230
 PARR1 only considers an emergency hospitalisation as a trigger if they are for 
one of the reference conditions. Reference conditions are conditions where improved 
management may have an impact, for example chronic diseases like angina or asthma. The 
set of reference conditions covers around 25% of all emergency hospitalisations. In contrast, 
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PARR2 considers any emergency hospitalisation as a trigger event. It therefore covers more 
patients but has been proven to be less accurate.
50
 
 
More recently, the Nuffield Trust has created a new version of the PARR score, PARR-30, 
which looks at readmissions within 30 days rather than 12 months.
225
 For acute providers the 
30 day readmissions are important as they impact reimbursement. Contrary to PARR1 and 2, 
PARR-30 considers any hospitalisation a trigger admission, including elective 
hospitalisations. To develop the PARR-30 algorithm, similar predictor variables to the 12-
month PARR score were analysed, in addition to major health conditions part of the Charlson 
index. The final model included 17 predictor variables. 
 
9.1.3 Combined Predictive Model 
The development of the Combined Predictive Model was funded by the Department of Health 
to create a metric that can be used to segment the patient population across the care 
continuum.
180
 It is therefore based on both primary and acute care data, while PARR uses 
only inpatient acute care data. It quantifies an individual’s risk of emergency hospitalisation in 
the following 12 months. The benefit of this model over PARR is that it can calculate a score 
for all patients in a population, not just for those with prior hospitalisations.
228
 However, it 
requires an integrated dataset including GP data, which is less standardised and difficult to 
obtain for commissioners. PARR runs off of SUS data (a precursor for HES data), which is 
readily and freely available to NHS organisations. 
 
To develop the Combined Predictive Model, over 850 variables were explored.
180
 The 
resulting algorithm contained 69 variables, extracted from inpatient, outpatient, A&E and GP 
data sources, covering demographics like age and gender, chronic conditions, previous 
healthcare activity, prescriptions and test results. All variables based on a healthcare activity 
were tested for different time frames, such as the last 90 days, or the last 90 to 180 days. The 
large number of variables, and the variety of sources and coding systems, make the 
Combined Predictive Model considerably more complex than PARR. 
 
9.1.4 Artificial neural networks 
The PARR and Combined Predictive models were both developed using regression analysis; 
a method that is simple to use and interpret. However, with the growing computing power 
available, more complex prediction methods, such as artificial neural networks (ANNs), have 
become a feasible alternative.
231
 
 
ANNs are a popular choice for prediction in medicine,
232-234
 because of their power and 
flexibility.
235
 In addition, ANNs are particularly useful for predicting complex processes, such 
as clinical risk. However, whether they are superior to traditional regression analyses remains 
contested. Several studies comparing ANNs to regression analysis for predicting various 
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clinical outcomes have found that ANNs perform better.
233, 234, 236
 Other studies found no 
significant increase in predictive power to justify the increased complexity of ANNs.
237, 238
 A 
review of studies comparing the two methods for predication in medicine found that while 
51% of studies favoured ANNs, 42% reported no difference.
232
 
 
ANN methods have their origins in research into brain functioning.
156, 235
 Their structure 
reflects the patterns of neural networks in the brain, in that they function through a learning 
process, and that knowledge is stored using synaptic weights connecting different neurons. A 
simple neural network model, with a feed-forward architecture allowing the network only to 
flow in one direction, consists of an input layer (the predictor variables), feeding into one or 
more hidden layers (see Figure 35).
232, 235
 The synapse between the input and the neuron is 
weighted to determine the relative contribution of the input. Each neuron combines the values 
coming in according to some formula, and produces an output for the next hidden layer, or for 
the output layer. 
 
Figure 35: Schematic overview of an artificial neural network 
 
 
The main difference from a regression model lies in the flexibly of neural networks.
235
 
Regression models require assumptions to be made, for example about whether the 
relationship is linear.
232, 235
 It is possible to include interaction terms to account for nonlinear 
effects between the covariates, but this still requires an assumption on which interaction 
variables to create.
232
 A neural network on the other hand does not require these 
assumptions, as the neurons within each layer process data in parallel and according to 
different functions. Because they are more flexible, ANNs could be expected to be more 
accurate than traditional regression methods.
234
 
 
9.1.5 Risk stratification for policymakers 
For a policymaker, it is important to understand how a prediction model preforms at a 
population level when used for risk stratification. To maximise the effectiveness of any 
intervention, true high-risk patients need to be identified. False positives will lead to 
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unnecessary care and spending, while false negatives mean that care is not reaching those 
people who need it most.
234
 The population-level performance of a model predicting the risk 
of an emergency hospitalisation will depend on the cut-off values used for the risk strata, the 
overall proportion of people with emergency hospitalisations, and the proportion of people 
included in the model. 
 
The aim of this chapter is to explore the predictive power of risk stratification from the 
policymaker's perspective. The first objective is to compare two different methods of risk 
prediction in terms of predictive accuracy. The second objective is to analyse how risk 
stratification performs at a population level, and what this means for policymakers planning 
interventions. 
 
9.2 METHODS 
9.2.1 Data 
To reflect a local population, eight CCGs in North-West London were selected: Brent, Central 
London (Westminster), Hammersmith & Fulham, Ealing, West London (Kensington & 
Chelsea), Harrow, Hillingdon, and Hounslow. For these CCGs, HES inpatient data was 
obtained for the financial years 2011/12 through to 2014/15. While a database with linked 
primary and secondary care data would provide more information, the availability of linked 
data in health systems is still limited.
50, 101, 239
 Therefore this analysis uses hospital data only, 
since this routinely collected data source is widely available to policymakers and often used 
for risk stratifcation.
99
 Consequently, the models only include people with at least one 
hospitalisation over the four-year period. 
 
9.2.2 Predictive variables 
The models were developed to predict an emergency hospitalisation in 2014/15. Data from 
2011/12, 2012/13 and 2013/14 was used for the predictive variables. The predictive variables 
were selected based on the variables in the PARR model, and the inpatient variables in the 
Combined Predictive Model.
180, 230
 Some variables in the PARR model were excluded (Sickle 
cell disease, Previous hospitalisation for respiratory infection, Observed:expected ratio for 
practice style sensitive hospitalisations in ward of residence, Observed:expected ratio for rate 
of rehospitalisation for hospital of current hospitalisation, Diagnostic cost groups/hierarchical 
condition category) as they are not generally included in other models,
226
 or the data was not 
available. 
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Table 31: Predictive variables included in the model 
Age 
Sex 
Ethnicity 
Diagnosis: AMI 
Diagnosis: Asthma 
Diagnosis: Cancer 
Diagnosis: Cerebrovascular disease 
Diagnosis: CHF 
Diagnosis: COPD 
Diagnosis: Dementia 
Diagnosis: Diabetes 
Diagnosis: HIV/AIDS 
Diagnosis: Learning disability 
Diagnosis: Mental health conditions 
Diagnosis: Liver disease 
Diagnosis: Paraplegia 
Diagnosis: Peptic ulcer disease 
Diagnosis: Peripheral vascular disease 
Diagnosis: Renal disease 
Diagnosis: Rheumatic arthritis 
Number of LTCs (sum of diagnoses above) 
Number of emergency hospitalisations in previous 90 days 
Number of emergency hospitalisations in previous 180 days 
Number of emergency hospitalisations in previous 365 days 
Total number of emergency hospitalisations in previous three years 
Average number of episodes per spell for emergency hospitalisations in previous 
three years 
Non-emergency hospitalisations in previous 365 days 
Number of different treatment specialists seen in the previous 365 days 
Hospitalisations for substance use in previous 365 days 
 
 
9.2.3 Statistical analysis 
To predict emergency hospitalisation in 2014/15, a backwards logistic regression was used 
(the 'regression' model) as well as a multilayer perceptron (the 'ANN' model), both in SPSS.
91
 
Multilayer perceptron is a popular method for ANN that has been applied to various 
healthcare problems.
237, 238
 Both models used the same split sample, where 50% of cases 
were used to train the model and the other 50% to test the model. For the regression model 
the predicted probability of having an emergency hospitalisation in 2014/15 was saved as the 
risk score, and for the ANN model a similar pseudo-probability was calculated. The 
performance of the models was examined in statistical terms, by analysing their predictive 
power, and at a population level, by exploring a hypothetical case of risk stratification in 
practice. 
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9.3 RESULTS 
9.3.1 Statistical performance of the risk prediction models 
The c-statistic, representing the area under the ROC curve, is a popular summary measure 
reflecting the overall accuracy of a model.
226, 234, 240
 Generally, models predicting risk of 
emergency hospitalisations or readmissions have c-statistics between 0.55 and 0.83 (where 
0.5 is a model performing no better than chance and 1 a perfect prediction).
226
 The regression 
and ANN model in this study had c-statistics of 0.741 and 0.753 respectively for the test 
dataset, in line with the literature. While the ANN model has a slightly higher c-statistic, some 
other performance metrics, such as specificity and precision, marginally favoured the 
regression model (see Table 32). 
 
Table 32: Comparison of model performance (cut-off at 0.5) 
Measure Model performance Interpretation 
 Regression ANN  
C-statistic 74.1% 75.3% 
The probability that, given one patient with an 
emergency hospitalisation and one without, the 
model correctly identifies which one is which 
Sensitivity/ True 
Positive Rate 
7.7% 8.8% 
The model correctly identifies x% of all people 
with an emergency hospitalisation 
Specificity/ True 
Negative Rate 
99.4% 99.3% 
The model correctly identifies x% of all people 
without an emergency hospitalisation 
Precision/ 
Positive 
Predictive Value 
55.9% 55.4% 
Of all people predicted to have an emergency 
hospitalisation, x% actually have one 
Negative 
Predictive Value 
91.2% 91.2% 
Of all people predicted to have no emergency 
hospitalisation, x% actually do not have one 
Accuracy 90.7% 90.7% Of all predictions, x% are correct 
 
The sensitivity of both models is low, at 7.7 and 8.8%. However, in this case a probability of 
over 0.5 (i.e. more likely than not to have an emergency hospitalisation) is considered a 
positive prediction. For risk stratification the cut-off is often based on a percentile score. 
Selecting, for example, the top 5% of high-risk patients requires a cut-off probability of 0.31 
and 0.26 for the regression and ANN models respectively. This increases the sensitivity to 
21.9 and 22.3% (see Table 33). However, at the same time this decreases the precision. By 
making the high-risk population larger, more patients with an emergency hospitalisation are 
captured, but the group also includes more patients without hospitalisation.  
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Table 33: Impact of different 'high-risk' cut-off values on sensitivity and precision 
 Sensitivity  Precision  
"High-risk"  Regression ANN Regression ANN 
Top 1% 6.2% 6.3% 58.7% 59.6% 
Top 2% 11.0% 11.2% 51.9% 52.8% 
Top 5% 21.9% 22.3% 41.4% 42.3% 
Top 10% 34.5% 35.2% 32.7% 33.3% 
 
 
9.3.2 Population-level performance of risk stratification 
To understand how risk prediction models perform specifically for the purpose of risk 
stratification, the ANN model was used to create a population level view. A 2% high-risk cut-
off was used, reflecting standard practice in the English NHS.
241
  
 
The results highlight the restrictions of using only hospital data for risk stratification (see 
Figure 36). In the total North West London population (based on combined populations of the 
eight CCGs
242
), only 28% of people had any inpatient activity for the three predictive years, 
and could be included in the analytical models. However, 48% of people with emergency 
hospitalisations in 2014/15 fell outside this group and had no previous hospital activity. This 
meant that only half of the emergency hospitalisations were theoretically predictable. 
 
Figure 36: Population level performance of ANN model 
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As described before, the ANN model had a 53% precision when using a cut-off value of 2% 
for high-risk. As Figure 36 shows, this means that 47% of the predicted high-risk population 
had no emergency hospitalisations in 2014/15. Sensitivity, at 11%, means that the large 
majority of people with emergency hospitalisations are not included in the high-risk group. 
 
While the high-risk population only covers a small part of the overall population with 
emergency hospitalisations, within the high-risk group the models perform better. Despite 
47% of the high-risk population having no emergency hospitalisations in 2014/15, the average 
number of emergency hospitalisations per person in the high-risk group is 1.48. This is 
because the 53% of the high-risk group that do have hospitalisations had on average 2.80 
emergency hospitalisations in 2014/15. This is compared to an overall average of 1.45 
emergency hospitalisations for people who have at least one in 2014/15. The regression 
model performed similarly, with 1.46 emergency hospitalisations per person across the entire 
high-risk group, and 2.82 per true positive in the high-risk group. 
 
9.4 DISCUSSION 
9.4.1 General findings 
While the ANN model had a slightly higher c-statistic, generally the performance metrics were 
similar to the regression model, at various cut-off levels. Despite the flexibility of ANN 
methods, they did not significantly outperform traditional regression. Considering the 
increased complexity of ANN models, which limits the end user's understanding of the 
methods and interpretation of the results, regression models may be preferred.  
 
The predictive power of both models is modest, which is a known issue associated with risk 
stratification.
178
 Even when focusing only on the top 1% of patients with the highest risk 
scores - leaving many people with emergency hospitalisations out of the high-risk population - 
the precision of the models is only around 60%. It is important to consider however that an 
emergency hospitalisation is a relatively rare event (5% of the population in 2014/15), making 
prediction more difficult.
243
 In addition, the true positives included in the high-risk population 
had a relatively high number of hospitalisations. 
 
9.4.2 Implications for policymakers 
Overall, there exist significant limitations to risk prediction that policymakers should consider 
when developing interventions based on risk stratification. A population-level view of the 
performance of risk stratification shows that many people with emergency hospitalisations are 
either not included in the model, as they have no previous hospital activity, or are not picked 
up by the model. Therefore, risk stratification may not be an appropriate tool for programmes 
aimed specifically at reducing total emergency care use in a system. However, it does 
perform reasonably well in identifying the few patients with a very high number of emergency 
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hospitalisations. Policymakers could therefore use risk stratification as a case finding tool to 
improve the quality of care and care experience for these high-risk patients. 
 
Policymakers face a trade-off between sensitivity and precision. Focusing on a very small 
high-risk population increases the precision, which means that the majority of patients in the 
target group will actually have an emergency hospitalisation. However, the sensitivity of both 
models is low, meaning a large proportion of the population with emergency hospitalisations 
is not identified as such. An important consideration here is the cost of the intervention. If the 
intervention is high-cost, for example a dedicated case manager, false positives would be 
expensive to the health system.
234
 In that case high precision is crucial. If the intervention is 
low-cost, for example mass communication, sensitivity could be favoured to reach as many 
target patients as possible. 
 
The results presented in this chapter highlight the limitations of the often-used c-statistic to 
compare predictive power.
226, 234
 Based solely on this statistic, a policymaker might decide 
that the ANN model (c-statistic=0.753) performs better than the regression model (c-
statistic=0.741). However, when looking at the issue in more detail using other performance 
metrics, different cut-off limits and at a population-level, the decision is less straightforward. 
Policymakers should explore a range of performance metrics, keeping in mind the aim of their 
specific analysis. 
 
In addition to predictive power, risk prediction methods should also be compared on their 
interpretability. Regression coefficients directly reflect the importance of the respective 
variable in predicting the outcome.
232
 This means that policymakers and healthcare 
professionals can easily trace a high risk score back to specific risk factors. Synaptic weights 
on the other hand are set at various steps and for various combinations of variables. This 
complex relation between the predictive variables and the outcome can make ANN models 
difficult to interpret.
235
  
 
While there exist many risk stratification tools that are based on only hospital data,
225, 230
 
policymakers should try to use linked datasets that go beyond the acute setting. As well as 
providing additional information, it also allows the risk stratification to include a larger portion 
of the population. However, emergency hospitalisations in people with no prior hospital 
activity are likely the result of acute events or trauma, which will remain difficult to predict. 
  
Finally, it is important to stress that risk stratification is not a solution in itself, and not all 
interventions targeted at high-risk individuals will be effective. For example, case 
management for high risk patients may not reduce emergency hospitalisations.
244
 
Policymakers should consider targeting groups of patients with a high impactability,
178
 or 
specific conditions for which hospitalisations are more easily avoided.
244
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9.4.3 Limitations and future research 
The ANN methods presented in this research are based on the options available in SPSS. 
However, there exist much more complex approaches that utilise this technique, creating 
deep learning networks.
245
 These multilayer models have dramatically improved prediction in 
other areas, and further research should be done to understand if and how they could create 
more accurate risk prediction models in healthcare. 
 
Another limitation of these results is that it is impossible to reflect all types of risk prediction 
models that would be used in practice. There exist many algorithms that are based on 
different datasets, populations, predictor variables, time periods, care settings or that focus on 
specific causes of hopsitalisation.
186, 225, 226, 246
 While the variables and approach in this 
research were chosen to reflect common practice in risk stratification, the results presented 
here may not be applicable if local risk prediction models are significantly different. 
  
9.4.4 Conclusion
 
It is important for policymakers using risk stratification to understand its predictive power at a 
population level. While ANN methods can theoretically deal with more complex problems, 
they do not significantly improve on the modest predictive power of regression models. Both 
models have a low sensitivity, meaning that risk stratification only identifies a small portion of 
all emergency hospitalisations. However, at high cut-off values (for example, the top 2% of 
high risk patients), risk stratification has a moderate precision and identifies patients with high 
use of emergency care, making it suitable as a case-finding tool for targeted individual 
interventions. When using risk stratification for this purpose, policymakers should consider 
various factors, including the cost of the intervention, when deciding on a predictive method 
and the cut-off limit. 
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CHAPTER 10: IDENTIFYING HIGH-NEEDS PATIENTS BASED ON 
A PRIORI FACTORS - A DECISION TREE ANALYSIS 
 
This chapter brings together elements of various previous chapters. It describes the 
development of a simple rule, based on a priori characteristics, which can be used to predict 
whether a person has high care needs across different settings. This rule can be used in 
data- or resource-limited situations, to identify high-needs users for integrated care initiatives. 
 
A paper based on this research is currently under review after resubmission with the 
International Journal of Integrated Care: Vuik SI, Mayer E, Darzi A. Developing a low-cost, 
low-tech population stratification tool for integrated care. 
 
 
10.1 INTRODUCTION 
Chapter 2 discussed how a number of integrated care programmes use a priori segmentation, 
where simple characteristics are used to segment the population without the need for data 
analysis. Chapter 6 described how descriptive segmentation can divide a population based 
multiple outcomes, in this case utilisation rates across different care settings. Finally, chapter 
9 discussed risk stratification, which uses risk prediction methods to identify high-risk 
individuals. This chapter aims to bring these three together. 
 
Each of the methods discussed in this thesis has its benefits and disadvantages. Descriptive 
segmentation is able to take into account multiple utilisation variables, thus describing 
patients with high needs across the care pathway, rather than focusing only on emergency 
care. However, the segments can only be identified and applied at a population level. 
Predictive risk algorithms need a population to train them, but can then be used at the 
individual level for case finding.
49
 However, risk prediction focuses on one outcome variable, 
and requires access to detailed patient-level data to train and calculate the risk scores. The 
case examples in chapter 2 highlighted that this is often a problem in practice. A priori 
methods on the other hand can be used in situations where little or no data is available, but 
their predictive power may be limited. 
 
To combine the best parts of each of these approaches, this chapter aimed to develop a 
method that predicts membership of a high-needs segment, based on a priori characteristics. 
Primary requirements for this new method were that it had low data requirements and simple 
calculations, so that it could be used without any IT, and that it identified patients with high 
care needs across different settings, who might benefit from integrated care initiatives.  
 
   
 147 
10.2 METHODS 
10.2.1 Decision tree analysis 
To develop a simple logic rule that predicts whether patients are high-needs, a decision tree 
analysis was used. Decision trees have been used to segment populations based on risk or 
outcomes.
72, 231
 A binary decision tree was used, predicting whether or not a certain patient is 
in one of the three high-needs segments as identified in chapter 6: 'very high needs and high 
emergency care use', ' high needs but low emergency care use' and 'high needs, emergency 
and home care use'. These three segments have a high utilisation across different care 
settings, and would therefore benefit from integrated care programmes. The tree was trained 
on half of the 298,432-person sample, with the other half functioning as the test dataset. The 
same training/test dataset split that was used for the risk model in chapter 8 was used in this 
analysis for the decision tree. This allowed the two methods to be compared based on the 
same data. 
 
The CART method has been widely used in healthcare research,
231, 247
 and is fast and easy to 
interpret.
247
 CART methods require a stopping rule, which determines when the algorithm 
stops splitting nodes and prevents overfitting.
231
 The rule can be based on the number of 
cases per terminal node, the marginal reduction in variance brought by another split, or the 
number of terminal nodes. For this analysis the default settings of SPSS were used, which 
limit a tree to 3 levels and require a minimum of 50 observations in a child node. Considering 
the large number of observations in the dataset, this does not overly limit the tree. The Gini 
minimum improvement criterion was used and set at 0.0002. This is higher than the default 
value of 0.0001 used in SPSS, to reduce the tree size and create a manageable and simple 
rule.
155
 
 
Predictive variables that were included in all decision tree models were age, sex, the number 
of LTCs and the Townsend deprivation score. One model also tested the number of 
emergency hospitalisations in the final year (2012) as a predictive variable. This utilisation 
variable was selected for two reasons. Firstly, of all care utilisation variables, emergency 
hospitalisations would be easiest to recollect by patients when asked. Secondly, it reflects the 
outcome variable upon which the risk prediction model is based. In addition to these 
variables, another model tested the inclusion of 11 LTCs with more than 0.5% prevalence in 
the sample (conditions with a lower prevalence, which included HIV/AIDS, learning 
disabilities, liver disease, mental health conditions, paraplegia and peptic ulcer, were left out 
to avoid overfitting). The various models were compared based on their sensitivity and 
specificity, as well as their simplicity in terms of data requirements. The results from the 
selected decision tree model were reduced to a simple rule to predict patients in the high-
need categories based on a priori characteristics. 
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10.2.2 Risk stratification comparison 
This rule-based prediction was compared to the actual allocation of patients to segments, as 
well as to predictions based on the risk of an emergency hospitalisation, which is often used 
to identify high-needs patients. The details of the risk prediction model used here have been 
described in chapter 8.  
 
10.3 RESULTS 
10.3.1 Creating the a priori high-needs prediction rule 
Three different decision tree models were tested (see Table 34). The simplest model was 
based on only four predictive variables, while models 2 and 3 contained more predictors. 
Model 2 had the highest specificity, while models 1 and 3 had a higher sensitivity. Since the 
main aim of the prediction is to find high-needs patients and provide them with integrated 
care, a high sensitivity is important.
248
 Model 1 was the simplest and had a high sensitivity 
with a high specificity, and was therefore selected. 
 
Table 34: Comparison of model performances 
Model Variables Sensitivity Specificity 
1 Age, sex, number of LTCs and deprivation score 48.20% 94.40% 
2 Model 1 + number of emergency hospitalisations in 
2012 
40.30% 96.60% 
3 Model 2 + 11 long-term condition flags 49.60% 94.20% 
 
The selected decision tree model contained a large number of nodes and branches (see 
Figure 37). However, the final groups could be combined if they predicted the same 
classification. The entire left side of the tree, under 0 LTCs, ends up in the lower-needs 
group. The group of people with 1 LTC is split into two branches based on age. In all the 
nodes under the '53 and younger' branch, people are more likely to be low-needs, while in all 
the nodes under the 'over 53' branch people are more likely to be high-needs. Finally, while 
there are several branches under the group with 2 or more LTCs, all nodes predict high 
needs. The entire tree can therefore be reduced into the following logic rule:  
 
If a person has 
 two or more LTCs, or 
 one LTC and is over 53 years old, 
they are likely to have high care needs across different care settings. 
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Figure 37: Decision tree 
   
 150 
Applying this rule to the test dataset identifies 50% of all high-needs patients; and 69% of the 
patients predicted to have high needs actually do have high needs (see Table 35). 
 
Table 35: Predictive power of a priori rule 
Measure Model 
performance 
Interpretation 
Sensitivity/True Positive Rate 50% 
The rule correctly identifies 50% of 
all high-needs patients 
Specificity/True Negative Rate 94% 
The rule correctly identifies 94% of 
all lower-needs patients 
Precision/Positive Predictive 
Value 
69% 
Of all patients predicted to have 
high needs, 69% are actually high-
needs 
Negative Predictive Value 87% 
Of all people predicted to have 
lower needs, 87% are actually 
lower-needs 
Accuracy 84% Of all predictions, 84% are correct 
 
10.3.2 Comparing the a priori rule to risk prediction models 
To understand the performance of the a priori rule for integrated care initiatives, its results 
were compared to traditional risk stratification. The rule identified 15.1% of the population as 
high-needs. The same cut-off was used for the risk stratification, marking the top 15.1% of the 
population with the highest risk scores as high-needs. Comparing the two methods on 
sensitivity and precision - the markers of how well the prediction identifies high-needs patients 
- risk stratification had a slightly higher predictive power (see Table 36). 
 
Table 36: Comparison of predictive power for the a priori rule and risk stratification 
 A priori rule Risk stratification 
Sensitivity 50% 54% 
Precision 69% 76% 
 
The two methods performed differently across the population segments (see Figure 38). 
While risk stratification identified more of the high-needs patients in the segment with 'very 
high needs and high emergency care', the a priori rule performed better in recognising people 
in the 'high needs but low emergency care' segment. This reflects the inherent bias of risk 
stratification towards emergency care. The same can be observed in the lower-needs 
segments. Risk stratification tended to wrongly classify people in the 'high emergency care 
use' segment as high-needs, while the a priori rule skewed towards the 'high primary care 
use' segment. 
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Figure 38: Percentage of people per segment identified as high-needs 
 
 
Looking at the composition of the identified high-needs populations, the largest segment for 
the a priori rule is the 'high needs but low emergency care use' group (see Figure 39). 
However, another considerable portion has only 'high primary care use'. In the high-needs 
population identified through risk stratification the greatest proportion of patients is 'very high 
needs and high emergency care use'. Overall, both methods identify mainly patients that 
actually have high care needs. 
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Figure 39: Composition of the high-needs population 
 
 
10.4 DISCUSSION 
10.4.1 General findings 
Traditional risk prediction methods calculate the risk of an emergency hospitalisation based 
on a wide range of variables, including the number of LTCs and age. The a priori rule uses 
only the latter two in a very simplistic way, yet its predictive power for identifying high-needs 
patients comes relatively close. 
 
Stratification based on the risk of emergency hospitalisations is, per definition, biased towards 
high utilisation of emergency care rather than other care settings. This means that this 
method identifies more people in high-needs segments that also have a high emergency care 
utilisation. However, there exists a high-needs segment that does not use much emergency 
care. The a priori rule is better than risk stratification in finding these people, however the 
sensitivity to this group is still relatively low at 41%. 
 
10.4.2 Implications for policymakers 
While risk prediction models are statistically better able to identify high-needs patients, they 
require detailed, patient-level data and analysis. The simplicity of the a priori rule means that 
it can be used by anyone, in any situation. For example, a community nurse visiting a patient 
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at home could identify whether they would qualify for an integrated care programme based on 
two simple questions: how old are you and how many long-term conditions do you have? 
 
In addition to the data requirements, the decision between the two methods will also depend 
on the type of integrated care programme or intervention. A high-cost programme may prefer 
to use the most accurate prediction, to ensure optimal allocation of funding. For interventions 
that can be delivered on the spot by a healthcare professional, the a priori rule could offer an 
instant assessment tool.  
 
10.4.3 Limitations and future research 
A limitation of this research is that it defines eligibility for integrated care solely on patients' 
utilisation. While high needs across different care settings logically presents an opportunity to 
integrate care, other factors should also be taken into account, such as patient engagement, 
the potential for improvement and willingness to participate on the side of the providers. 
However, these factors will depend on local circumstances and cannot easily be explored in a 
theoretical study such as this one. 
 
Another limitation that could be raised is that the simple formula was developed to predict 
high-needs patients, while the traditional risk stratification approach was trained based on 
emergency admissions. It could therefore be considered unfair to compare the two based on 
their accuracy in predicting high-needs patients. However, the aim of this analysis was not to 
compare these two approaches on paper, but to simulate how they perform in practice. The 
way risk stratification is used in England is similar to the method in this paper, based on 
emergency admissions and a regression analysis of a wide range of variables. This approach 
was compared to the hypothetical application of the simplified formula, to understand whether 
the latter would provide a feasible, practical alternative. 
 
10.4.4 Conclusion 
While risk stratification more accurately predicted whether a patient has high care needs 
across different care settings, a simple a priori rule based on the patient's number of long-
term conditions and age performed reasonably well. In situations where no data is available, 
this could provide a useful tool for integrated care initiatives to identify high-needs patients.  
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CHAPTER 11: DISCUSSION 
 
11.1 SUMMARY OF RESULTS 
Patient-centred integrated care aims to organise care around the patient and their complete 
set of healthcare needs. However, it is not feasible to develop a personalised care model for 
each individual patient. Instead, segmentation methods as applied in marketing can be used 
to divide the population into groups of patients with similar care needs. Data-driven 
segmentation methods identify patterns in the data to create segments, while a priori methods 
define the segments based on experience or prior knowledge. Data-driven segmentation can 
be descriptive, where multiple variables are used to segment the population into homogenous 
groups, or predictive, where a predicted risk score is used to stratify the population. (Chapter 
1) 
 
Segmentation can play an important role in designing patient-centred integrated care. There 
exist a number of integrated care programmes that use segmentation to identify high-needs 
patients and design tailored care plans for them. Other programmes segment an entire 
population to understand the full picture of healthcare needs. This information can then be 
used to design population health programmes, bringing together all stakeholders around a 
specific segment. While some of these initiatives used data-driven segmentation, most 
defined their segments a priori. (Chapter 2) 
 
A framework was developed which outlined four high-level applications of data-driven 
segmentation in patient-centred integrated care. Integrated care can take three population 
strategies - whole population, subpopulation or high-risk population - and descriptive 
population segmentation can inform each of these. By applying cluster analysis, the different 
patient groups within the target population can be identified and described. In addition, risk 
stratification to identify the high-risk population is also a form of segmentation, based on 
predictive rather than descriptive methods. (Chapter 3) 
 
While data-driven population segmentation is not a well-established concept in healthcare, a 
large number of studies exist that implicitly conduct segmentation analysis. The papers 
identified through a systematic review of the literature used cluster analysis to explore a 
variety of healthcare issues, from policy to care delivery. Popular methods were k-means and 
hierarchical clustering. The former can be used for very large datasets, while the latter 
provides information on the optimal number of clusters. (Chapter 4) 
 
Administrative healthcare datasets are a great resource as they provide readily available, 
standardised data for large numbers of patients. However, to be able to use this data for 
segmentation, extensive data manipulation was needed. In addition, healthcare utilisation 
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variables are highly skewed which complicated many of the analyses. It is important to keep 
in mind that in cluster analysis, as opposed to traditional statistics, there are no absolute right 
answers. Instead, the results need to be evaluated based on both mathematical fit and 
practical usefulness. 
 
For the descriptive segmentation analyses in this thesis, the k-means method with a 
Euclidean distance was selected. Through data reduction analysis, four to six care utilisation 
variables were selected for the cluster analyses, covering different care settings and types. 
However, this reflects choices made for this specific study, and in other situations these 
methods will need to be tailored to the research question and data. (Chapter 5) 
 
Whole population segmentation can be used to inform the design of macro-level integrated 
care. These programmes include an entire population and often focus on improving overall 
population health. The analysis showed that, using a cluster analysis, eight different care user 
types could be identified in a general population, each with specific care needs. These data-
driven segments cut across traditional population groups based on age or long-term condition 
counts. (Chapter 6) 
 
Data-driven segmentation can also be applied at the meso-level, to develop integrated care 
programmes for subpopulations. Traditional methods, looking at overall averages for the 
population and only one care setting, did not provide sufficient insight into the drivers of 
ACSC hospitalisations. Segmenting the population of people with hospitalisations for ACSCs 
identified four different patterns of care utilisation prior to ACSC hospitalisation. This 
information can be used to understand the different drivers of ACSC hospitalisation and 
develop tailored policies and interventions. (Chapter 7) 
 
Descriptive population segmentation can also be used together with risk stratification, to 
understand the high-risk population. The results showed that while risk stratification based on 
emergency hospitalisations can predict care utilisation at a high level, within the high-risk 
stratum there existed four very different patient types. The utilisation patterns of the four 
segments were predictive of future care use. When integrated care models are designed for 
the high-risk population, these differences should be taken into account. (Chapter 8) 
 
Risk stratification is itself a form of population segmentation, where a population is stratified 
based on a single outcome. In England there exist many integrated care initiatives and 
policies that are designed around risk stratification based on emergency hospitalisation. 
Regression models and artificial neural networks can be used to predict this risk, but their 
predictive power is limited. At the population level, traditional acute care-based algorithms 
only identify a small portion of emergency hospitalisations and leave a large group of patients 
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out of scope. It is important to understand the limitations of these methods when using them 
for integrated care interventions. (Chapter 9) 
 
A priori and risk stratification methods offer certain benefits over data-driven descriptive 
segmentation. A priori methods require no IT or data, making them easy to use in a 
community setting. Risk stratification methods are predictive rather than descriptive, and can 
therefore be used on an individual patient basis. By developing an a priori rule predicting 
membership of a high-needs segment, these benefits were combined into one approach.  
 
The analysis resulted in a rule that identified people with two or more LTCs, or one LTC and 
over 54 years old, as high-needs. This simple, a priori rule performed reasonably well 
compared to traditional risk stratification, which is based on a large number of predictor 
variables. Moreover, it was more accurate in identifying high-needs patients with low 
emergency care use. This method could provide a good alternative in settings where there is 
no data, no access to IT or where an easily identifiable subpopulation is desired. (Chapter 10) 
 
Overall, this research has shown that there exist many different applications of population 
segmentation in integrated care, and that data-driven methods can be applied to identify 
patient segments in administrative datasets. Descriptive segmentation of a whole population, 
subpopulation or high-risk population provides new insights into the different patient groups 
within that population. Predictive segmentation, such as risk stratification, can be used at the 
individual patient-level to predict care needs. All of these data-driven segmentation methods 
allow programmes and interventions to be designed around the patient's needs across the 
care continuum, creating patient-centred integrated care. 
 
11.2 CONTRIBUTIONS TO THE FIELD 
There exists very little literature on the topic of population segmentation in healthcare or 
integrated care. A number of studies apply clustering methods and implicitly carry out a data-
driven segmentation analysis – a few of which mention integrated care as an application
29, 96, 
157, 249, 250
 – but they do not discuss the general concept of segmentation. No other reviews of 
data-driven segmentation methods in healthcare were found. This thesis therefore makes an 
important contribution in defining the topic and methodically analysing the applications, 
methods and complications. A more explicit approach to segmentation may improve the 
quality of the analyses and widen its uptake and application. 
 
In addition to exploring a novel topic, this research also describes novel methods. The studies 
that do specifically describe segmentation in healthcare generally focus on high-level a priori 
approaches to segmentation.
38, 39, 251
 The results of this research show that a data-driven 
approach, based on data mining techniques such as cluster analysis, can be used to identify 
different and sometimes unexpected segments. It advocates the use of more advanced data 
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analysis to create a quantitative evidence base for integrated care design, using methods that 
are nowadays easily accessible in standard statistical software. 
 
Risk prediction and stratification are more established in the literature as tools for integrated 
care. However, the majority of existing papers focus on the models' internal statistical 
predictive power rather than their performance at a population level.
186, 225, 226, 252
 For 
policymakers, the population-level implications are important to understand when using these 
methods to design care models and interventions.  
 
Moreover, this research presents a case study of how big data and advanced data analysis 
can be used in healthcare, where generally the use of these methods is limited. Healthcare 
organisations generate a wealth of data every day, and more advanced methods are needed 
to analyse this information and extract knowledge. The results of this study describe one of 
the many ways machine learning techniques can be used to improve the quality of care. 
 
11.3 IMPLICATIONS AND RECOMMENDATIONS FOR POLICYMAKERS 
The analyses presented in this thesis demonstrate the heterogeneity of patient populations, 
and policymakers should consider this when designing integrated care models. They can use 
segmentation to understand the different population groups they serve and to tailor policies, 
care models and interventions. 
 
When deciding on a segmentation approach, it is important to consider the aim of the 
initiative. Whole system integrated care programmes can use descriptive segmentation to 
inform their strategies and population health programmes. When integrated care initiatives 
are aimed at a subpopulation or high-risk patients, descriptive segmentation can be used to 
understand differences within this target population.  
 
Predictive segmentation should be used at an individual level, to ascertain whether a specific 
patient is within the target population. Risk stratification can be used for predictive population 
segmentation, but it is important to be aware of the limitations of this method. The algorithms 
have limited predictive power, and are skewed towards the use of emergency acute care. 
Moreover, the high-risk stratum does not have homogeneous care needs. A descriptive 
segmentation analysis of the high-risk population can help understand differences between 
patients and predict future needs across care settings.  
 
Where no data is available, a priori methods can be used for predictive population 
segmentation. However, traditional a priori segments, based on only age or long-term 
conditions, do not necessarily provide homogeneous segment. If possible, data-driven 
methods should be used to develop the a priori criteria, which can thereafter be used without 
IT or data. 
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The concept of segmentation comes from the marketing industry, where is it is used 
extensively. While the objectives of the healthcare industry are different, this research shows 
that the same methods can be used to generate new insights into patient populations. This 
research focuses on integrated care, but the applications of segmentation are extensive. 
Policymakers should consider using segmentation to design patient-centred care and policies 
in all areas of healthcare. 
 
Throughout this research, the importance of data - and the lack of access to it - has been a 
consistent theme. Policymakers need to commit to making patient-level data available, linked 
across care settings, and in a secure and confidential way. Big data is playing a major part in 
transforming other industries, and healthcare cannot afford to lack behind. The analyses 
presented in this thesis are only the tip of the iceberg of the potential that big data presents. 
 
While this research primarily focuses on the application of segmentation by policymakers, 
these methods can also be used by others, including NHS commissioners and healthcare 
professionals. For NHS commissioners, segmentation can provide vital information for the 
creation of capitalised payments. In North West London, population segmentation was used 
to calculate the per person cost within specific population groups, and to understand which 
providers need to be included in a capitated payment for each population group.
12
 Grouping 
people with similar care needs will reduce variation in cost and therefore risk for integrated 
care providers relying on capitated payments. 
 
For healthcare professionals, segmentation can be used to identify high-risk patients, as 
described in several of the examples in this thesis, or to describe the general profile of a 
patient. However, it is important to note that if this segment data is not linked to a specific 
intervention or treatment protocol, this information is likely of very little use in day-to-day 
medical practice.  
 
Instead, the model needs to be developed according to ‘choice architecture’, which aims to 
link analytics to choices or actions through recommendations, alerts or even automated 
actions.
253  
In the example of Kaiser Permanente’s Senior Segmentation Algorithm, the 
segment allocation in the electronic health record was used to recommend specific actions to 
the medical team, such as an assessment of complex social and caregiver needs.
42
 This 
approach can help improve adherence to guidelines, early detection of adverse events or 
deterioration, and reduce workload for doctors through automation. However, it is crucial that 
the choice architecture is designed in cooperation with the end-users (doctors and other 
healthcare professionals), to ensure it is tailored to their requirements.  
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Segmentation can also be used at the practice level, for strategic and planning purposes. For 
example, segment information can be used to automatically allocate different consultation 
times – reserving longer time slots for patients in complex, high-needs segments. 
 
11.4 ETHICAL IMPLICATIONS 
Population segmentation is associated with important ethical implications, around the use of 
data as well as the concept of segmentation. 
 
There exists a chance that the use of segments, which aims to make care more patient-
centred by moving away from a one-size-fits-all model, actually leads to less patient-centred 
care. Healthcare professionals focussing on the segment allocation may overlook the 
individual patient’s needs. It is therefore crucial that any IT or data-driven tool is used only for 
decision support, and that doctors have the power to override the system if this is in the 
individual patient’s best interest.
253
 Specific prompts should be included in the tool to 
encourage doctors to explore individual patients’ needs and preferences that cannot be 
understood from clinical data.  
 
Where segmentation is used for case-finding rather than high-level planning, there exists the 
risk that providers (particularly private providers who have more freedom to select patients) 
use segment predictions to cherry-pick patients in healthier segments and avoid higher-need 
patients.
253,254
 This would have serious consequences for the individual patient, as well as 
exacerbating existing health inequalities. These concerns are not limited to segmentation, but 
apply to patient-level data and predictive analytics in healthcare in general. To ensure that the 
move to an electronic and data-driven healthcare system benefits everyone, legislation and 
well-designed reimbursement systems are needed to mitigate the risks of cherry-picking.
254
 
 
Linking data across different settings and using identifiable patient data is subject to privacy 
concerns and needs to be strictly governed. While it is not clear whether specific opt-in 
consent is required for the use of predictive methods in a patient-doctor encounter,
253
 patients 
need to be able to opt-out of data sharing schemes. It is important to note that the 
communication of consent policies is key to the success of any data programme. One of the 
reasons the care.data scheme failed was the lack of communication, clarity and access to the 
opt-out procedure, which harmed public trust in the programme.
255
 Careful public consultation 
and engagement is needed to secure a social license for the use of patient-level data for 
segmentation. 
 
In general, the use of patient data carries risks that need to be mitigated, with an important 
role for clear and strong governance.
60
 In addition, new safeguarding technologies can 
provide additional security and surveillance. For example, trust networks can provide a legal 
framework for sharing and accessing data by labelling each variable with restrictions around 
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its use.
60
 New data security technologies developed in other industries can be adapted to 
protect healthcare data. Google is using blockchain technology, the concept behind the 
electronic currency Bitcoin, to protect the healthcare data they use.
256
 In addition to securing 
data, this technology also creates a ledger that records all instances the data is accessed, 
providing essential information for audits. 
 
11.5 STRENGTHS 
An important strength of this research is its focus on data-driven segmentation, thus avoiding 
the biases caused by using a priori segmentation methods. The results show that some 
commonly used a priori groups, such as age or number of long-term conditions, do not predict 
care utilisation across all care settings. Data-driven methods like cluster analysis look at the 
patterns of care usage first and determine the characterising patient features post-hoc. 
Nevertheless, a priori methods are easy to use in practice and this is an important benefit. 
This research therefore also defines a priori characteristics for use in integrated care, based 
on data-driven segmentation. 
 
Methodologically, a strength of this research is its use of linked primary and secondary care 
data. Despite the existence of NHS identifiers, it is still difficult to obtain and analyse data 
from different care settings linked at the patient level. Using linked primary and secondary 
care data, this research has shown that some patients use numerous services across various 
settings, while others only require one type of care. For an integrated care initiative, it is 
important to understand these differences and target the right subpopulations. 
 
The population size of 300,000 patients is another strength of this research. It is a large 
sample, and the results of many analyses were statistically significant. In addition, it reflects a 
real-life situation. In England, CCGs are responsible for the planning and commissioning of 
care for local populations. The sample size in this study is similar to the population of a CCG 
in the 75
th
 percentile,
189
 and therefore it reflects a typical local population in England. This 
ensures that the effects observed in the analyses would also be found in a real-life setting. 
 
11.6 LIMITATIONS 
There are a number of important limitations associated with this research, in addition to the 
analysis-specific limitations discussed in the relevant chapters (and not repeated here).  
 
Firstly, this research only looks at one way of segmenting a patient population: based on care 
utilisation. Utilisation was chosen as it can be considered a proxy for care needs, which are 
important to understand for integrated care. However, there exist many other applications of 
segmentation, in integrated care and beyond. The results presented here should therefore be 
considered as a proof of concept, and in no way an exhaustive overview. 
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Secondly, utilisation is only a proxy for care needs. It is important to note that this metric 
measures the patient's frequency of contact with healthcare providers, but it does not 
consider other aspects of care such as the length of the contact, the quality of the care 
provided, or instances where a patient needed care but did not receive any. 
 
Thirdly, the dataset used in this research may not accurately reflect a typical population. 
While the CPRD dataset is broadly representative of the age, sex and ethnic composition of 
the UK population,
104
 the study sample was more affluent that the UK average. In addition, 
information in this type of routine dataset is imperfect. Routine administrative healthcare data 
is often inputted by healthcare workers who have conflicting priorities in their daily activities 
and may have a limited understanding of the purpose of the data.
99
  
 
The recording of diagnoses, in particular for underdiagnosed conditions such as diabetes and 
depression,
102
 is one issue that may have affected the results in this study. The prevalence of 
chronic conditions for the study population, which was based on diagnoses in care records, 
was lower than the average prevalence in the UK population, as calculated from disease 
registries. 
 
The representativeness of the data was further reduced by the limited number of practices 
(57%
104
) that participated in the CPRD linkage scheme. As this research required linked HES 
data, the remaining 43% of practices were left out of scope. Factors that may have influenced 
the practices’ decision to participate in the linkage scheme, for example size or resources, 
would have been reflected in the data used for this study. While these data limitations may 
have affected the representativeness of the population and changed the characteristics of 
segments, they are unlikely to have changed the overall validity of using segmentation as a 
tool. 
 
Fourthly, choosing the optimal number of clusters proved to be complex at times. There exist 
many different methods and approaches to evaluate the number of clusters, including 
quantitative indicators like the pseudo-F statistic, hierarchical cluster analyses of subsamples, 
analysing the resulting clusters for statistically significant differences, and qualitative review 
based on the interpretability and applicability of the results. No one method performed well for 
all the analyses in this research. Therefore, different approaches were used combining 
multiple evaluation techniques. 
 
Finally, the research presented here is theoretical, and focuses only on the data analysis 
phase of designing integrated care. The suggested integrated care initiatives for the various 
segments need to be tested and evaluated to understand whether the approach is effective. 
However, the effectiveness of segmentation in improving care quality, patient experience or 
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reducing cost partly depends on the effectiveness of the intervention. This complicates 
effectiveness research for segmentation, as the evidence on the general effectiveness of 
primary care and care coordination initiatives for high risk patients in inconclusive.
178,208
 In 
addition, since segmentation in integrated care is a relatively new concept, there exist no 
studies explicitly researching its impact on care quality or other outcomes. 
 
Nevertheless, evidence from experience does indicate that segmentation can help create 
more effective integrated care interventions. A review of 18 successful primary care or 
integrated complex care management programmes found that effective programmes used 
qualitative and quantitative approaches to identify their target population, and tailored the 
composition of their care management team to this target population.
257
 These programmes 
showed decreases in utilisation and cost, and improvements in quality of care and of life. 
Another review of 45 programmes aimed at high-need, high-cost individuals found that many 
successful programmes – defined as significantly improving at least one of the three elements 
of the triple aim – targeted a narrow subpopulation, and stratified the population enrolled in 
the programme to provide additional services to certain high-need, high-cost individuals.
258
 
 
11.7 FUTURE RESEARCH 
This research aimed to define the potential application of data-driven segmentation in 
designing patient-centred integrated care. It has shown that there is significant potential to 
use segmentation, opening up a range of new research avenues. 
 
An important limitation of this research is that it only uses primary and secondary care data. 
To truly understand people's total health and social care needs, and design integrated care 
models around this, patient-level linked data is needed from mental healthcare, community 
and social care. Segmentation of such a dataset could inform whole system integration. 
 
Administrative healthcare data was used in this research as it directly applies to healthcare 
services and is available in a coded, structured format. However, other big data sources also 
offer great potential and should be explored. For example, social media data could be used to 
understand what patients think and talk about; mobile GPS data could be used to understand 
where people go in their daily life; and supermarket loyalty card information could provide 
insight into shopping and eating habits. 
 
The concept of segmentation as presented in this research was adopted from commercial 
marketing. This suggests that there may be more data analysis practices that healthcare 
could adopt from other industries. Customer insights form a key part of almost every modern 
company's strategy, and healthcare organisations should learn how they too could use the 
extensive amounts of data available to their advantage. 
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Future research could also explore the use of more advanced methods. Deep learning and 
other artificial intelligence approaches could take pattern recognition and segment discovery 
to a new level. In this research the clustering variables were predefined (utilisation rates), 
creating an element of a priori assumptions. Deep learning algorithms would be able to 
analyse the data with little to no prior inputs, potentially discovering unexpected patterns. 
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APPENDIX I: OVERVIEW OF STUDIES INCLUDED IN THE 
SYSTEMATIC REVIEW 
 
Authors Year Title Country Segmen-
tation 
base 
Topic Data mining 
methods 
Suggested 
application  
Alonso-
Morán et al. 
2015 Multimorbidity in people 
with type 2 diabetes in 
the Basque Country 
(Spain): Prevalence, 
comorbidity clusters and 
comparison with other 
chronic patients 
Spain Patient 
type 
Morbidity 
patterns 
Hierarchical 
clustering 
(Ward's) 
Design of care 
delivery models 
Armstrong 
et al. 
2012 K-means cluster 
analysis of rehabilitation 
service users in the 
home health care 
system of Ontario: 
Examining the 
heterogeneity of a 
complex 
geriatric population 
Canada Patient 
type 
Types of 
older people 
K-means Planning and 
resource 
allocation; Design 
of care delivery 
models 
Bamvita et 
al. 
2014 Portraying persons who 
inject drugs recently 
infected with hepatitis C 
accessing antiviral 
treatment: a cluster 
analysis 
Canada Patient 
behaviour 
Treatment 
decisions 
TwoStep Development of 
individual care 
plans 
Basen-
Engquist et 
al. 
2007 Patient assessment of 
tests to detect cervical 
cancer 
USA Patient 
behaviour 
Screening 
decisions 
K-means Development of 
new 
technologies/drugs 
Becue-
Bertaut et 
al. 
2008 Health-risk behaviour in 
Croatia 
Croatia Patient 
behaviour 
Lifestyle 
choices 
K-means & 
hierarchical 
clustering 
Design of 
intervention 
programmes 
Borglin et 
al. 
2006 Older people in Sweden 
with various degrees of 
present quality of life: 
their health, social 
support, everyday 
activities and sense of 
coherence 
Sweden Patient 
type 
Quality of life TwoStep Design of 
intervention 
programmes 
Boslaugh et 
al. 
2005 Comparing 
demographic, health 
status and psychosocial 
strategies of audience 
segmentation to promote 
physical activity.  
USA Patient 
behaviour 
Lifestyle 
choices 
Decision tree 
(CHAID) 
N/A 
Bowen et 
al. 
2012 An investigation of 
bioecological influences 
associated with first use 
of methamphetamine in 
a rural state 
USA Patient 
behaviour 
Substance 
use 
Hierarchical 
clustering 
Design of 
intervention 
programmes 
Chan and 
Zhu 
2008 Investigating the health 
profile of Macau Chinese 
China Patient 
type 
Types of 
older people 
TwoStep Development of 
individual care 
plans 
Cheng et al. 2005 Enhancing care services 
quality of nursing homes 
using data mining 
Taiwan Patient 
needs 
Service use K-means Development of 
individual care 
plans 
Choi et al. 2006 Configuration of services 
used by depressed older 
adults 
USA Patient 
needs 
Service use K-means N/A 
Cocchi et 
al. 
2014 Patients With First-
Episode Psychosis are 
Not a 
Homogeneous Populatio
n: Implications for 
Treatment 
Italy Patient 
outcomes 
Treatment 
outcomes 
TwoStep Development of 
individual care 
plans 
Coste et al. 2000 A population-based 
analytical approach to 
assessing patterns, 
determinants, and 
outcomes of health care 
with application to 
ectopic pregnancy 
France Patient 
outcomes 
Treatment 
outcomes 
K-means Designing clinical 
guidelines, 
practices and 
standards 
Cryer et al. 2001 Clusters within a general 
adult population of 
alcohol abstainers 
UK Patient 
needs 
Service use K-means N/A 
Dolan 2005 Patient Priorities in 
Colorectal Cancer 
Screening Decisions 
USA Patient 
behaviour 
Screening 
decisions 
K-medoids Design of 
screening 
programmes 
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Dong et al. 2013 Multimorbidity patterns 
of and use 
of health services by 
Swedish 85-year-olds: 
an exploratory study 
Sweden Patient 
needs 
Service use Hierarchical 
clustering 
(Yule's Q) 
Planning and 
resource allocation 
Durant et al. 2014 Increasing preventive 
health services via 
tailored health 
communications 
USA Patient 
behaviour 
Screening 
decisions 
Decision tree 
(CHAID) 
Improvement of 
communication 
Eastwood 
et al. 
2002 Patients with Hip 
Fracture: Subgroups and 
Their Outcomes 
USA Patient 
outcomes 
Treatment 
outcomes 
K-means Development of 
individual care 
plans 
Eissens van 
der Laan et 
al. 
2014 A person-centred 
segmentation study in 
elderly care: Towards 
efficient demand-
driven care 
Netherlands Patient 
needs 
Service use Latent class 
analysis 
Development of 
individual care 
plans; Planning 
and resource 
allocation 
Fattori et al. 2014 Cluster analysis to 
identify elderly people's 
profiles: a healthcare 
strategy based on frailty 
characteristics 
Brazil Patient 
type 
Types of 
older people 
K-means Design of 
intervention 
programmes 
Fleury et al. 2011 Typology of adults 
diagnosed with mental 
disorders based on 
socio-demographics and 
clinical and service use 
characteristics 
Canada Patient 
needs 
Service use Unclear (cluster 
analysis in 
SPSS) 
Design of care 
delivery models 
Fraenkel et 
al. 
2014 Understanding 
Preferences for Disease-
Modifying Drugs in 
Osteoarthritis 
USA Patient 
behaviour 
Treatment 
decisions 
Latent class 
analysis 
Development of 
new 
technologies/drugs 
Francescutt
i et al. 
2011 Description of the 
person-environment 
interaction: 
methodological issues 
and empirical results of 
an Italian large-scale 
disability assessment 
study using an ICF-
based protocol 
Italy Patient 
needs 
Care needs K-means Designing clinical 
guidelines, 
practices and 
standards 
Garcia-
Olmos et al. 
2012 Comorbidity Patterns in 
Patients with Chronic 
Diseases in General 
Practice 
Spain Patient 
type 
Morbidity 
patterns 
Multiple 
correspondence 
analysis 
Design of care 
delivery models; 
Designing clinical 
guidelines, 
practices and 
standards 
Gilligan et 
al. 
2009 Identifying pregnant 
women at risk of poor 
birth outcomes 
Australia Patient 
outcomes 
Risk TwoStep Development of 
individual care 
plans 
Gopichandr
an and 
Chetlapalli 
2014 Factors influencing trust 
in doctors: a community 
segmentation strategy 
for quality improvement 
in healthcare 
India Patient 
behaviour 
Service 
preferences 
K-means Improvement of 
patient experience 
Gordon et 
al. 
2014 Developing a Typology 
of African Americans 
With Limited Literacy 
Based on Preventive 
Health Practice 
Orientation: Implications 
for Colorectal Cancer 
Screening Strategies 
USA Patient 
behaviour 
Screening 
decisions 
K-means Improvement of 
communication 
Green et al. 2015 Who are the obese? A 
cluster analysis 
exploring subgroups of 
the obese 
UK Patient 
type 
Functional/ 
behavioural/ 
psychological 
types 
TwoStep Design of 
intervention 
programmes 
Guinot et al. 2001 Use of Multiple 
Correspondence 
Analysis and Cluster 
Analysis to Study 
Dietary Behaviour: Food 
Consumption 
Questionnaire in the 
SU.VI.MAX. Cohort  
France Patient 
behaviour 
Diet PCA N/A 
Hamilton et 
al. 
2011 Coping Profiles 
Common to Older 
African American 
Cancer Survivors: 
Relationships With 
Quality of Life 
USA Patient 
behaviour 
Coping K-means Design of 
intervention 
programmes 
Hao et al. 2014 Risk prediction of 
emergency department 
revisit 30 days post 
discharge: a prospective 
study 
USA Patient 
outcomes 
Risk K-means Development of 
individual care 
plans 
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Hung et al. 2013 Web usage mining for 
analysing elder self-
care behavior patterns 
Taiwan Patient 
behaviour 
e-Health use K-means; ART2 
neural network 
N/A 
Ishikawa et 
al. 
2013 Classification tree 
analysis to enhance 
targeting for follow-up 
exam of colorectal 
cancer screening 
Japan Patient 
behaviour 
Screening 
decisions 
Decision tree 
(CHAID) 
Design of 
screening 
programmes 
Islam et al. 2014 Multimorbidity and 
Comorbidity of Chronic 
Diseases among the 
Senior Australians: 
Prevalence and Patterns 
Australia Patient 
type 
Morbidity 
patterns 
K-medoids; 
Latent class 
analysis 
Designing clinical 
guidelines, 
practices and 
standards 
Jo et al. 2010 Market segmentation of 
health information use 
on the Internet in Korea 
South Korea Patient 
behaviour 
e-Health use Decision tree 
(CHAID) 
Improvement of 
communication 
John et al. 2003 Patterns and Impact of 
Comorbidity and 
Multimorbidity Among 
Community-Resident 
American Indian Elders 
USA Patient 
type 
Morbidity 
patterns 
Hierarchical 
clustering 
(Yule's Q) 
Planning and 
resource 
allocation; Design 
of intervention 
programmes 
Kannan and 
Veazie 
2014 Who Avoids Going to the 
Doctor and Why? 
Audience Segmentation 
Analysis for Application 
of Message 
Development 
USA Patient 
behaviour 
Service 
preferences 
Decision tree 
(CHAID) 
Improvement of 
communication 
Kazbare et 
al. 
2010 A-priori and post-hoc 
segmentation in the 
design of healthy eating 
campaigns 
Denmark Patient 
behaviour 
Diet Latent class 
analysis 
Improvement of 
communication 
Kendig et 
al. 
2012 Assessing patterns of 
home and community 
care service use and 
client profiles in 
Australia: a cluster 
analysis approach using 
linked data 
Australia Patient 
needs 
Service use K-means Design of care 
delivery models 
Kidachi et 
al. 
2007 Personality types and 
coping style in 
hemodialysis patients 
Japan Patient 
behaviour 
Coping Unclear (cluster 
analysis in 
SPSS) 
Development of 
individual care 
plans 
Kuzmanovi
c et al. 
2012 Using Conjoint Analysis 
to Elicit Patients' 
Preferences for Public 
Primary Care Service in 
Serbia 
Serbia Patient 
behaviour 
Service 
preferences 
K-means Improvement of 
patient experience 
Lafortune et 
al. 
2009 Health State Profiles and 
Service Utilization in 
Community-Living 
Elderly 
Canada Patient 
needs 
Service use Latent class 
analysis 
N/A 
Lafortune et 
al. 
2009 Health status transitions 
in community-living 
elderly with complex 
care needs: a latent 
class approach 
Canada Patient 
type 
Types of 
older people 
Latent class 
analysis 
Planning and 
resource 
allocation; 
Designing clinical 
guidelines, 
practices and 
standards 
Landsberg 
et al. 
2010 Clustering of lifestyle 
factors and association 
with overweight in 
adolescents of the Kiel 
Obesity Prevention 
Study  
Germany Patient 
behaviour 
Lifestyle 
choices 
TwoStep Design of 
intervention 
programmes 
Lega and 
Mengoni 
2012 Profiling the different 
needs and expectations 
of patients 
for population-based 
medicine: a case study 
using segmentation 
analysis 
Italy Patient 
behaviour 
Service 
preferences 
K-means & 
hierarchical 
clustering 
Improvement of 
communication 
Leijon et al. 2006 Target groups for 
prevention of 
neck/shoulder and low 
back disorders: an 
exploratory cluster analy
sis of working and living 
conditions 
Sweden Patient 
outcomes 
Risk K-means & 
hierarchical 
clustering 
Design of 
intervention 
programmes 
Leite et al. 2003 Dietary and nutritional 
patterns in an elderly 
rural population in 
Northern and Southern 
Italy: II. Nutritional 
profiles associated with 
food behaviours 
Italy Patient 
behaviour 
Diet K-means Design of 
intervention 
programmes 
Li and 
Rapkin 
2009 Classification and 
regression tree 
USA Patient 
type 
Quality of life Decision tree 
(CART) 
Development of 
individual care 
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uncovered hierarchy of 
psychosocial 
determinants underlying 
quality-of-life response 
shift in HIV/AIDS 
plans 
Liew and 
Gardner 
2014 Determinants of patient 
satisfaction with 
outpatient care in 
Indonesia: A conjoint 
analysis approach 
Indonesia Patient 
behaviour 
Service 
preferences 
TwoStep Improvement of 
patient experience 
Liu and Liu 2011 Mining the optimal 
clustering of people's 
characteristics 
of health care choices 
Taiwan Patient 
behaviour 
Service 
preferences 
K-means & 
hierarchical 
clustering 
N/A 
Liu and 
Chen 
2009 Using data mining to 
segment healthcare 
markets from patients' 
preference perspectives 
USA Patient 
behaviour 
Service 
preferences 
K-means & 
hierarchical 
clustering 
Improvement of 
patient experience 
Lora et al. 2001 A Cluster Analysis of 
Patients with 
Schizophrenia in 
Community Care 
Italy Patient 
needs 
Service use Hierarchical 
clustering 
(Ward's) 
Planning and 
resource 
allocation; 
Development of 
individual care 
plans 
Lucchetti et 
al. 
2009 Relationship between 
socio-economic features 
and health status in 
elderly hospitalized 
patients 
Italy Patient 
type 
Types of 
older people 
K-means Development of 
individual care 
plans 
Lucini et al. 2011 Health Promotion in the 
Workplace: Assessing 
Stress and Lifestyle With 
an Intranet Tool 
Italy Patient 
outcomes 
Risk K-means Design of 
intervention 
programmes 
Marengoni 
et al. 
2009 Patterns of Chronic 
Multimorbidity in the 
Elderly Population 
Sweden Patient 
type 
Morbidity 
patterns 
Hierarchical 
clustering 
(Yule's Q) 
Design of 
intervention 
programmes 
Mathijssen 
et al. 
2012 Adolescents and 
alcohol: an explorative 
audience segmentation 
analysis 
Netherlands Patient 
behaviour 
Substance 
use 
Latent class 
analysis 
Design of 
intervention 
programmes 
Matzer et al. 2012 Biopsychosocial Health 
Care Needs at the 
Emergency Room: 
Challenge of Complexity 
(Biopsychosocial 
Complexity at the 
Emergency Room) 
Austria Patient 
type 
Functional/ 
behavioural/ 
psychological 
types 
Hierarchical 
clustering 
(Ward's) 
Development of 
individual care 
plans 
McNamee 2004 A comparison of the 
grade of membership 
measure with alternative 
health indicators in 
explaining costs for older 
people. 
UK Patient 
cost 
Cost Grade-of-
membership 
Planning and 
resource allocation 
Michel et al. 2000 Prognosis of Functional 
Recovery 1 Year After 
Hip Fracture: Typical 
Patient Profiles Through 
Cluster Analysis 
Switzerland Patient 
outcomes 
Treatment 
outcomes 
Hierarchical 
clustering 
Development of 
individual care 
plans 
Nagel et al. 2001 Quality of life in breast 
cancer patients: a 
cluster analytic approach 
Germany Patient 
type 
Quality of life K-means & 
hierarchical 
clustering 
Development of 
individual care 
plans 
Ng et al. 2012 Identifying comorbidity 
patterns of health 
conditions via cluster 
analysis of pairwise 
concordance statistics 
Australia Patient 
type 
Morbidity 
patterns 
Proprietary 
methods 
N/A 
Nigenda-
Lopez et al. 
2013 Identification of users 
according to degree of 
satisfaction with 
geriatric care services 
using cluster analysis 
Mexico Patient 
behaviour 
Service 
preferences 
K-means Improvement of 
patient experience 
Ogden et al. 2012 Cluster Analysis of the 
National Weight Control 
Registry to Identify 
Distinct Subgroups 
Maintaining Successful 
Weight Loss  
USA Patient 
behaviour 
Lifestyle 
choices 
Latent class 
analysis 
Design of 
intervention 
programmes 
Penrod et 
al. 
2007 Heterogeneity in hip 
fracture patients: Age, 
functional status, and 
comorbidity 
USA Patient 
outcomes 
Treatment 
outcomes 
Hierarchical 
clustering 
Development of 
individual care 
plans 
Poblador-
Plou et al. 
2014 Comorbidity of 
dementia: a cross-
sectional study of 
primary care older 
patients 
Spain Patient 
type 
Morbidity 
patterns 
Factor analysis Development of 
individual care 
plans 
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Prados-
Torres et al. 
2012 Multimorbidity Patterns 
in Primary Care: 
Interactions among 
Chronic Diseases Using 
Factor Analysis 
Spain Patient 
type 
Morbidity 
patterns 
Factor analysis Design of care 
delivery models 
Riley et al. 2006 Dental attitudes: 
proximal basis for oral 
health disparities in 
adults 
USA Patient 
behaviour 
Preventive 
behaviour 
Hierarchical 
clustering 
(Ward's) 
Improvement of 
communication 
Rimondini 
et al. 
2001 Self-preventive oral 
behavior in an Italian 
university student 
population 
Italy Patient 
behaviour 
Preventive 
behaviour 
Hierarchical 
clustering 
Design of 
intervention 
programmes 
Rose et al. 2007 A latent class typology of 
young women smokers 
USA Patient 
behaviour 
Substance 
use 
Latent class 
analysis 
Improvement of 
communication; 
Design of 
intervention 
programmes 
Rudman et 
al. 
2007 Women's satisfaction 
with intrapartum care – a 
pattern approach 
Sweden Patient 
behaviour 
Service 
preferences 
Hierarchical 
clustering 
(Ward's) 
Improvement of 
patient experience 
Rudman et 
al. 
2008 Evaluating multi-
dimensional aspects of 
postnatal hospital care 
Sweden Patient 
behaviour 
Service 
preferences 
Hierarchical 
clustering 
(Ward's) 
Improvement of 
patient experience 
Schafer et 
al. 
2010 Multimorbidity Patterns 
in the Elderly: A New 
Approach of Disease 
Clustering Identifies 
Complex Interrelations 
between Chronic 
Conditions 
Germany Patient 
type 
Morbidity 
patterns 
Factor analysis N/A 
Schommer 
and Gaither 
2014 A segmentation analysis 
for pharmacists' and 
patients' views of 
pharmacists' roles 
USA Patient 
behaviour 
Service 
preferences 
TwoStep Design of care 
delivery models; 
Improvement of 
patient experience 
Smith et al. 2011 Investigating 
preferences for 
mosquito-control 
technologies in 
Mozambique with latent 
class analysis 
Mozambique Patient 
behaviour 
Preventive 
behaviour 
Latent class 
analysis 
Development of 
new 
technologies/drugs 
Stanek et 
al. 
2000 Preferences for 
treatment outcomes 
in patients with heart 
failure: Symptoms 
versus survival 
USA Patient 
behaviour 
Treatment 
decisions 
Unclear 
(Cluster 
analysis) 
Development of 
new 
technologies/drugs 
Sturmberg 
et al. 
2009 Identifying patterns in 
primary care consultatio
ns: a cluster analysis 
Australia Patient 
needs 
Service use Neural network 
clustering 
Design of care 
delivery models 
Tibi-Levy et 
al. 
2006 Determinants of 
resource utilization in 
four palliative care units 
France Patient 
cost 
Cost Decision tree Planning and 
resource allocation 
Trask and 
Griffith 
2004 The identification of 
empirically derived 
cancer patient 
subgroups using 
psychosocial variables 
USA Patient 
type 
Quality of life K-means Development of 
individual care 
plans 
Vu et al. 2011 Patterns of comorbidity 
in community-dwelling 
older people hospitalised 
for fall-related injury: A 
cluster analysis 
Australia Patient 
type 
Morbidity 
patterns 
Hierarchical 
clustering 
(Yule's Q) 
Development of 
individual care 
plans 
Wadolowsk
a et al. 
2008 Food choice models and 
their relation with food 
preferences and eating 
frequency in the Polish 
population: POFPRES 
study 
Poland Patient 
behaviour 
Diet K-means Design of 
intervention 
programmes 
Walrath et 
al. 
2004 Gender differences in 
patterns of risk factors 
among children 
receiving mental health 
services: Latent class 
analyses 
USA Patient 
type 
Functional/ 
behavioural/ 
psychological 
types 
Latent class 
analysis 
Development of 
individual care 
plans 
Waschbusc
h et al. 
2011 A Discrete Choice 
Conjoint Experiment to 
Evaluate Parent 
Preferences for 
Treatment of Young, 
Medication Naïve 
Children with ADHD 
USA Patient 
behaviour 
Treatment 
decisions 
Latent class 
analysis 
Development of 
individual care 
plans 
Watts et al. 2015 Clustering of lifestyle risk 
behaviours among 
residents of forty 
deprived 
neighbourhoods in 
UK Patient 
behaviour 
Lifestyle 
choices 
Latent class 
analysis 
Design of 
intervention 
programmes 
   
 186 
London: lessons for 
targeting public health 
interventions 
Wieland et 
al. 
2000 Participants in the 
Program of All-Inclusive 
Care for the Elderly 
(PACE) Demonstration: 
Developing Disease–
Impairment–Disability 
Profiles 
USA Patient 
type 
Types of 
older people 
Grade-of-
membership 
Design of care 
delivery models 
Wittink et 
al. 
2013 Towards Personalizing 
Treatment for 
Depression 
USA Patient 
behaviour 
Treatment 
decisions 
Latent profile 
analysis 
Design of care 
delivery models 
Zapert et al. 2002 Patterns of Substance 
Use in Early Through 
Late Adolescence 
USA Patient 
behaviour 
Substance 
use 
Sleipner 
program 
Design of 
intervention 
programmes 
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APPENDIX II: VARIABLES CONSIDERED FOR AND INCLUDED IN 
THE RISK PREDICTION MODEL 
 
Table 37: Variables included in existing risk models; and variables selected in this study 
Variables 
considered in 
hospital 
admission risk 
studies 
Number of 
studies out of 
30 including 
variable in final 
model
226
 
Variable in 
PARR
186
 
Variable in 
PARR-30
225
 
Variable in 
Combined 
Predictive 
Model
180
 
(selected 
variables)  
Included in initial 
model / 
included in final 
model after 
backwards 
elimination 
Diagnoses Medical diagnoses 
or comorbidity 
indices: 24 
Cerebrovascular 
disease 
  Any diagnosis of 
cerebrovascular 
disease in 2008-
2011 (in primary or 
secondary care) 
Chronic obstructive 
pulmonary disease 
Chronic pulmonary 
disease 
COPD Any diagnosis of 
COPD in 2008-
2011 (in primary 
or secondary 
care) 
  Asthma (only 
considered in LTC 
counts) 
Any diagnosis of 
Asthma in 2008-
2011 (in primary or 
secondary care) 
Connective tissue 
disease/rheumatoid 
arthritis 
  Any diagnosis of 
Rheumatic 
disease in 2008-
2011 (in primary 
or secondary 
care) 
Developmental 
disability 
  Any diagnosis of 
Learning disability 
in 2008-2011 (in 
primary or 
secondary care) 
Diabetes Diabetes with 
chronic 
complications 
Diabetes (only 
considered in LTC 
counts) 
Any diagnosis of 
Diabetes in 2008-
2011 (in primary or 
secondary care) 
Ischaemic heart 
disease 
 CAD (only 
considered in LTC 
counts) 
Any diagnosis of 
Ischaemic heart 
disease in 2008-
2011 (in primary 
or secondary 
care) 
Peripheral vascular 
disease 
Peripheral vascular 
disease 
 Any diagnosis of 
Peripheral vascular 
disease in 2008-
2011 (in primary or 
secondary care) 
Renal failure Renal disease  Any diagnosis of 
Renal disease in 
2008-2011 (in 
primary or 
secondary care) 
Sickle cell disease    
 Metastatic cancer 
with solid tumour 
Cancer (only 
considered in LTC 
counts) 
Any diagnosis of 
Cancer in 2008-
2011 (in primary 
or secondary 
care) 
 Other malignant 
cancer 
 
 Congestive heart 
failure 
CHF (only 
considered in LTC 
counts) 
Any diagnosis of 
Congestive heart 
failure in 2008-
2011 (in primary or 
secondary care) 
 Moderate/severe 
liver disease 
 Any diagnosis of 
Liver disease in 
2008-2011 (in 
primary or 
secondary care) 
 Other liver disease  
 Haemiplegia or 
paraplegia 
 Any diagnosis of 
Paraplegia in 2008-
2011 (in primary or 
secondary care) 
   Dementia  Any diagnosis of 
Dementia in 2008-
2011 (in primary or 
secondary care) 
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  Hypertension (only 
considered in LTC 
counts) 
 
Diagnostic cost 
groups/hierarchical 
condition category 
  
 
  1 LTC Flag if the sum of 
conditions listed 
is 0, 1 or 2 or 
more 
  2+ LTCS 
Mental health 
morbidities 
Alcohol or 
substance use: 11 
Alcohol related 
diagnosis 
 Psychoactive 
substance abuse 
 
Mental illness: 9   Psychotic disorder  
    Inpatient admission 
with diagnosis of 
mental illness 
Any diagnosis of 
Mental health 
disorder in 2008-
2011 (in primary 
or secondary 
care) 
  Depression (only 
as included in LTC 
counts) 
Prior use of medical 
services 
Hospitalisations: 
14 
Previous admission 
for respiratory 
infection 
  
 
Previous admission 
for a reference 
condition 
  
 
Number of emergency 
admissions in 
previous 90, 180 and 
365 days 
Whether there had 
been a prior 
emergency hospital 
discharge in the 
past 30 days 
[Combinations of] 
1, 1+, 2, 2+, 3+ 
emergency 
admissions in last 
30, 30 to 90, 90 to 
180, 180 to 365, 
365 to 730 days 
Number of 
emergency 
admissions in 
2011 
&  
Number of 
emergency 
admissions over 
2008-2011 
Average number of 
episodes per spell for 
emergency 
admissions 
 Average number of 
episodes per spell 
for emergency 
admissions >=3 
 Whether the current 
admission was an 
emergency 
admission 
 
Total number of 
previous emergency 
admissions in 
previous three years 
Number of 
emergency hospital 
discharges in the 
last year 
 
Number of non-
emergency 
admissions in 
previous 365 
  Number of non-
emergency 
admissions over 
2008-2011 
Emergency 
department visits: 
4 
  A&E visits and 
investigations  
Clinic visits or 
missed visits: 3 
Number of different 
treatment specialists 
seen 
  
 
  [Combinations of] 
1, 1-5, 2, 3+, 6-10, 
11+ out-patient 
specialty visits in 
last 30, 30 to 90, 
365 to 730 days 
Number of 
outpatient visits 
over 2008-2011 
Index hospital 
length of stay: 4 
   
 
Other   Polypharmacy: 1-4 
unique drugs in any 
month (last 0 to 90 
days); 5-9; 10+ 
Number of GP 
visits over 2008-
2011 (including 
home visits) 
Sociodemographic 
factors 
Age: 19 Age 65-74 or age 75+ Age squared Age band (0-4, 15-
39, 40-59, 5 year 
age bands, 85+) 
5-year age bands 
& 
Over 75 flag 
 Sex: 15 Sex  Gender Gender 
 Race/ ethnicity: 7 Ethnicity    
Social determinants 
of health 
SES, income and 
employment: 5 
 Index of multiple 
deprivation band for 
the place of 
residence 
 
Townsend score 
(5 groups) 
Insurance status: 6     
 Education: 0     
Marital status and 
people in 
household: 4 
   
 
Social support: 2     
Access to care: 5     
Discharge location: 
2 
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Hospital specific 
metrics 
Not included in 
review 
Observed:expected 
ratio for practice style 
sensitive admissions 
in ward of residence 
  
 
Observed:expected 
ratio for rate of 
readmissions for 
hospitals of current 
admission 
Hospital-specific 
variable 
 
 
Illness severity Severity index: 1     
Laboratory 
findings: 4 
   
 
Other: 4     
Overall health and 
function 
Functional status, 
ADL: 2 
   
 
Self-rated health, 
QOL: 3 
   
 
Cognitive 
impairment: 7 
   
 
Visual/hearing 
impairment: 1 
   
 
 
 
 
